<SEC-DOCUMENT>0001437749-22-007683.txt : 20220330
<SEC-HEADER>0001437749-22-007683.hdr.sgml : 20220330
<ACCEPTANCE-DATETIME>20220330161757
ACCESSION NUMBER:		0001437749-22-007683
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		11
CONFORMED PERIOD OF REPORT:	20220511
FILED AS OF DATE:		20220330
DATE AS OF CHANGE:		20220330

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NovaBay Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001389545
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				680454536
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33678
		FILM NUMBER:		22786692

	BUSINESS ADDRESS:	
		STREET 1:		2000 POWELL STREET, SUITE 1150
		CITY:			EMERYVILLE
		STATE:			CA
		ZIP:			94608
		BUSINESS PHONE:		(510) 899-8800

	MAIL ADDRESS:	
		STREET 1:		2000 POWELL STREET, SUITE 1150
		CITY:			EMERYVILLE
		STATE:			CA
		ZIP:			94608
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>nby20220324_def14a.htm
<DESCRIPTION>FORM DEF 14A
<TEXT>
<html><head>
	<title>nby20220324_def14a.htm</title>

	<!-- Generated by ThunderDome Portal - 3/30/2022 5:12:51 PM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; padding: 0in 0.1in; cursor: auto;">
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>SCHEDULE 14A INFORMATION</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Proxy Statement Pursuant to Section 14(a) of</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>the Securities Exchange Act of 1934 </b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(Amendment No.&nbsp; &nbsp; &nbsp; )</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Filed by the Registrant &#9746;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Filed by a Party other than the Registrant&nbsp;&#9744;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Check the appropriate box:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<p style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;">&#9744;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;">Preliminary Proxy Statement</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<p style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;">&#9744;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;">Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2))</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<p style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;">&#9746;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;">Definitive Proxy Statement</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<p style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;">&#9744;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;">Definitive Additional Materials</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<p style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;">&#9744;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;">Soliciting Material Pursuant to &#167;&nbsp;240.14a-12</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>NOVABAY PHARMACEUTICALS, INC. </b></p>

<hr style="height: 1px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 3pt 0">
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Name of Registrant as Specified in Its Charter)</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<hr style="height: 1px; color: #000000; background-color: #000000; width: 100%; border: none; margin: 3pt 0">
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Payment of Filing Fee (Check the appropriate box):</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px; font-family: Times New Roman; font-size: 10pt;">

		<tr style="vertical-align: top; font-family: Times New Roman; font-size: 10pt;">
			<td style="width: 36pt; font-family: Times New Roman; font-size: 10pt;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#9746;</p>
			</td>
			<td style="width: auto; font-family: Times New Roman; font-size: 10pt;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">No fee required.</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px; font-family: Times New Roman; font-size: 10pt;">

		<tr style="vertical-align: top; font-family: Times New Roman; font-size: 10pt;">
			<td style="width: 36pt; font-family: Times New Roman; font-size: 10pt;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&#9744;</p>
			</td>
			<td style="width: auto; font-family: Times New Roman; font-size: 10pt;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Fee paid previously with preliminary materials.</p>
			</td>
		</tr>
		<tr>
			<td style="width: 36pt; font-family: Times New Roman; font-size: 10pt;">&#9744;</td>
			<td style="width: auto; font-family: Times New Roman; font-size: 10pt;">Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="text-align:center;font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><img alt="logo01.jpg" src="logo01.jpg"></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>NOVABAY PHARMACEUTICALS, INC.</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>2000 Powell Street, Suite 1150</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Emeryville, California 94608</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:12pt;font-variant:small-caps;text-align:center;margin:0pt;"><font style="text-transform:uppercase;"><b>Notice of 2022 Annual Meeting of Stockholders</b></font></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr style="background-color: rgb(230, 230, 230);">
			<td style="vertical-align: bottom; width: 26.7%; border-top: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><u>Date</u></b><b>:</b></p>
			</td>
			<td style="vertical-align: bottom; width: 23.8%; border-top: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><u>Time</u></b><b>:</b></p>
			</td>
			<td style="vertical-align: bottom; width: 52.2%; border-top: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b><u>Place</u></b><b>:</b></p>
			</td>
		</tr>
		<tr style="background-color: rgb(230, 230, 230);">
			<td style="vertical-align: top; width: 26.7%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>May 11, 2022</b></p>
			</td>
			<td style="vertical-align: top; width: 23.8%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>11:00 a.m. PDT</b></p>
			</td>
			<td style="vertical-align: top; width: 52.2%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Virtual meeting at: </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">www.virtualshareholdermeeting.com/NBY2022</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">To the Stockholders of NovaBay Pharmaceuticals, Inc.:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">You are cordially invited to attend the 2022 Annual Meeting of Stockholders (the &#8220;<b><i>Annual Meeting</i></b>&#8221;) of NovaBay Pharmaceuticals, Inc., a Delaware corporation (&#8220;<b><i>NovaBay</i></b><i>,</i>&#8221;&nbsp;&#8220;<b><i>we</i></b><i>,</i>&#8221;&nbsp;&#8220;<b><i>our</i></b>&#8221; and &#8220;<b><i>us</i></b>&#8221;). Stockholders will be able to participate in the meeting, vote, and submit questions during the virtual meeting by visiting www.virtualshareholdermeeting.com/NBY2022.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Annual Meeting will be held for the purposes of the following:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:18pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">(1)</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">To elect two (2) Class III directors nominated by our Board of Directors to hold office for a term of three (3) years or until their respective successors are elected and qualified. The nominees for election are Paul E. Freiman and Swan Sit (&#8220;<b><i>Proposal One</i></b>&#8221;).</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width: 18pt; text-align: justify;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">(2)</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">To approve, on an advisory basis, the compensation of NovaBay&#8217;s named executive officers, as disclosed in this proxy statement (&#8220;<b><i>Proposal Two</i></b>&#8221;).</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width: 18pt; text-align: justify;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">(3)</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">To ratify the appointment by our Audit Committee of WithumSmith+Brown, PC as our independent registered public accounting firm for the fiscal year ending December 31, 2022 (&#8220;<b><i>Proposal Three</i></b>&#8221;&nbsp;and together with Proposal One and Proposal Two, the &#8220;<b><i>Proposals</i></b>&#8221;).</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width: 18pt; text-align: justify;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">(4)</p>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">To transact any other business that may properly come before the Annual Meeting or any adjournment or postponement thereof.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Each of the Proposals are described in the accompanying proxy statement (&#8220;<b><i>Proxy Statement</i></b>&#8221;), which we encourage you to read in its entirety before voting. After careful consideration, the NovaBay Board of Directors has determined that the Proposals are advisable and in the best interests of NovaBay and its stockholders and recommends that the holders of common stock entitled to vote with respect to each of the Proposals, vote or give instruction to vote &#8220;FOR&#8221; each of the nominees for Proposal One, &#8220;FOR&#8221; Proposal Two and &#8220;FOR&#8221; Proposal Three.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Stockholders may attend the Annual Meeting online, vote their shares electronically, and submit questions during the Meeting by visiting www.virtualshareholdermeeting.com/NBY2022<b> </b>and entering the 16-digit control number included in their proxy card, the Notice of Internet Availability, or the voting information form provided by their bank or broker. Prior to the Annual Meeting, stockholders can vote at www.proxyvote.com using their 16-digit control number or by the other methods described in the Proxy Statement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The record date for the Annual Meeting is March 16, 2022. Only stockholders of record at the close of business on that date are entitled to notice of, and may vote at, the virtual Annual Meeting or any adjournment or postponement thereof. A Notice of Internet Availability of Proxy Materials or this Notice of Annual Meeting and the Proxy Statement are being distributed and made available on or about March 30, 2022.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">A list of stockholders entitled to vote at the Annual Meeting will be available at NovaBay Pharmaceuticals, Inc., 2000 Powell Street, Suite 1150, Emeryville, California 94608, for a period of ten (10) days prior to the Annual Meeting. If you would like to inspect the stockholder list, please contact our Corporate Secretary at (510) 899-8800. The stockholder list will also be available during the virtual Annual Meeting through the following secure link www.virtualshareholdermeeting.com/NBY2022.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; width: 100%;">

		<tr>
			<td style="width: 50%;">March 30, 2022</td>
			<td style="width: 50%;">By Order of the Board of Directors,</td>
		</tr>
		<tr>
			<td style="width: 50%;">&nbsp;</td>
			<td style="width: 50%;">&nbsp;</td>
		</tr>
		<tr>
			<td>&nbsp;</td>
			<td>
			<div><img alt="sig01.jpg" src="sig01.jpg"></div>
			</td>
		</tr>
		<tr>
			<td>&nbsp;</td>
			<td>Paul E. Freiman</td>
		</tr>
		<tr>
			<td>&nbsp;</td>
			<td><i>Chairman of the Board</i></td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 100%;">

		<tr>
			<td style="vertical-align: middle; width: 101.2%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:12pt;font-variant:small-caps;text-align:center;margin:0pt;"><font style="text-transform:uppercase;"><font style="color:#294c6c;"><b>Proxy Statement Summary</b></font></font></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">To assist you in reviewing the proposals to be acted upon at the Annual Meeting, we call your attention to the following information about NovaBay Pharmaceuticals, Inc.&#8217;s (&#8220;<b><i>NovaBay</i></b><i>,</i>&#8221;&nbsp;the &#8220;<b><i>Company</i></b>,&#8221; &#8220;<b><i>we</i></b>,&#8221; &#8220;<b><i>our</i></b>&#8221; or<b><i> </i></b>&#8220;<b><i>us</i></b>&#8221;) financial performance, key executive compensation actions and decisions, and corporate governance highlights. The following description is only a summary. For more complete information about these topics, please review the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2021, and the complete Proxy Statement that follows.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 100%;">

		<tr>
			<td style="vertical-align: top; width: 101.2%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="color:#294c6c;"><b>Proposals Which Require Your Vote</b></font></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 100%;">

		<tr>
			<td style="vertical-align: bottom; width: 16%; border-bottom: 2px solid rgb(41, 76, 108);">&nbsp;</td>
			<td style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(41, 76, 108);">&nbsp;</td>
			<td style="vertical-align: bottom; width: 25%; border-bottom: 2px solid rgb(41, 76, 108);">&nbsp;</td>
			<td style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(41, 76, 108);">&nbsp;</td>
			<td style="vertical-align: bottom; width: 15%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>More </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Information</b></p>
			</td>
			<td style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(41, 76, 108);">&nbsp;</td>
			<td style="vertical-align: bottom; width: 15%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Board </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Recommendation</b></p>
			</td>
			<td style="vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(41, 76, 108);">&nbsp;</td>
			<td style="vertical-align: bottom; width: 25%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Vote Required for </b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Approval</b></p>
			</td>
		</tr>
		<tr style="background-color: rgb(230, 230, 230);">
			<td style="vertical-align: top; width: 16%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:small-caps;margin:0pt;"><font style="text-transform:uppercase;"><b>Proposal One</b></font></p>
			</td>
			<td style="vertical-align: top; width: 1%; border-bottom: 2px solid rgb(41, 76, 108);">&nbsp;</td>
			<td style="vertical-align: top; width: 25%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Election of the two (2) following director nominees:</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 32pt;text-indent:-5pt;">&#9658;&nbsp; Paul E. Freiman</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 32pt;text-indent:-5pt;">&#9658;&nbsp; Swan Sit</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 32pt;text-indent:-5pt;">&nbsp;</p>
			</td>
			<td style="vertical-align: top; width: 1%; border-bottom: 2px solid rgb(41, 76, 108);">&nbsp;</td>
			<td style="vertical-align: top; width: 15%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Page 5</p>
			</td>
			<td style="vertical-align: top; width: 1%; border-bottom: 2px solid rgb(41, 76, 108);">&nbsp;</td>
			<td style="vertical-align: top; width: 15%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">FOR each nominee</p>
			</td>
			<td style="vertical-align: top; width: 1%; border-bottom: 2px solid rgb(41, 76, 108);">&nbsp;</td>
			<td style="vertical-align: top; width: 25%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Plurality of the votes entitled to be cast in the election of directors.</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 16%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:small-caps;margin:0pt;"><font style="text-transform:uppercase;"><b>Proposal Two</b></font></p>
			</td>
			<td style="vertical-align: top; width: 1%; border-bottom: 2px solid rgb(41, 76, 108);">&nbsp;</td>
			<td style="vertical-align: top; width: 25%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">To approve, on an advisory basis, the compensation of NovaBay&#8217;s named executive officers, as disclosed in this Proxy Statement.</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align: top; width: 1%; border-bottom: 2px solid rgb(41, 76, 108);">&nbsp;</td>
			<td style="vertical-align: top; width: 15%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Page 17</p>
			</td>
			<td style="vertical-align: top; width: 1%; border-bottom: 2px solid rgb(41, 76, 108);">&nbsp;</td>
			<td style="vertical-align: top; width: 15%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">FOR</p>
			</td>
			<td style="vertical-align: top; width: 1%; border-bottom: 2px solid rgb(41, 76, 108);">&nbsp;</td>
			<td style="vertical-align: top; width: 25%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Majority of shares present or represented by proxy duly authorized and entitled to vote.</p>
			</td>
		</tr>
		<tr style="background-color: rgb(230, 230, 230);">
			<td style="vertical-align: top; width: 16%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:small-caps;margin:0pt;"><font style="text-transform:uppercase;"><b>Proposal Three</b></font></p>
			</td>
			<td style="vertical-align: top; width: 1%; border-bottom: 2px solid rgb(41, 76, 108);">&nbsp;</td>
			<td style="vertical-align: top; width: 25%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Ratification, on an advisory basis, of the selection of WithumSmith+Brown, PC as our independent registered public accounting firm for the fiscal year ending December 31, 2022</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align: top; width: 1%; border-bottom: 2px solid rgb(41, 76, 108);">&nbsp;</td>
			<td style="vertical-align: top; width: 15%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Page 18</p>
			</td>
			<td style="vertical-align: top; width: 1%; border-bottom: 2px solid rgb(41, 76, 108);">&nbsp;</td>
			<td style="vertical-align: top; width: 15%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">FOR</p>
			</td>
			<td style="vertical-align: top; width: 1%; border-bottom: 2px solid rgb(41, 76, 108);">&nbsp;</td>
			<td style="vertical-align: top; width: 25%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Majority of shares present or represented by proxy duly authorized and entitled to vote.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 100%;">

		<tr>
			<td style="vertical-align: top; width: 101.2%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="color:#294c6c;"><b>Introduction to NovaBay</b></font></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 100%;">

		<tr>
			<td style="vertical-align:middle;width:44%;">
			<p style="text-align:center;font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><img alt="logo01.jpg" src="logo01.jpg"></p>
			</td>
			<td style="vertical-align:middle;width:7.8%;">
			<p style="font-family:Times New Roman;font-size:24pt;font-variant:normal;text-align:center;margin:0pt;"><b>+</b></p>
			</td>
			<td style="vertical-align:middle;width:51.8%;">
			<div style="text-align: center;"><img alt="a06.jpg" src="a06.jpg"></div>
			</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:middle;width:103.5%;">
			<p style="font-family:Times New Roman;font-size:18pt;font-variant:normal;text-align:center;margin:0pt;"><font style="color:#294c6c;">Transforming Clinical Skincare Together</font></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">We develop and sell scientifically-created and clinically-proven eyecare and skincare products.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Our leading product, Avenova&#174; Antimicrobial Lid and Lash Solution (&#8220;<i><b>Avenova Spray</b></i>&#8221;), is proven in laboratory testing to have broad antimicrobial properties as it removes foreign material including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is formulated with our proprietary, stable and pure form of hypochlorous acid and is cleared by the U.S. Food and Drug Administration (&#8220;<i><b>FDA</b></i>&#8221;) for sale in the United States. Other eyecare products offered under the Avenova eyecare brand include Novawipes by Avenova, Avenova Lubricant Eye Drops, Avenova Moist Heating Eye Compress, and the i-Chek.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">On November 5, 2021, we significantly expanded our business by acquiring DERMAdoctor, LLC (&#8220;<i><b>DERMAdoctor</b></i>&#8221;) as our wholly-owned subsidiary (the &#8220;<i><b>DERMAdoctor Acquisition</b></i>&#8221;). DERMAdoctor offers over 30 dermatologist-developed products targeting common skin concerns, ranging from aging and blemishes to dry skin, perspiration and keratosis pilaris. DERMAdoctor branded products are marketed and sold through the DERMAdoctor website, well-known traditional and digital beauty retailers, and a network of international distributors.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">- i -</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">We expect to grow commercial sales of both Avenova and DERMAdoctor branded products through an expansion of domestic and international market penetration, with a particular focus on online channels, and the development of new product offerings under both brand names.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 100%;">

		<tr>
			<td style="vertical-align: top; width: 101.2%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="color:#294c6c;"><b>Business Highlights</b></font></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:18pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<div><img alt="a01.jpg" src="a01.jpg"></div>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Completed the DERMAdoctor Acquisition in November 2021.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:18pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;"><img alt="a01.jpg" src="a01.jpg"></td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Company 2021 full year net product revenue of $8.4 million, which includes $0.6 million from the sale of DERMAdoctor products since the completion of the DERMAdoctor Acquisition.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:18pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;"><img alt="a01.jpg" src="a01.jpg"></td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Gross profit of $5.6 million in 2021, with a gross profit margin of 67.0% as compared to 60.0% in 2020.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 100%;">

		<tr>
			<td style="vertical-align: top; width: 101.2%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="color:#294c6c;"><b>Compensation Highlights</b></font></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Compensation Committee (the &#8220;<b><i>Compensation Committee</i></b>&#8221;) of the Board of Directors (the &#8220;<b><i>Board</i></b>&#8221;) continues its historic practice of an annual performance incentive program, pursuant to which each Company executive may earn an annual performance bonus, tied to a percentage of his or her base salary. The Compensation Committee has the sole discretion to pay any portion of, or the entire, annual performance bonus in the form of equity compensation.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">As a result of such annual performance incentive program, our practice of issuing equity awards upon hire and/or as a part of our employment arrangements, our executives&#8217; annual total compensation is variable and based upon their individual performance as well as the Company&#8217;s performance.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; width: 100%;">

		<tr>
			<td style="width: 50%;">
			<div style="text-align: center;"><img alt="a02.jpg" src="a02.jpg"></div>
			</td>
			<td style="width: 50%; text-align: center;">
			<div><img alt="a03.jpg" src="a03.jpg"></div>
			</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">We implemented a stockholder advisory vote on executive compensation (commonly referred to as the &#8220;<b><i>Say-on-Pay</i></b>&#8221; proposal) beginning at our 2013 Annual Meeting and every three years thereafter, which gives stockholders the opportunity to endorse or not endorse the Company&#8217;s named executive compensation program. At the Company&#8217;s 2019 Annual Meeting, our stockholders voted to continue conducting its Say-on-Pay vote every three years, and approximately 99.5% of the votes cast on such proposal were voted in favor of the Say-on-Pay proposal. We will conduct our next vote on the frequency of the Say-on-Pay proposal at our 2025 Annual Meeting of Stockholders.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">- ii -</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 100%;">

		<tr>
			<td style="vertical-align: top; width: 101.2%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="color:#294c6c;"><b>Corporate Governance Highlights</b></font></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">NovaBay has a longstanding commitment to effective governance of its business and affairs for the benefit of stockholders, including through the below highlighted measures.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><font style="color:#294c6c;"><b><i>Board Leadership Structure</i></b></font></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Our Board leadership structure currently consists of an independent Chairman of the Board (the &#8220;<b><i>Chairman</i></b>&#8221;) and independent committees. The Chairman performs all duties and has all powers commonly incident to the office of Chairman of the Board, including presiding at all meetings of the Board. In March 2019, the Board nominated Paul E. Freiman to serve as Chairman due to his service on the Company&#8217;s Board since May 2002 and his prior position as the Board&#8217;s Lead Independent Director. Since this date, Mr. Freiman has and continues to serve as our Chairman.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Beginning in August 2020, Justin M. Hall, the Company&#8217;s Chief Executive Officer, General Counsel and Chief Compliance Officer, was elected to serve on the Board. In his executive officer role, Mr. Hall has responsibility for the management and control of the day-to-day business and affairs of the Company, as well as general supervision of the Company&#8217;s executives, employees and agents. Given Mr. Hall&#8217;s tenure with the Company beginning in 2013 and his vast knowledge of its operations, the Board believes he offers invaluable business insight to its deliberations.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Board believes that separating the roles of Chairman and Chief Executive Officer enhances both the independence of the Board and its effectiveness in discharging its responsibilities and that NovaBay is currently best served with an independent Chairman.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><font style="color:#294c6c;"><b><i>Board Committees</i></b></font></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The three (3) standing committees established by the Board meet on a regular basis and operate under written charters approved by the Board. Each committee performs an annual self-evaluation to determine whether the committee is functioning effectively and fulfilling its duties as prescribed by its charter. All directors serving on the Audit Committee of the Board (the &#8220;<b><i>Audit Committee</i></b>&#8221;), the Compensation Committee and the Nominating and Corporate Governance Committee (the &#8220;<b><i>N&amp;CG Committee</i></b>&#8221;) are independent, and each committee has the ability to hire and terminate its own outside advisors. A copy of each committee&#8217;s charter is available on the Corporate Governance section of our website at <u>www.novabay.com</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><font style="color:#294c6c;"><b><i>Board Composition and Diversity </i></b></font></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Our Board seeks directors with a broad diversity of experience, professions, skills, geographic representation and backgrounds as well as gender and racial/ethnic diversity that will enhance the quality of the Board&#8217;s governance. Our directors&#8217; expertise combines to provide a broad mix of skills, qualifications and proven leadership abilities. This N&amp;CG Committee regularly identifies individuals who have expertise that would complement and enhance the current Board&#8217;s skills and experience. In addition, as part of our stockholder engagement dialogue, we routinely ask our investors for input regarding director recommendations.</p>

<div style="text-align: center;">&nbsp;</div>

<div style="text-align: center;"><img alt="a04.jpg" src="a04.jpg"></div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">- iii -</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><font style="color:#294c6c;"><b><i>Other Governance Practices</i></b></font></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:18pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;">
			<div><img alt="a01.jpg" src="a01.jpg"></div>
			</td>
			<td style="vertical-align:top;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">In January 2022, the Board increased the number of directors from six (6) to eight (8) to expand the range of talents and perspectives on the Board.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width: 18pt; text-align: justify;">&nbsp;</td>
			<td style="vertical-align: top; width: 18pt; text-align: justify;"><img alt="a01.jpg" src="a01.jpg"></td>
			<td style="vertical-align:top;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The Board reflects a range of talents, ages, skills, diversity, and expertise.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width: 18pt; text-align: justify;">&nbsp;</td>
			<td style="vertical-align: top; width: 18pt; text-align: justify;"><img alt="a01.jpg" src="a01.jpg"></td>
			<td style="vertical-align:top;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Each director attended over 75% of applicable Board/Committee meetings in fiscal year 2021.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width: 18pt; text-align: justify;">&nbsp;</td>
			<td style="vertical-align: top; width: 18pt; text-align: justify;"><img alt="a01.jpg" src="a01.jpg"></td>
			<td style="vertical-align:top;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The Board conducts an annual evaluation of the CEO.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width: 18pt; text-align: justify;">&nbsp;</td>
			<td style="vertical-align: top; width: 18pt; text-align: justify;"><img alt="a01.jpg" src="a01.jpg"></td>
			<td style="vertical-align:top;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The directors participate in an annual evaluation of the full Board and each committee on which they serve, in order to assess the performance and effectiveness of the Board and its committees. The responses and comments are presented to, and discussed with, the Board and each committee of the Board.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width: 18pt; text-align: justify;">&nbsp;</td>
			<td style="vertical-align: top; width: 18pt; text-align: justify;"><img alt="a01.jpg" src="a01.jpg"></td>
			<td style="vertical-align:top;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">No stockholder rights plan or &#8220;poison pill&#8221;&nbsp;has been adopted.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 100%;">

		<tr>
			<td style="vertical-align: top; width: 101.2%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="color:#294c6c;"><b>Corporate Governance Policies</b></font></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">NovaBay has established Corporate Governance Guidelines, as routinely reviewed and updated by the N&amp;CG Committee, to maintain effective and appropriate standards of corporate governance. We have also established a Code of Ethics and Business Conduct (the &#8220;<b><i>Code of Ethics</i></b>&#8221;) that establishes standards of conduct and expectations for our employees and the overall manner in which we conduct business. The Code of Ethics, along with our other policies and business standards and our overall risk and compliance programs, are components of mitigating the risks associated with the operation of our business. The full text of our Code of Ethics is available on the Corporate Governance section of our website at <u>www.novabay.com</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">NovaBay also maintains an Insider Trading Policy. Pursuant to the Company&#8217;s Insider Trading Policy, the Company considers it improper and inappropriate for any employee, officer or director of the Company to engage in short-term or speculative transactions in the Company&#8217;s securities. The Insider Trading Policy specifically prohibits directors, officers and other employees from engaging in short sales, margin accounts, pledging or hedging transactions of the Company&#8217;s securities. To the Company&#8217;s knowledge, each of the NEOs (as defined below) and directors complied with the Insider Trading Policy during fiscal year 2021.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 100%;">

		<tr>
			<td style="vertical-align: top; width: 101.2%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="color:#294c6c;"><b>Stockholder Proposals at the 2022 Annual Meeting</b></font></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><font style="color:#294c6c;"><b><i>Election of Directors (Proposal One)</i></b></font></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">You will find important information in the Proxy Statement about the qualifications and experience of each of the director nominees listed below whom you are being asked to elect at the 2022 Annual Meeting. The N&amp;CG Committee performs an annual assessment to evaluate whether each of NovaBay&#8217;s directors has the skills and experience to oversee the Company effectively. All of our directors, including the director nominees listed below, have demonstrated that they have proven leadership ability, sound judgment, integrity and a commitment to the success of our Company.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align: bottom; width: 26.9%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Director Nominees</b></p>
			</td>
			<td style="vertical-align: bottom; width: 9.4%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Director Since</b></p>
			</td>
			<td style="vertical-align: bottom; width: 5.8%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Age</b></p>
			</td>
			<td style="vertical-align: bottom; width: 12.8%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Independent</b></p>
			</td>
			<td style="vertical-align: bottom; width: 29.8%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Principal Occupation</b></p>
			</td>
			<td style="vertical-align: bottom; width: 16.5%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>NovaBay Board Committees</b></p>
			</td>
		</tr>
		<tr style="background-color: rgb(230, 230, 230);">
			<td style="vertical-align:top;width:26.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Paul E. Freiman</p>
			</td>
			<td style="vertical-align:top;width:9.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2002</p>
			</td>
			<td style="vertical-align:top;width:5.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">87</p>
			</td>
			<td style="vertical-align:top;width:12.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Yes</p>
			</td>
			<td style="vertical-align:top;width:29.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Independent Pharmaceutical Professional Consultant</p>
			</td>
			<td style="vertical-align:top;width:16.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Compensation (Chair), Audit and N&amp;CG</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:top;width:26.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Swan Sit</p>
			</td>
			<td style="vertical-align:top;width:9.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2019</p>
			</td>
			<td style="vertical-align:top;width:5.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">44</p>
			</td>
			<td style="vertical-align:top;width:12.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Yes</p>
			</td>
			<td style="vertical-align:top;width:29.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Independent Business Consultant</p>
			</td>
			<td style="vertical-align:top;width:16.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Audit, Compensation and N&amp;CG</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">- iv -</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Our Board recommends unanimously that you vote &#8220;FOR&#8221; the two (2) Class III director nominees listed above.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><font style="color:#294c6c;"><b><i>Approval of Executive Compensation (Proposal Two)</i></b></font></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Our Board is requesting stockholder approval of an advisory, non-binding resolution to approve the Company&#8217;s executive compensation as described in this Proxy Statement. The Board and the Compensation Committee value the opinions of the Company&#8217;s stockholders and, based on the outcome of this vote, will consider stockholders&#8217; concerns regarding executive compensation, if any, and evaluate whether any action is necessary to address those concerns.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><font style="color:#294c6c;"><b><i>Ratification of the Selection of the Independent Registered Public Accounting Firm (Proposal Three)</i></b></font></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Audit Committee has appointed WithumSmith+Brown, PC (&#8220;<b><i>Withum</i></b>&#8221;) as the Company&#8217;s independent registered public accounting firm for 2022. While we are not required to have stockholders ratify the selection of Withum as the Company&#8217;s independent auditor, we are doing so because we believe it is good corporate practice. If our stockholders do not ratify the selection, the Audit Committee will reconsider the appointment, but may nevertheless retain Withum as the Company&#8217;s independent auditor. Even if the selection is ratified, the Audit Committee may, at its discretion, direct the appointment of a different independent registered public accounting firm at any time during the year if it determines that such change is in the best interests of the Company and its stockholders.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 100%;">

		<tr>
			<td style="vertical-align: top; width: 101.2%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="color:#294c6c;"><b>Submission of Stockholder Proposals/Nominations for 2023 Annual Meeting </b></font></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Stockholder proposals submitted for inclusion in our 2023 annual meeting proxy statement pursuant to Rule 14a-8 of the Securities Exchange Act of 1934, as amended, must be received by us by November 30, 2022. Notice of stockholder proposals to nominate a person for election as a director or to introduce an item of business at the 2023 annual meeting of stockholders outside Rule 14a-8 must be received by us no earlier than January 11, 2023 and no later than February 10, 2023.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">- v -</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 100%;">

		<tr>
			<td style="vertical-align: middle; width: 100%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:12pt;font-variant:small-caps;text-align:center;margin:0pt;"><font style="text-transform:uppercase;"><font style="color:#294c6c;"><b>Table of Contents</b></font></font></p>
			</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 8pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:middle;width:91.8%;">&nbsp;</td>
			<td style="vertical-align: middle; width: 12.5%; text-align: right;"><b><u>Page</u></b></td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:91.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">PROXY STATEMENT FOR THE 2022 ANNUAL MEETING OF STOCKHOLDERS</p>
			</td>
			<td style="vertical-align:middle;width:12.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">1</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:94.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 18pt;">Purpose of Meeting</p>
			</td>
			<td style="vertical-align:middle;width:15.2%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">1</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:94.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 18pt;">Notice of Internet Availability</p>
			</td>
			<td style="vertical-align:middle;width:15.2%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">1</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:94.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 18pt;">Attendance at the Annual Meeting</p>
			</td>
			<td style="vertical-align:middle;width:15.2%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">1</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:94.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 18pt;">Voting; Quorum</p>
			</td>
			<td style="vertical-align:middle;width:15.2%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">2</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:94.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 18pt;">Required Votes</p>
			</td>
			<td style="vertical-align:middle;width:15.2%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">2</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:94.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 18pt;">Effect of Not Voting</p>
			</td>
			<td style="vertical-align: middle; width: 15.2%; text-align: right;">3</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:94.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 18pt;">Voting Methods</p>
			</td>
			<td style="vertical-align:middle;width:15.2%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">3</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:94.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 18pt;">Revoking Proxies</p>
			</td>
			<td style="vertical-align: middle; width: 15.2%; text-align: right;">4</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:94.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 18pt;">Solicitation</p>
			</td>
			<td style="vertical-align:middle;width:15.2%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">4</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:94.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 18pt;">Other Matters</p>
			</td>
			<td style="vertical-align:middle;width:15.2%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">4</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:94.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 18pt;">Results of the Voting at the Annual Meeting</p>
			</td>
			<td style="vertical-align:middle;width:15.2%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">4</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:91.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">MATTERS TO BE CONSIDERED AT THE ANNUAL MEETING</p>
			</td>
			<td style="vertical-align:middle;width:12.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">5</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:91.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">PROPOSAL ONE: ELECTION OF DIRECTORS</p>
			</td>
			<td style="vertical-align:middle;width:12.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">5</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:94.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 18pt;">Current Directors and Nominees</p>
			</td>
			<td style="vertical-align:middle;width:15.2%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">6</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:93.1%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 18pt;"><i>Class III Directors </i>&#8211;<i>&nbsp;Terms Expiring at the 2022 Annual Meeting</i></p>
			</td>
			<td style="vertical-align:middle;width:13.8%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;"><i>6</i></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:94.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 18pt;">Recommendation of Our Board</p>
			</td>
			<td style="vertical-align:middle;width:15.2%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">7</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:93.1%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 18pt;"><i>Class I Directors </i>&#8211;<i>&nbsp;Terms Expiring at the 2023 Annual Meeting</i></p>
			</td>
			<td style="vertical-align:middle;width:13.8%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;"><i>7</i></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:93.1%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 18pt;"><i>Class II Directors </i>&#8211;<i>&nbsp;Terms Expiring at the 2024 Annual Meeting</i></p>
			</td>
			<td style="vertical-align:middle;width:13.8%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;"><i>8</i></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:94.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 18pt;">Family Relationships</p>
			</td>
			<td style="vertical-align:middle;width:15.2%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">9</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:91.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Corporate Governance</p>
			</td>
			<td style="vertical-align:middle;width:12.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">10</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:94.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 18pt;">Code of Ethics and Business Conduct</p>
			</td>
			<td style="vertical-align:middle;width:15.2%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">10</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:94.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 18pt;">Director Independence</p>
			</td>
			<td style="vertical-align:middle;width:15.2%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">10</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:94.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Board Committees and Meetings</p>
			</td>
			<td style="vertical-align:middle;width:15.2%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">10</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:94.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 18pt;">Environmental, Social and Governance (ESG)</p>
			</td>
			<td style="vertical-align:middle;width:15.2%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">13</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:94.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 18pt;">Other Board Matters</p>
			</td>
			<td style="vertical-align:middle;width:15.2%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">13</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:94.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 18pt;">Stockholder Communications to the Board</p>
			</td>
			<td style="vertical-align:middle;width:15.2%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">16</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:91.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">PROPOSAL TWO:&nbsp;&nbsp;ADVISORY, NON-BINDING VOTE TO APPROVE EXECUTIVE COMPENSATION</p>
			</td>
			<td style="vertical-align:middle;width:12.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">17</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:94.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 18pt;">Recommendation of Our Board</p>
			</td>
			<td style="vertical-align:middle;width:15.2%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">17</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:91.8%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">PROPOSAL THREE:&nbsp;ADVISORY, NON-BINDING VOTE TO RATIFY THE SELECTION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</p>
			</td>
			<td style="vertical-align:middle;width:12.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">18</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:94.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 18pt;">Fees Paid to Independent Registered Public Accounting Firm</p>
			</td>
			<td style="vertical-align:middle;width:15.2%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">18</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:94.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 18pt;">Policy on Audit Committee Pre-Approval of Audit and Permissible Non-Audit Services</p>
			</td>
			<td style="vertical-align:middle;width:15.2%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">19</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:94.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 18pt;">Recommendation of Our Board</p>
			</td>
			<td style="vertical-align:middle;width:15.2%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">19</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:94.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 18pt;">Audit Committee Report</p>
			</td>
			<td style="vertical-align:middle;width:15.2%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">19</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:91.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">EXECUTIVE COMPENSATION AND OTHER INFORMATION</p>
			</td>
			<td style="vertical-align:middle;width:12.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">20</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:94.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 18pt;">Executive Officers</p>
			</td>
			<td style="vertical-align:middle;width:15.2%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">20</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:94.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 18pt;">Business Highlights</p>
			</td>
			<td style="vertical-align:middle;width:15.2%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">20</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:94.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 18pt;">Summary Compensation Table</p>
			</td>
			<td style="vertical-align:middle;width:15.2%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">21</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:94.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 18pt;">Outstanding Equity Awards at Fiscal Year End</p>
			</td>
			<td style="vertical-align:middle;width:15.2%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">23</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:94.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 18pt;">Employment-Related Agreements and Potential Payments upon Termination or Change in Control</p>
			</td>
			<td style="vertical-align:middle;width:15.2%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">24</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:94.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 18pt;">Director Compensation</p>
			</td>
			<td style="vertical-align:middle;width:15.2%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">26</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:91.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</p>
			</td>
			<td style="vertical-align:middle;width:12.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">28</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:91.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">EQUITY COMPENSATION PLAN INFORMATION</p>
			</td>
			<td style="vertical-align:middle;width:12.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">30</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:91.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS</p>
			</td>
			<td style="vertical-align:middle;width:12.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">31</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:91.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">OTHER PROXY MATTERS</p>
			</td>
			<td style="vertical-align:middle;width:12.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">32</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:94.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 18pt;">Delinquent Section 16(a) Reports</p>
			</td>
			<td style="vertical-align:middle;width:15.2%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">32</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:94.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 18pt;">Annual Report</p>
			</td>
			<td style="vertical-align:middle;width:15.2%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">32</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:94.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 18pt;">Deadline for Receipt of Stockholder Proposals and Nominations</p>
			</td>
			<td style="vertical-align:middle;width:15.2%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">32</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:94.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 18pt;">Householding of Proxy Materials</p>
			</td>
			<td style="vertical-align:middle;width:15.2%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">33</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:middle;width:94.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 18pt;">Other Business</p>
			</td>
			<td style="vertical-align:middle;width:15.2%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">33</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="1" data-prefix="- " data-suffix=" -" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<div contenteditable="false" data-applyto="p" data-auto-pgnum="start" data-displaynum="1" data-fontname="Times New Roman" data-fontsize="10pt" data-numstyle="a" data-prefix="- " data-startnum="1" data-suffix=" -" data-textalign="center">&nbsp;</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: center;"><img alt="logo01.jpg" src="logo01.jpg"></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>2000 Powell Street, Suite 1150</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Emeryville, California 94608</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align: middle; width: 101.6%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:12pt;font-variant:small-caps;text-align:center;margin:0pt;"><font style="text-transform:uppercase;"><font style="color:#294c6c;"><b>Proxy Statement</b></font></font></p>

			<p style="font-family:Times New Roman;font-size:12pt;font-variant:small-caps;text-align:center;margin:0pt;"><font style="text-transform:uppercase;"><font style="color:#294c6c;"><b>For The 2022 Annual Meeting of Stockholders</b></font></font></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">This proxy statement (the &#8220;<b><i>Proxy Statement</i></b>&#8221;), our Notice of 2022 Annual Meeting of Stockholders (the &#8220;<b><i>Notice</i></b>&#8221;) and our proxy card are being furnished in connection with the solicitation of proxies by the Board of Directors (the &#8220;<b><i>Board</i></b>&#8221;) of NovaBay Pharmaceuticals, Inc., a Delaware corporation (&#8220;<b><i>NovaBay</i></b><i>,</i>&#8221; the &#8220;<b><i>Company</i></b><i>,</i>&#8221; &#8220;<b><i>we</i></b><i>,</i>&#8221; &#8220;<b><i>our</i></b><i>,</i>&#8221; or<i> </i>&#8220;<b><i>us</i></b>&#8221;), to be voted at the 2022 Annual Meeting of Stockholders to be held on Wednesday, May 11, 2022 (the &#8220;<b><i>Annual Meeting</i></b>&#8221;), and at any adjournment or postponement of the Annual Meeting. The Annual Meeting will be held at 11:00 a.m. Pacific Time<b> </b>and, in line with prior practice, will be a virtual meeting of stockholders. You will be able to participate in the 2022 Annual Meeting, vote, and submit your questions during the meeting via live webcast by visiting www.virtualshareholdermeeting.com/NBY2022. You must have your 16-digit control number on your proxy card to enter and participate in the virtual meeting. This Proxy Statement and the proxy card are being made available over the Internet or delivered by mail on or about March 30, 2022, to stockholders of record as of March 16, 2022.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align: top; width: 101.6%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="color:#294c6c;"><b>Purpose of Meeting</b></font></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The specific proposals to be considered and acted upon at the Annual Meeting are summarized in the Notice and are described in more detail in this Proxy Statement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align: top; width: 101.6%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="color:#294c6c;"><b>Notice of Internet Availability </b></font></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We are pleased to offer our stockholders the convenience of notice and access to our electronic Proxy Statement and Annual Report on Form 10-K for the year ended December 31, 2021 (the &#8220;<b><i>Annual Report</i></b>&#8221;) and the opportunity to vote online. This delivery method also helps NovaBay reduce the mailing of paper copies of our proxy materials and Annual Report. Pursuant to rules adopted by the U.S. Securities and Exchange Commission (the &#8220;<b><i>SEC</i></b>&#8221;), we are permitted to furnish proxy materials, including this Proxy Statement, to our stockholders by providing access to such documents on the Internet instead of mailing printed copies. Consequently, our stockholders generally will not receive paper copies of our proxy materials unless they request them. Beginning on or about March 30, 2022, we will send to our stockholders a Notice of Internet Availability (the &#8220;<b><i>Availability Notice</i></b>&#8221;) containing instructions on how to access this Proxy Statement, our Annual Report and proxy card via the Internet and vote online. As a result, you will not receive a printed copy of the proxy materials in the mail unless you request a copy. All stockholders will have the ability to access the proxy materials on a website referred to in the Availability Notice and may request a printed set of the proxy materials free of charge by mail or electronically from such website. If you would like to receive a printed set of our proxy materials, you should follow the instructions for requesting such materials included in the Availability Notice. By participating in the Availability Notice process, we save printing and mailing expenses and reduce the environmental impact of our Annual Meeting.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align: top; width: 101.6%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="color:#294c6c;"><b>Attendance at the Annual Meeting </b></font></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">As permitted by Delaware law and our Bylaws, the Annual Meeting will be held as a virtual meeting live via the Internet. You will be able to attend the Annual Meeting via live webcast by visiting NovaBay&#8217;s virtual meeting website (www.virtualshareholdermeeting.com/NBY2022) at the meeting time. Upon visiting the meeting website, you will be prompted to enter your 16-digit control number provided on your Availability Notice or your proxy card. Your unique control number allows us to identify you as a stockholder and will enable you to securely log on, vote and submit questions during the Annual Meeting on the meeting website.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="1" data-prefix="- " data-suffix=" -" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">- 1 -</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Shares of which you are the beneficial owner but not the stockholder of record also may be voted electronically during the Annual Meeting if you have a 16-digit control number. If there is no 16-digit control number included on your instructions, please refer to the information provided by your broker, bank or other holder of record for voting information and/or instruction on how to attend the Annual Meeting.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Even if you plan to attend the Annual Meeting virtually, NovaBay recommends that you vote your shares in advance, so that your vote will be counted if you later decide not to attend the Annual Meeting.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align: top; width: 101.6%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="color:#294c6c;"><b>Voting; Quorum </b></font></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The record date for determining those stockholders who are entitled to notice of, and to vote at, the Annual Meeting has been fixed as March 16, 2022 (&#8220;<b><i>Record Date</i></b>&#8221;). Only stockholders of record at the close of business on the Record Date are entitled to notice of, and to vote at, the Annual Meeting and any adjournment or postponement thereof. Each stockholder is entitled to one (1) vote for each share of our common stock held by such stockholder as of the Record Date. As of the Record Date, 51,018,364 shares of our common stock were outstanding, and 12,570 shares of our Series B Non-Voting Convertible Preferred Stock (the &#8220;<i><b>Preferred Stock</b></i>&#8221;) were outstanding. The holders of the Preferred Stock have no voting rights for any of the Proposals and therefore will not vote at the Annual Meeting.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The presence at the Annual Meeting, either in person or by duly authorized proxy, of holders of a majority of the voting power of all the outstanding shares of our Common Stock entitled to vote will constitute a quorum for the transaction of business at the Annual Meeting. Stockholders who log on and vote at our virtual meeting of stockholders with their 16-digit control number (which is provided on your Availability Notice or proxy card) are considered present in person at the meeting. Abstentions are counted as present for purposes of determining the presence of a quorum. A broker non-vote occurs when the broker, bank or other nominee holding shares for a beneficial owner does not vote on a particular proposal because such broker, bank or other nominee does not have discretionary voting power to vote on that proposal without specific voting instructions from the beneficial owner. Proposal One and Proposal Two described in this Proxy Statement are non-discretionary items, and Proposal Three in this Proxy Statement is a discretionary item. If a quorum is not present, the Annual Meeting will be adjourned or postponed in order to permit further solicitation of proxies until a quorum is obtained. All votes will be tabulated by the inspector of election appointed for the Annual Meeting, who will separately tabulate &#8220;FOR&#8221; votes, &#8220;AGAINST&#8221; votes, abstentions and broker non-votes.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align: top; width: 101.6%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="color:#294c6c;"><b>Required Votes </b></font></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">For Proposal One, a stockholder may vote &#8220;FOR&#8221; the election of any one of the Class III director nominees proposed by the Board or &#8220;WITHHOLD&#8221; authority to vote for one or more of the proposed nominees. In accordance with our Bylaws, as amended (&#8220;<b><i>Bylaws</i></b>&#8221;), and as permitted under Delaware law, our directors are elected by a plurality of votes represented and entitled to vote at a meeting of stockholders. Accordingly, for our election of Class III directors, the two (2) director candidates nominated by our Board who receive the highest number of &#8220;FOR&#8221; votes of our common stock, present or represented by proxy duly authorized and entitled to vote at the Annual Meeting, will be elected. &#8220;WITHHELD&#8221; votes and broker non-votes will have no effect.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">For Proposal Two, to approve, on an advisory basis, the compensation of NovaBay&#8217;s named executive officers, as disclosed in this proxy statement requires &#8220;FOR&#8221; votes from a majority of the shares present or represented by proxy duly authorized and entitled to vote at the Annual Meeting. Abstentions will have the same effect as &#8220;AGAINST&#8221; votes and broker non-votes will have no effect.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">For Proposal Three, the ratification of the appointment by our Audit Committee of WithumSmith+Brown, PC as our independent registered public accounting firm for the fiscal year ending December 31, 2022 will reflect stockholder approval of such advisory vote if we receive &#8220;FOR&#8221; votes from a majority of the shares present or represented by proxy duly authorized and entitled to vote at the Annual Meeting. Abstentions will have the same effect as &#8220;AGAINST&#8221; votes and we do not expect to have any broker non-votes on this proposal.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="2" data-prefix="- " data-suffix=" -" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">- 2 -</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align: top; width: 101.6%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="color:#294c6c;"><b>Effect of Not Voting </b></font></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><font style="color:#294c6c;"><b><i>Stockholder of Record; Shares Registered in Your Name</i></b></font></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">If you are a stockholder of record and do not vote by telephone or over the Internet or by completing and returning your proxy card, your shares will not be voted.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><font style="color:#294c6c;"><b><i>Beneficial Owner; Shares Registered in the Name of a Broker, Bank or Other Nominee</i></b></font></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">If you are a beneficial owner and do not instruct your broker, bank or other nominee how to vote your shares, the question of whether your broker, bank or other nominee will still be able to vote your shares depends on whether the New York Stock Exchange (&#8220;<b><i>NYSE</i></b>&#8221;) deems the particular proposal to be a &#8220;routine&#8221; matter. Brokers, banks or other nominees can use their discretion to vote &#8220;uninstructed&#8221; shares with respect to matters that are considered to be &#8220;routine,&#8221; but not with respect to &#8220;non-routine&#8221; matters. Under the rules and interpretations of the NYSE, &#8220;non-routine&#8221; matters are matters that may substantially affect the rights or privileges of stockholders, such as mergers, stockholder proposals, elections of directors (even if not contested), executive compensation (including any advisory stockholder votes on executive compensation and on the frequency of stockholder votes on executive compensation), and certain corporate governance proposals, even if management supported. Accordingly, your broker, bank or other nominee may not vote your shares on Proposal One or Proposal Two, but may vote your shares on Proposal Three.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align: top; width: 101.6%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="color:#294c6c;"><b>Voting Methods </b></font></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">If you were a registered stockholder on the Record Date, you may vote your shares at the virtual Annual Meeting, www.virtualshareholdermeeting.com/NBY2022, which contains voting instructions. You may also vote your shares by telephone by calling (toll free within the U.S. and Canada) 1-800-690-6903 and following the voting instructions read to you by the automated operator. Internet and telephone voting facilities for stockholders of record will be available 24 hours a day beginning at 12:01 a.m. Pacific Time on March 30, 2022. Internet and telephone voting will close promptly at 11:59 p.m. Pacific Time on Tuesday, May 10, 2022.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">After this, you will only be able to vote by attending the Annual Meeting via live webcast and voting at the Annual Meeting. The meeting starts at 11:00 a.m. (Pacific Time). After voting is closed during the Annual Meeting, you will no longer have the ability to vote your shares for the specific proposals considered at the Annual Meeting.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Upon visiting the meeting website or calling the call-in telephone line, you will be prompted to enter your 16-digit control number provided to you on your proxy card. Your unique control number allows us to identify you as a stockholder and will enable you to securely cast votes.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">If you are a registered stockholder as of the Record Date and hold your shares in more than one fund or other affiliated investment vehicle, you will receive separate voting credentials for each such entity that is a record holder of shares of our Common Stock. Please be sure to log on separately for each fund in order to cast all votes that you are entitled to cast at the Annual Meeting.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">If you receive proxy materials by mail or if you request paper copies of the proxy materials, you can vote by mail by marking, dating, signing and returning your proxy card in the postage-paid envelope. Further instructions on how to vote by mail are included on the proxy card. Only proxy cards that have been signed, dated, and timely returned will be counted towards the quorum and entitled to vote.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">If your proxy card does not specify how the shares represented thereby are to be voted, the proxy will be voted &#8220;FOR&#8221; the election of the directors proposed by the Board under Proposal One and &#8220;FOR&#8221; the approval of Proposals Two and Three described in the Notice and this Proxy Statement. The proxy card also grants the proxy holder discretionary authority to vote on any other business that may properly come before the Annual Meeting. We have not been notified by any stockholder of his or her intent to present a stockholder proposal at the Annual Meeting.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="3" data-prefix="- " data-suffix=" -" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">- 3 -</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align: top; width: 101.6%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="color:#294c6c;"><b>Revoking Proxies </b></font></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">If your shares are held in your name, you may revoke or change your vote at any time before the Annual Meeting by (i) submitting another proxy on a later date on the Internet or by telephone (only your latest Internet or telephone proxy submitted prior to the Annual Meeting will be counted); or (ii) attending the Annual Meeting live via webcast and voting during the meeting (simply attending the virtual meeting will not, by itself, revoke your proxy); or (iii) by filing a notice of revocation or submitting another signed proxy card with a later date with our Corporate Secretary, Mr. Justin Hall, Esq., at our principal executive offices at 2000 Powell Street, Suite 1150, Emeryville, California 94608. Unless so revoked, the shares represented by such proxies or voting instructions will be voted at the Annual Meeting and all adjournments or postponements of the Annual Meeting. Proxies solicited on behalf of the Board will be voted in accordance with the directions given.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align: top; width: 101.6%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="color:#294c6c;"><b>Solicitation </b></font></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">NovaBay will bear the entire cost of proxy solicitation, including the costs of preparing, assembling, printing and mailing this Proxy Statement, the Notice, the proxy card and any additional solicitation materials furnished to the stockholders. Copies of these materials will be furnished to brokers, banks or other nominees holding shares in their names that are beneficially owned by others so they may forward these materials to such beneficial owners. In addition, we may reimburse such persons for their reasonable expenses in forwarding the solicitation materials to the beneficial owners. The original solicitation of proxies by mail may be supplemented by a solicitation by personal contact, telephone, facsimile, email or any other means by our directors, officers or employees. No additional compensation will be paid to these individuals for any such services.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align: top; width: 101.6%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="color:#294c6c;"><b>Other Matters </b></font></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Other than the proposals described in the Proxy Statement, the Board is not aware of any other business that will be presented for consideration at the Annual Meeting. If any other matters should be properly presented at the Annual Meeting or any adjournments or postponements of the Annual Meeting for action by stockholders, the person named in the form of proxy will vote the proxy, pursuant to the authority provided to him or her, in accordance with his or her best judgment on that matter.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align: top; width: 101.6%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="color:#294c6c;"><b>Results of the Voting at the Annual Meeting </b></font></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Preliminary voting results will be announced at the Annual Meeting. In addition, final voting results will be published in a current report on Form 8-K that we expect to file within four (4) business days after the Annual Meeting.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" data-number="4" data-prefix="- " data-suffix=" -" style="text-align: center; width: 100%; font-size: 10pt; font-family: Times New Roman;">- 4 -</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">&nbsp;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align: middle; width: 101.6%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:12pt;font-variant:small-caps;text-align:center;margin:0pt;"><font style="text-transform:uppercase;"><font style="color:#294c6c;"><b>Matters to be Considered at the Annual Meeting</b></font></font></p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: small-caps; text-align: center; margin: 0pt;">&nbsp;</p>

			<p style="font-family:Times New Roman;font-size:12pt;font-variant:small-caps;text-align:center;margin:0pt;"><font style="text-transform:uppercase;"><font style="color:#294c6c;"><b>Proposal One: </b></font></font></p>

			<p style="font-family:Times New Roman;font-size:12pt;font-variant:small-caps;text-align:center;margin:0pt;"><font style="text-transform:uppercase;"><font style="color:#294c6c;"><b>Election of Directors</b></font></font></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;text-indent:9pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Our Certificate of Incorporation provides for a classified Board consisting of three (3) classes of directors, Class I, Class II and Class III, each with staggered three (3)-year terms. As a result, a portion of our Board will be elected at each year&#8217; annual meeting. Our Board currently consists of eight (8) directors. At this year&#8217;s Annual Meeting, the current term of the Class III directors will expire and our stockholders will vote on the two Class III director nominees identified below.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Upon the recommendation of the Nominating and Corporate Governance (&#8220;<b><i>N&amp;CG</i></b>&#8221;) Committee of the Board, our Board selected and approved Mr. Paul Freiman (&#8220;<b><i>Mr. Freiman</i></b>&#8221;) and Ms. Swan Sit (&#8220;<b><i>Ms. Sit</i></b>&#8221;) as nominees for election as Class III directors at this Annual Meeting to serve for a term of three (3) years, expiring at the 2025 Annual Meeting of Stockholders, until their successors are duly elected and qualified or until their earlier resignation or removal. Each nominee has agreed to serve if elected. Management has no reason to believe either of the nominees will be unable to serve. In the event either of the nominees named herein is unable to serve or declines to serve at the time of the Annual Meeting, the proxy holders will exercise discretionary authority to vote for substitutes. Unless otherwise instructed, the proxy holders will vote the proxies received by them &#8220;FOR&#8221; the nominees named above.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">On January 27, 2022, the Board expanded the size of the Board from six (6) directors to eight (8) directors. The Board filled the two new vacancies created by the expansion of the Board by appointing Dr. Audrey Kunin as a Class I director and Ms. Julie Garlikov (&#8220;<b><i>Ms. Garlikov</i></b>&#8221;) as a Class II director. Also on January 27, 2022, director Xinzhou (Paul) Li, a Class II director, resigned from the Board, and the Board appointed Mr. Yongxiang (Sean) Zheng (&#8220;<b><i>Mr. Sean Zheng</i></b>&#8221;) to fill the vacancy as a Class II director created by the resignation of Mr. Li, effective the same day.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Mr. Mijia (Bob) Wu (&#8220;<b><i>Mr. Wu</i></b>&#8221;) and Dr. Yenyou (Jeff) Zheng (&#8220;<b><i>Dr. Jeff Zheng</i></b>&#8221;) have been designated as Class I directors whose terms expire at the 2023 Annual Meeting of Stockholders. Mr. Justin M. Hall (&#8220;<b><i>Mr. Hall</i></b>&#8221;), Ms. Garlikov and Mr. Sean Zheng have been designated as Class II directors whose terms expire at the 2024 Annual Meeting of Stockholders.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" data-number="5" data-prefix="- " data-suffix=" -" style="text-align: center; width: 100%; font-size: 10pt; font-family: Times New Roman;">- 5 -</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">&nbsp;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align: top; width: 101.6%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="color:#294c6c;"><b>Current Directors and Nominees </b></font></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The names of our current directors and nominees, their ages and biographical information about them are as follows:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Class III Directors </i></b>&#8211;<b><i> Terms Expiring at the 2022 Annual Meeting</i></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr style="background-color: rgb(230, 230, 230);">
			<td colspan="2" style="vertical-align: top; width: 107.2%; border-top: 2px solid rgb(41, 76, 108); border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:small-caps;text-align:center;margin:0pt;"><font style="text-transform:uppercase;"><b>Paul E. Freiman, Ph.D.</b></font></p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 34.2%; border-right: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Chairman &amp; Independent Director</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Age: </b>87</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 73%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;"><b>Director since: </b>May 2002</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;"><b>Committees: </b>Compensation (Chair), Audit and N&amp;CG</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;"><b>Current Occupation: </b>Independent Pharmaceutical Professional &amp; Consultant</p>
			</td>
		</tr>
		<tr>
			<td colspan="2" style="vertical-align: top; width: 107.2%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Selected Director Qualifications:</b></p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;"><img alt="a05.jpg" src="a05.jpg">&nbsp; &nbsp;Extensive historical knowledge about NovaBay, having served over 19 years as one of our directors, providing valuable Board continuity</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 27pt; text-indent: -18pt;"><img alt="a05.jpg" src="a05.jpg">&nbsp; &nbsp;Valuable operational and industry expertise and leadership skills from prior experiences as a client executive officer as well as a board member of various pharmaceutical companies</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;"><img alt="a05.jpg" src="a05.jpg">&nbsp; &nbsp;Experience in multiple acquisitions, for example guiding Syntex Corporation (&#8220;<b><i>Syntex</i></b>&#8221;) through an acquisition by Roche for $5.3 billion</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Since January 2009, Mr. Freiman has been an independent pharmaceutical professional and consultant. Currently, he is also a board member of Chronix Biomedical Inc., a private molecular diagnosis company. Mr. Freiman&#8217;s prior experience includes serving as the president and chief executive officer of Neurobiological Technologies, Inc. (OTC: NTII) and a member of its board of directors from April 1997 until 2009. Mr. Freiman&#8217;s prior experience also includes serving as the former chairman and chief executive officer of Syntex from 1989 to 1994. He is credited with much of the marketing success of Syntex&#8217;s lead product, Naprosyn, and was responsible for moving the product to over-the-counter status, marketed as Aleve. Mr. Freiman served as chairman of the board of Neurotrope, Inc. (OTCBB: BLFL) from 2013 until August 2016. Mr. Freiman served as chairman of Penwest Pharmaceutical Co. (NASDAQ: PPCO) until 2010 and served on the board of directors of Otsuka American Pharmaceuticals, Inc. and Otsuka America, Inc. until 2011, NeoPharm, Inc. (NASDAQCM: NEOL) until 2010 and Calypte Biomedical Corporation (OTC: CBMC) until September 2009. Mr. Freiman also served on the board (including as chairman) of the Pharmaceutical Research and Manufacturers Association of America. He has also served on a number of industry task forces both domestically and internationally. Mr. Freiman received a B.S. in pharmacy from Fordham University and an honorary doctorate from the Arnold &amp; Marie Schwartz College of Pharmacy.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr style="background-color: rgb(230, 230, 230);">
			<td colspan="2" style="vertical-align: top; width: 107.2%; border-top: 2px solid rgb(41, 76, 108); border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:small-caps;text-align:center;margin:0pt;"><font style="text-transform:uppercase;"><b>Swan Sit</b></font></p>
			</td>
		</tr>
		<tr>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:34.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Independent Director</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Age: </b>44</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 73%; border-left: 1px solid rgb(0, 0, 0);">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;"><b>Director since: </b>December 2019</p>

			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;"><b>Committees: </b>Audit, Compensation and N&amp;CG</p>

			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;"><b>Current Occupation: </b>Independent Business Consultant</p>
			</td>
		</tr>
		<tr>
			<td colspan="2" style="vertical-align: top; width: 107.2%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Selected Director Qualifications:</b></p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;"><img alt="a05.jpg" src="a05.jpg">&nbsp; &nbsp;Experience in brand management and advertising</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;"><img alt="a05.jpg" src="a05.jpg">&nbsp; &nbsp;Expertise in the digital transformation of companies through ecommerce</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Ms. Sit currently acts as an independent business consultant to various public and private companies. Ms. Sit also serves as a director of Edgewell Personal Care Company (NYSE: EPC) (since September 2020) and Far Niente Winery (since August 2020). She previously served as the Vice President of NA Digital Commerce Capabilities, Business Operations and Service and the Vice President of Global Digital Marketing of Nike, Inc. from 2018 to 2019. Prior to such position, Ms. Sit served as the Vice President of Global Digital of Revlon and Elizabeth Arden, Inc. from 2015 to 2017 and the Executive Director of Strategy and Planning, Online of The Est&#233;e Lauder Companies, Inc. Ms. Sit brings business experience including digital transformation experience supplemented by management consulting, brand management and advertising. Ms. Sit has built front-end consumer experiences across ecommerce, omnichannel, mobile, media, social, apps and innovation as well as integrated back-end operations. Ms. Sit received an MBA from Columbia Business School and a B.A. in Economics from Harvard University.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="6" data-prefix="- " data-suffix=" -" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">- 6 -</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr style="background-color: rgb(230, 230, 230);">
			<td style="vertical-align: middle; width: 102.2%; border-top: 2px solid rgb(41, 76, 108); border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><font style="color:#294c6c;"><b><u>Recommendation of Our Board</u></b></font></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><font style="color:#294c6c;">Our Board unanimously recommends that you vote &#8220;FOR&#8221;&nbsp;the</font></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><font style="color:#294c6c;">Class III director nominees listed above.</font></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Class I Directors </i></b>&#8211;<b><i> Terms Expiring at the 2023 Annual Meeting</i></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr style="background-color: rgb(230, 230, 230);">
			<td colspan="2" style="vertical-align: top; width: 107.2%; border-top: 2px solid rgb(41, 76, 108); border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:small-caps;text-align:center;margin:0pt;"><font style="text-transform:uppercase;"><b>Dr. Audrey Kunin</b></font></p>
			</td>
		</tr>
		<tr>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:34.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Director</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Age: </b>63</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 73%; border-left: 1px solid rgb(0, 0, 0);">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;"><b>Director since: </b>January 2022</p>

			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;"><b>Committees: </b>None</p>

			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;"><b>Current Occupation: </b>Chief Product Officer of NovaBay</p>
			</td>
		</tr>
		<tr>
			<td colspan="2" style="vertical-align: top; width: 107.2%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Selected Director Qualifications:</b></p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;"><img alt="a05.jpg" src="a05.jpg">&nbsp; &nbsp;Over 20 years of experience in developing and marketing cosmetic and dermatology related products</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;"><img alt="a05.jpg" src="a05.jpg">&nbsp; &nbsp;As one of the co-founders of DERMAdoctor, extensive knowledge of DERMAdoctor&#8217;s products and business operations</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Dr. Audrey Kunin is the Chief Product Officer and a director of NovaBay. Dr. Audrey Kunin co-founded DERMAdoctor and served as the Chief Creative Officer of DERMAdoctor since March 2018 and as the Chief Executive Officer at its predecessor since 1998. Dr. Audrey Kunin graduated from Ohio State University in December 1980 and received her M.D. at the Medical College of Ohio in June 1985. She received her postgraduate training in Dermatology at the Medical College of Virginia after serving as Chief Resident in July 1989. She is a fellow of the American Academy of Dermatology and formerly served as an Assistant Clinical Instructor of Dermatology at the University of Kansas School of Medicine.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr style="background-color: rgb(230, 230, 230);">
			<td colspan="2" style="vertical-align: top; width: 107.2%; border-top: 2px solid rgb(41, 76, 108); border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:small-caps;text-align:center;margin:0pt;"><font style="text-transform:uppercase;"><b>Mijia (Bob) Wu, M.B.A.</b></font></p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:34.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Director</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Age: </b>47</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 73%; border-left: 1px solid rgb(0, 0, 0);">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;"><b>Director since: </b>January 2016</p>

			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;"><b>Committees: </b>None</p>

			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;"><b>Current Occupation: </b>Managing Director of China Kington Asset Management (&#8220;<i><b>China Kington</b></i>&#8221;)</p>
			</td>
		</tr>
		<tr>
			<td colspan="2" style="vertical-align: top; width: 107.2%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Selected Director Qualifications:</b></p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;"><img alt="a05.jpg" src="a05.jpg">&nbsp; &nbsp;Over a decade of valuable experience in finance and investments</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;"><img alt="a05.jpg" src="a05.jpg">&nbsp; &nbsp;Uniquely positioned to represent our stockholders&#8217;&nbsp;interests as a representative of one of the Company&#8217;s largest stockholders</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;"><img alt="a05.jpg" src="a05.jpg">&nbsp; &nbsp;Expertise in the international market</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Since June 2008, Mr. Wu has been the Managing Director of China Kington (an affiliated entity of China Kington Investment Co. Ltd.), which has a long-standing relationship with NovaBay. Certain related-party transactions between the Company and China Kington are described in the &#8220;<i>Certain Relationships and Related Transactions</i>&#8221; section below and further historic transactions are described in the Company&#8217;s prior filings with the SEC. Concurrently, Mr. Wu serves as the Managing Director of Shanghai Ceton Investment Management Co. Ltd. From October 2013 until December 2021, he also served as a Non-Executive Director of China Pioneer Pharma Holdings Limited, an affiliate of one of the Company&#8217;s largest stockholders, Pioneer Pharma (Hong Kong) Company Ltd. Previously, Mr. Wu served as director at UBS AG, Hong Kong Branch, in 2007 and Vice President of BNP Paribas Hong Kong from 2005 to 2006. He was also the Assistant Vice President at ABN AMRO Bank (China) Co., Ltd. from 2002 to 2005. He holds an M.B.A. from Manchester Business School, University of Manchester, and an Executive M.B.A. from Cheung Kong Graduate School of Business.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="7" data-prefix="- " data-suffix=" -" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">- 7 -</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr style="background-color: rgb(230, 230, 230);">
			<td colspan="2" style="vertical-align: top; width: 107.2%; border-top: 2px solid rgb(41, 76, 108); border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:small-caps;text-align:center;margin:0pt;"><font style="text-transform:uppercase;"><b>Yenyou (Jeff) Zheng, Ph.D.</b></font></p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:34.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Independent Director</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Age: </b>65</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 73%; border-left: 1px solid rgb(0, 0, 0);">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;"><b>Director since: </b>September 2019</p>

			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;"><b>Committees: </b>N&amp;CG (Chair), Audit (Chair) and Compensation</p>

			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;"><b>Current Occupation: </b>Director of Business Development of Craft Capital Management LLC</p>
			</td>
		</tr>
		<tr>
			<td colspan="2" style="vertical-align: top; width: 107.2%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Selected Director Qualifications:</b></p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 27pt; text-indent: -18pt;"><img alt="a05.jpg" src="a05.jpg">&nbsp; &nbsp;Significant strategic experience in corporate financing solutions from his current experience at both Craft Capital Management LLC and Spartan Securities Group, Ltd.</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;"><img alt="a05.jpg" src="a05.jpg">&nbsp; &nbsp;Extensive network of contacts related to financing, partnering and support services</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Dr. Zheng currently serves as the Director of Business Development of, and as a broker with, Craft Capital Management LLC and has served in such positions since September 2019. Prior to that, Dr. Zheng served as the Director of Business Development of Spartan Securities Group, Ltd. from 2014 to August 2019. Dr. Zheng&#8217;s experience includes providing innovative financial solutions and consulting services for initial public offering underwriting and investment banking as well as corporate financing solutions with a particular focus on Chinese companies listed overseas. Dr.&nbsp;Zheng&nbsp; previously served as a financial advisor for various Canadian public companies including: P &amp; P Ventures Inc. (TSX-V: PPV.H) where he served as president and a director; Damon Capital Corp (TSX-V: DAM.H) where he served as Chief Financial Officer and a director; and Cantronic Systems Inc. (TSX-V: CTS) where he served as a director and chair of the audit committee. Dr.&nbsp;Zheng&nbsp;received a Ph.D. in physics from Flinders University of South Australia.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Class II Directors </i></b>&#8211;<b><i> Terms Expiring at the 2024 Annual Meeting</i></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr style="background-color: rgb(230, 230, 230);">
			<td colspan="2" style="vertical-align: top; width: 107.2%; border-top: 2px solid rgb(41, 76, 108); border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:small-caps;text-align:center;margin:0pt;"><font style="text-transform:uppercase;"><b>Justin M. Hall</b></font></p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:34.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Director</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Age: </b>44</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 73%; border-left: 1px solid rgb(0, 0, 0);">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;"><b>Director since: </b>August 2020</p>

			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;"><b>Committees: </b>None</p>

			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt; text-align: justify;"><b>Current Occupation: </b>Chief Executive Officer, General Counsel and Chief Compliance Officer of NovaBay</p>
			</td>
		</tr>
		<tr>
			<td colspan="2" style="vertical-align: top; width: 107.2%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Selected Director Qualifications:</b></p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;"><img alt="a05.jpg" src="a05.jpg">&nbsp; &nbsp;Extensive knowledge of NovaBay&#8217;s products, business and employees due to his tenure and continuing leadership of the Company</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;"><img alt="a05.jpg" src="a05.jpg">&nbsp; &nbsp;Expertise in the pharmaceutical industry and legal issues surrounding NovaBay&#8217;s business</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Mr. Hall currently serves as NovaBay&#8217;s Chief Executive Officer, General Counsel and Chief Compliance Officer and has served in such positions since June 2019. Mr. Hall served as the Company&#8217;s Interim President and Chief Executive Officer from March 2019 to June 2019 and as the Company&#8217;s Senior Vice President and General Counsel beginning in December 2015. Prior to this, he served as the Company&#8217;s lead in-house counsel beginning in February 2013. Prior to joining the Company, Mr. Hall worked as Corporate Counsel at Accuray Incorporated, a radiation oncology company, which he joined in October 2006, where he provided substantive legal advice on a broad range of complex legal matters with a focus on employment, corporate compliance, and corporate governance. Mr. Hall&#8217;s prior experience also includes serving as an investment advisor at Sagemark Consulting from 2000 to 2006, and a stockbroker at First Security Van Kasper from 1998 to 2001. Mr. Hall received a B.A. in Business Administration and Management from the University of California, San Diego, and a J.D. from the University of San Diego, School of Law.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr style="background-color: rgb(230, 230, 230);">
			<td colspan="2" style="vertical-align: top; width: 107.2%; border-top: 2px solid rgb(41, 76, 108); border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:small-caps;text-align:center;margin:0pt;"><font style="text-transform:uppercase;"><b>Yongxiang (Sean) Zheng</b></font></p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:34.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Director</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Age: </b>52</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 73%; border-left: 1px solid rgb(0, 0, 0);">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;"><b>Director since: </b>January 2022</p>

			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;"><b>Committees: </b>None</p>

			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt; text-align: justify;"><b>Current Occupation: </b>Managing Director of Q3 Medical Devices (Shanghai) Co. Ltd.</p>
			</td>
		</tr>
		<tr>
			<td colspan="2" style="vertical-align: top; width: 107.2%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Selected Director Qualifications:</b></p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;"><img alt="a05.jpg" src="a05.jpg">&nbsp; &nbsp;More than 27 years&#8217;&nbsp;experience in mergers and acquisitions, fund management and import/export businesses</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Mr. Sean Zheng currently serves as the Managing Director of Q3 Medical Devices (Shanghai) Co. Ltd. Prior to joining Q3 Medical, Mr. Zheng held several leadership positions, including Managing Director of Boill Fund Management (HK) Co., Ltd. and Managing Director and Chief Executive Officer of Sprott- Zijin Mining fund, a JV fund between Zijin Mining Group and Sprott Asset Management LP. From 2007 to 2011, Mr. Sean Zheng served as a director of Dingtian Asset Management. Mr. Zheng has also been a CFA chartered holder since 2006. Mr. Zheng graduated from Renmin University of China in 1992 and holds a B.S degree in Commodity Science. He received his MBA from the University of New South Wales in 2002 and earned a master&#8217;s degree of EMBA from China Europe International Business School (CEIBS) in 2010.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="8" data-prefix="- " data-suffix=" -" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">- 8 -</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr style="background-color: rgb(230, 230, 230);">
			<td colspan="2" style="vertical-align: top; width: 107.2%; border-top: 2px solid rgb(41, 76, 108); border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:small-caps;text-align:center;margin:0pt;"><b>JULIE GARLIKOV</b></p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:34.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Independent Director</b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Age: </b>51</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 73%; border-left: 1px solid rgb(0, 0, 0);">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;"><b>Director since: </b>January 2022</p>

			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;"><b>Committees: </b>None</p>

			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt; text-align: justify;"><b>Current Occupation: </b>Vice President of Marketing of GRAIL, LLC</p>
			</td>
		</tr>
		<tr>
			<td colspan="2" style="vertical-align: middle; width: 107.2%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Selected Director Qualifications:</b></p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;"><img alt="a05.jpg" src="a05.jpg">&nbsp; &nbsp;Over 25 years of experience in consumer marketing</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;"><img alt="a05.jpg" src="a05.jpg">&nbsp; &nbsp;Extensive expertise in health, beauty and eyecare products, as well as in direct to consumer advertising and digital demand generation</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Ms. Garlikov is the Vice President of Marketing of GRAIL, LLC, a biotechnology and pharmaceutical company. She has served in this position since November 2020. Ms. Garlikov has over 25 years of experience in marketing, which includes serving as the Chief Marketing Officer at New Age and Shaklee, as well as senior marketing positions at Rodan &amp; Fields, Obagi Medical and Nuvesse Skin Therapies. Julie is a classically trained CPG marketer who gained her consumer experience at Procter &amp; Gamble, Johnson &amp; Johnson and PepsiCo. She has deep expertise in both health and beauty and eyecare products, as well as in DTC advertising and digital demand generation. Ms. Garlikov has a Bachelors degree from the University of California, Berkley and a Masters degree in Business Administration from Columbia University.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align: top; width: 101.6%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="color:#294c6c;"><b>Family Relationships </b></font></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">There are no family relationships among any of our directors, director nominees or executive officers, except Dr. Audrey Kunin, NovaBay&#8217;s Chief Product Officer and a director, is the spouse of Dr. Jeff Kunin, the President and Chief Executive Officer of DERMAdoctor, LLC.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="9" data-prefix="- " data-suffix=" -" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">- 9 -</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align: middle; width: 101.6%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:12pt;font-variant:small-caps;text-align:center;margin:0pt;"><font style="text-transform:uppercase;"><font style="color:#294c6c;"><b>Corporate Governance</b></font></font></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;text-indent:9pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align: top; width: 101.6%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="color:#294c6c;"><b>Code of Ethics and Business Conduct </b></font></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Our Board has adopted a Code of Ethics and Business Conduct (the &#8220;<b><i>Code of Ethics</i></b>&#8221;) which applies to all directors, officers (including our principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions) and employees. The full text of our Code of Ethics is available on the Corporate Governance section of our website at <u>www.novabay.com</u>. We intend to disclose future amendments to certain provisions of the Code of Ethics, and any waivers of provisions of the Code of Ethics required to be disclosed under the rules of the SEC, at the same location on our website.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align: top; width: 101.6%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="color:#294c6c;"><b>Director Independence </b></font></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Our Board has determined that each of Mr. Freiman, Ms. Sit, Dr. Jeff Zheng and Ms. Garlikov satisfies the requirements for &#8220;independence&#8221; as defined in the NYSE American Company Guide (the &#8220;<b><i>Company Guide</i></b>&#8221;). The remaining non-independent directors do not and will not serve on any committees of the Board as long as they are not independent.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align: top; width: 101.6%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="color:#294c6c;"><b>Board Committees and Meetings </b></font></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Our Board has an Audit Committee, a Compensation Committee and an N&amp;CG Committee. Each such committee has a written charter that is reviewed annually and revised as appropriate. A copy of each committee&#8217;s charter is available on the Corporate Governance section of our website at www.novabay.com.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="border-width: 2px 1px 1px 2px; border-style: solid; border-color: rgb(41, 76, 108) rgb(0, 0, 0) rgb(0, 0, 0) rgb(41, 76, 108); vertical-align: bottom; width: 30.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Name</b></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 21.6%; border-right: 1px solid rgb(0, 0, 0); border-top: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Audit Committee</b></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 21.6%; border-right: 1px solid rgb(0, 0, 0); border-top: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Compensation Committee</b></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 26.4%; border-top: 2px solid rgb(41, 76, 108); border-right: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>N&amp;CG Committee</b></p>
			</td>
		</tr>
		<tr style="background-color: rgb(230, 230, 230);">
			<td style="vertical-align: top; width: 30.3%; border-right: 1px solid rgb(0, 0, 0); border-left: 2px solid rgb(41, 76, 108);">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;">Paul E. Freiman, Ph.D.*</p>
			</td>
			<td style="vertical-align: bottom; width: 21.6%; border-right: 1px solid rgb(0, 0, 0);">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#9679;</p>
			</td>
			<td style="vertical-align: bottom; width: 21.6%; border-right: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">C</p>
			</td>
			<td style="vertical-align: bottom; width: 26.4%; border-right: 2px solid rgb(41, 76, 108);">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#9679;</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 30.3%; border-right: 1px solid rgb(0, 0, 0); border-left: 2px solid rgb(41, 76, 108);">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;">Justin M. Hall</p>
			</td>
			<td style="vertical-align: bottom; width: 21.6%; border-right: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td style="vertical-align: bottom; width: 21.6%; border-right: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td style="vertical-align: bottom; width: 26.4%; border-right: 2px solid rgb(41, 76, 108);">&nbsp;</td>
		</tr>
		<tr style="background-color: rgb(230, 230, 230);">
			<td style="vertical-align: top; width: 30.3%; border-right: 1px solid rgb(0, 0, 0); border-left: 2px solid rgb(41, 76, 108);">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;">Dr. Audrey Kunin</p>
			</td>
			<td style="vertical-align: bottom; width: 21.6%; border-right: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td style="vertical-align: bottom; width: 21.6%; border-right: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td style="vertical-align: bottom; width: 26.4%; border-right: 2px solid rgb(41, 76, 108);">&nbsp;</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 30.3%; border-right: 1px solid rgb(0, 0, 0); border-left: 2px solid rgb(41, 76, 108);">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;">Julie Garlikov</p>
			</td>
			<td style="vertical-align: bottom; width: 21.6%; border-right: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td style="vertical-align: bottom; width: 21.6%; border-right: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td style="vertical-align: bottom; width: 26.4%; border-right: 2px solid rgb(41, 76, 108);">&nbsp;</td>
		</tr>
		<tr style="background-color: rgb(230, 230, 230);">
			<td style="vertical-align: top; width: 30.3%; border-right: 1px solid rgb(0, 0, 0); border-left: 2px solid rgb(41, 76, 108);">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;">Swan Sit</p>
			</td>
			<td style="vertical-align: bottom; width: 21.6%; border-right: 1px solid rgb(0, 0, 0);">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#9679;</p>
			</td>
			<td style="vertical-align: bottom; width: 21.6%; border-right: 1px solid rgb(0, 0, 0);">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#9679;</p>
			</td>
			<td style="vertical-align: bottom; width: 26.4%; border-right: 2px solid rgb(41, 76, 108);">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#9679;</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 30.3%; border-right: 1px solid rgb(0, 0, 0); border-left: 2px solid rgb(41, 76, 108);">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;">Mijia (Bob) Wu, M.B.A.</p>
			</td>
			<td style="vertical-align: bottom; width: 21.6%; border-right: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td style="vertical-align: bottom; width: 21.6%; padding: 0pt; text-align: center; border-right: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td style="vertical-align: bottom; width: 26.4%; border-right: 2px solid rgb(41, 76, 108);">&nbsp;</td>
		</tr>
		<tr style="background-color: rgb(230, 230, 230);">
			<td style="vertical-align: top; width: 30.3%; border-right: 1px solid rgb(0, 0, 0); border-left: 2px solid rgb(41, 76, 108);">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;">Yenyou (Jeff) Zheng<sup style="vertical-align:top;line-height:120%;font-size:pt"> +</sup></p>
			</td>
			<td style="vertical-align: bottom; width: 21.6%; border-right: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">C</p>
			</td>
			<td style="vertical-align: bottom; width: 21.6%; border-right: 1px solid rgb(0, 0, 0);">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&#9679;</p>
			</td>
			<td style="vertical-align: bottom; width: 26.4%; border-right: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">C</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 30.3%; border-right: 1px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(41, 76, 108); border-left: 2px solid rgb(41, 76, 108);">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;">Mr. Yongxiang (Sean) Zheng</p>
			</td>
			<td style="vertical-align: bottom; width: 21.6%; border-right: 1px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(41, 76, 108);">&nbsp;</td>
			<td style="vertical-align: bottom; width: 21.6%; border-right: 1px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(41, 76, 108);">&nbsp;</td>
			<td style="vertical-align: bottom; width: 26.4%; border-bottom: 2px solid rgb(41, 76, 108); border-right: 2px solid rgb(41, 76, 108);">&nbsp;</td>
		</tr>

</table>

<p style="margin: 0pt; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">Member</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">C</p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">Chair</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt">+</sup></p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">Audit Committee Financial Expert</p>
			</td>
		</tr>

</table>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">*</p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">Chairman of the Board</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The table below shows the number of Board and Committee meetings held in 2021.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:47%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align: top; width: 61.6%; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td style="border-width: 2px 2px 1px; border-style: solid; border-color: rgb(41, 76, 108) rgb(41, 76, 108) rgb(0, 0, 0); vertical-align: bottom; width: 40.9%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Number of Meetings Held</b></p>
			</td>
		</tr>
		<tr style="background-color: rgb(230, 230, 230);">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 61.6%; border-top: 2px solid rgb(41, 76, 108); border-left: 2px solid rgb(41, 76, 108);">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;">Board of Directors</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 40.9%; border-left: 2px solid rgb(41, 76, 108); border-right: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">9</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 61.6%; border-left: 2px solid rgb(41, 76, 108);">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;">Audit Committee</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 40.9%; border-left: 2px solid rgb(41, 76, 108); border-right: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">5</p>
			</td>
		</tr>
		<tr style="background-color: rgb(230, 230, 230);">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 61.6%; border-left: 2px solid rgb(41, 76, 108);">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;">Compensation Committee</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 40.9%; border-left: 2px solid rgb(41, 76, 108); border-right: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">3</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 61.6%; border-left: 2px solid rgb(41, 76, 108); border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;">N&amp;CG Committee</p>
			</td>
			<td style="vertical-align: bottom; width: 40.9%; border-bottom: 2px solid rgb(41, 76, 108); border-left: 2px solid rgb(41, 76, 108); border-right: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">1</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Directors are expected to attend Board meetings, our annual stockholders&#8217; meeting and the meetings of the committees on which they serve. In 2021, no director attended fewer than 75% of the aggregate number of Board and Committee meetings of the Board and committees on which he or she served. Following all of the regularly scheduled 2021 Board meetings, the independent directors met in an executive session. During 2021, Mr. Freiman served as Chairman of the Board.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="10" data-prefix="- " data-suffix=" -" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">- 10 -</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 100%;">

		<tr style="background-color: rgb(230, 230, 230);">
			<td style="vertical-align: bottom; width: 12.1%; border-right: 1px solid rgb(0, 0, 0); border-top: 2px solid rgb(41, 76, 108); border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;"><b>Committee</b></p>
			</td>
			<td style="vertical-align: bottom; width: 39.3%; border-top: 2px solid rgb(41, 76, 108); border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;"><b>Committee Function</b></p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: top; width: 12.1%; border-right: 1px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;"><b>Audit:</b></p>

			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">Yenyou (Jeff) Zheng, Chair</p>

			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">Paul E. Freiman</p>

			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">Swan Sit</p>
			</td>
			<td style="vertical-align: top; width: 39.3%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;">Our Board has determined that each member of the Audit Committee is independent, as defined in the Company Guide and Rule 10A-3 under the Securities Exchange Act of 1934, as amended (the &#8220;<b><i>Exchange Act</i></b>&#8221;). Dr. Jeff Zheng qualifies as an &#8220;audit committee financial expert&#8221;&nbsp;as that term is defined in the rules and regulations established by the SEC.</p>

			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;">&nbsp;</p>

			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;">The functions of this committee include, but are not limited to:</p>

			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;">&nbsp;</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 45pt; text-indent: -9pt;"><img alt="a01.jpg" src="a01.jpg">&nbsp; &nbsp;meeting with our management and our independent registered public accounting firm periodically to consider the adequacy and effectiveness of our disclosure controls and procedures and our internal controls;</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 45pt; text-indent: -9pt;">&nbsp;</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 45pt; text-indent: -9pt;"><img alt="a01.jpg" src="a01.jpg">&nbsp; reporting findings regularly to the Board, including any issues that arise with respect to the quality or integrity of our financial statements, our compliance with legal or regulatory requirements, and the performance and independence of our independent registered public accounting firm;</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 45pt; text-indent: -9pt;">&nbsp;</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 45pt; text-indent: -9pt;"><img alt="a01.jpg" src="a01.jpg">&nbsp; considering and pre-approving all audit and non-audit services to be rendered by our independent registered public accounting firm;</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 45pt; text-indent: -9pt;">&nbsp;</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 45pt; text-indent: -9pt;"><img alt="a01.jpg" src="a01.jpg">&nbsp; appointing, evaluating, engaging and determining the compensation of, overseeing the work of, and, when appropriate, dismissing our independent registered public accounting firm;</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 45pt; text-indent: -9pt;">&nbsp;</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 45pt; text-indent: -9pt;"><img alt="a01.jpg" src="a01.jpg">&nbsp; reviewing with management and our independent registered public accounting firm, prior to public release, our financial statements (including annual and quarterly financial statements in periodic reports to be filed with the SEC);</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 45pt; text-indent: -9pt;">&nbsp;</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 45pt; text-indent: -9pt;"><img alt="a01.jpg" src="a01.jpg">&nbsp; reviewing with our independent registered public accounting firm all of its significant findings during the year, including the status of previous audit recommendations, and any significant unadjusted audit differences;</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 45pt; text-indent: -9pt;">&nbsp;</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 45pt; text-indent: -9pt;"><img alt="a01.jpg" src="a01.jpg">&nbsp; reviewing and discussing with management and our independent registered public accounting firm the accounting policies that may be viewed as critical, and reviewing and discussing any significant changes in our accounting policies and any accounting and financial reporting proposals that may have a significant impact on our financial reports;</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 45pt; text-indent: -9pt;">&nbsp;</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 45pt; text-indent: -9pt;"><img alt="a01.jpg" src="a01.jpg">&nbsp; resolving disagreements between management and our independent registered public accounting firm regarding financial reporting;</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 45pt; text-indent: -9pt;">&nbsp;</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 45pt; text-indent: -9pt;"><img alt="a01.jpg" src="a01.jpg">&nbsp; &nbsp;inquiring of management, the Chief Financial Officer (&#8220;<b><i>CFO</i></b>&#8221;) and/or the Controller, and our independent registered public accounting firm, about significant risks or exposures and assessing the steps management has taken to minimize such risks; and</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 45pt; text-indent: -9pt;">&nbsp;</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 45pt; text-indent: -9pt;"><img alt="a01.jpg" src="a01.jpg">&nbsp; &nbsp;establishing procedures for the receipt, retention and treatment of complaints received by us regarding accounting, internal accounting controls and auditing matters.</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 54pt; text-indent: -9pt;">&nbsp;</p>

			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;">Both our independent registered public accounting firm and internal financial personnel regularly meet privately with the Audit Committee and have unrestricted access to this committee.</p>
			</td>
		</tr>

</table>

<p style="margin: 0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="11" data-prefix="- " data-suffix=" -" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">- 11 -</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 100%;">

		<tr>
			<td style="vertical-align: top; width: 12.1%; border-right: 1px solid rgb(0, 0, 0); border-top: 2px solid rgb(41, 76, 108); border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;"><b>Compensation:</b></p>

			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">Paul E. Freiman, Chair</p>

			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">Yenyou (Jeff) Zheng</p>

			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;">Swan Sit</p>
			</td>
			<td style="vertical-align: top; width: 39.3%; border-top: 2px solid rgb(41, 76, 108); border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;">Our Board has determined that each member of the Compensation Committee is independent, as defined in the Company Guide.</p>

			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;">&nbsp;</p>

			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;">The functions and scope of authority of the Compensation Committee include, but are not limited to:</p>

			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;">&nbsp;</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 45pt; text-indent: -9pt;"><img alt="a01.jpg" src="a01.jpg">&nbsp;establishing, approving and reviewing the overall corporate policies, goals and objectives for the compensation of our CEO and other executive officers, as well as annually evaluating the performance of our CEO and other executive officers in light of the corporate goals and objectives, and determining and approving the compensation of our CEO and other executive officers;</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 45pt; text-indent: -9pt;">&nbsp;</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 45pt; text-indent: -9pt;"><img alt="a01.jpg" src="a01.jpg">&nbsp;periodically reviewing and making recommendations to the Board concerning our equity and other incentive compensation plans, including the need to amend existing plans or adopt new plans or arrangements;</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 45pt; text-indent: -9pt;">&nbsp;</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 45pt; text-indent: -9pt;"><img alt="a01.jpg" src="a01.jpg">&nbsp;assisting the Board in the administration of our stock option plans and any equity or incentive compensation plans, and making recommendations to the Board as to stock option grants and other discretionary awards under such plans as to the executive officers; and</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 45pt; text-indent: -9pt;">&nbsp;</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 45pt; text-indent: -9pt;"><img alt="a01.jpg" src="a01.jpg">&nbsp;reviewing, at least annually, our pension and retirement plans, including any supplemental executive retirement plans, and making recommendations to the Board regarding the need to amend existing plans or adopt new ones for the purpose of implementing the Compensation Committee&#8217;s strategy regarding pension and retirement benefits.</p>

			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 63pt; text-indent: -9pt;">&nbsp;</p>

			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;">Decisions regarding executive compensation are ultimately determined by the Board upon recommendations of the Compensation Committee, which reviews a number of factors in its decisions, including market information about the compensation of executive officers at similarly-sized biotechnology companies within our geographic region, or peer group companies, and recommendations from our CEO and CFO. The CEO and CFO attend all meetings of the Compensation Committee and participate in Compensation Committee discussions setting compensation of NovaBay&#8217;s officers and employees, except neither the CEO nor CFO attend when the CEO&#8217;s compensation package is being discussed and the CFO does not attend when his compensation package is being discussed. This process allows the Compensation Committee to set compensation at levels it believes are appropriate to retain and motivate our named executive officers (&#8220;<b><i>NEOs</i></b>&#8221;).</p>

			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;">&nbsp;</p>

			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;">Future decisions regarding executive compensation will continue to be the responsibility of our Compensation Committee. Outside director compensation is determined by the entire Board after review and approval by the Compensation Committee. Director compensation is discussed further under the caption &#8220;<i>Director Compensation</i>&#8221;&nbsp;below.</p>

			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;">&nbsp;</p>
			</td>
		</tr>

</table>

<p style="margin: 0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="12" data-prefix="- " data-suffix=" -" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">- 12 -</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 100%;">

		<tr>
			<td style="vertical-align: top; width: 12.1%; border-right: 1px solid rgb(0, 0, 0); border-top: 2px solid rgb(41, 76, 108); border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;"><b>Nominating and Corporate Governance:</b></p>

			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">Yenyou (Jeff) Zheng, Chair</p>

			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 9pt;">Paul E. Freiman</p>

			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;">Swan Sit</p>
			</td>
			<td style="vertical-align: top; width: 39.3%; border-top: 2px solid rgb(41, 76, 108); border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;">Our Board has determined that each member of the N&amp;CG Committee is independent, as defined in the Company Guide.</p>

			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;">&nbsp;</p>

			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 9pt;">The functions of the N&amp;CG Committee include, but are not limited to:</p>

			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">&nbsp;</p>

			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 54pt; text-indent: -9pt;"><img alt="a01.jpg" src="a01.jpg">&nbsp;assisting the Board in establishing the minimum qualifications for a director nominee, including the qualities and skills that Board members are expected to possess;</p>

			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 54pt; text-indent: -9pt;">&nbsp;</p>

			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 54pt; text-indent: -9pt;"><img alt="a01.jpg" src="a01.jpg">&nbsp;leading the search for and identifying qualified candidates to become members of our Board;</p>

			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 54pt; text-indent: -9pt;">&nbsp;</p>

			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 54pt; text-indent: -9pt;"><img alt="a01.jpg" src="a01.jpg">&nbsp;selecting nominees for election of directors at the next annual meeting of stockholders (or special meeting of stockholders at which directors are to be elected);</p>

			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 54pt; text-indent: -9pt;">&nbsp;</p>

			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 54pt; text-indent: -9pt;"><img alt="a01.jpg" src="a01.jpg">&nbsp;selecting candidates to fill vacancies on our Board;</p>

			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 54pt; text-indent: -9pt;">&nbsp;</p>

			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 54pt; text-indent: -9pt;"><img alt="a01.jpg" src="a01.jpg">&nbsp;reviewing and recommending to the Board a determination with respect to each director&#8217;s &#8220;independence&#8221;&nbsp;under the listing standards, the rules and regulations of the SEC and any other laws applicable to us;</p>

			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 54pt; text-indent: -9pt;">&nbsp;</p>

			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 54pt; text-indent: -9pt;"><img alt="a01.jpg" src="a01.jpg">&nbsp;receiving, reviewing and responding to director nominations submitted in writing by our stockholders;</p>

			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 54pt; text-indent: -9pt;">&nbsp;</p>

			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 54pt; text-indent: -9pt;"><img alt="a01.jpg" src="a01.jpg">&nbsp;reviewing and assisting the Board in developing a succession plan for the CEO;</p>

			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 54pt; text-indent: -9pt;">&nbsp;</p>

			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 54pt; text-indent: -9pt;"><img alt="a01.jpg" src="a01.jpg">&nbsp;developing, assessing annually, and making recommendations to the Board concerning appropriate corporate governance policies, including our Code of Ethics, and monitoring compliance with our Code of Ethics and other corporate governance policies; and</p>

			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 54pt; text-indent: -9pt;">&nbsp;</p>

			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 54pt; text-indent: -9pt;"><img alt="a01.jpg" src="a01.jpg">&nbsp;overseeing an annual review of the performance of the full Board and management and overseeing the annual self-evaluation process of each Board committee.</p>

			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 63pt; text-indent: -9pt;">&nbsp;</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align: top; width: 101.6%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="color:#294c6c;"><b>Environmental, Social and Governance (ESG)</b></font></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">NovaBay is committed to operating in a sustainable manner and being a responsible corporate citizen for the benefit of our consumers, our investors, the environment, and the communities in which we live and work. Consistent with our values and commitments, NovaBay has taken steps to further its environmental, social and governance (&#8220;<i><b>ESG</b></i>&#8221;) practice, including:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width: 36pt; text-align: justify;">&nbsp;</td>
			<td style="vertical-align: top; width: 18pt; text-align: justify;"><img alt="a01.jpg" src="a01.jpg"></td>
			<td style="vertical-align:top;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">NovaBay and DERMAdoctor are strongly committed to conducting quality control and performance tests before products are marketed to ensure all products meet our high standards. Testing activities are performed by laboratories with ISO 17025 accreditation and FDA registration and no tests are performed on animals.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width: 36pt; text-align: justify;">&nbsp;</td>
			<td style="vertical-align: top; width: 18pt; text-align: justify;"><img alt="a01.jpg" src="a01.jpg"></td>
			<td style="vertical-align:top;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">In the first half of 2020, we responded to the national need for protective personal equipment (&#8220;<i><b>PPE</b></i>&#8221;) by tapping into our international supply network and launching the sale of KN95 Masks and other PPE. In 2022, NovaBay has committed to donating 2.5 million KN95 protective masks to schools, youth groups and other charitable organizations.</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width: 36pt; text-align: justify;">&nbsp;</td>
			<td style="vertical-align: top; width: 18pt; text-align: justify;"><img alt="a01.jpg" src="a01.jpg"></td>
			<td style="vertical-align:top;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">We value our employees and suppliers and prioritize inclusivity, work ethic, collaboration, and a commitment to deliver quality results. In 2021, we continued to monitor and implement COVID-19 protocols for the safety of our employees and other stakeholders.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align: top; width: 101.6%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="color:#294c6c;"><b>Other Board Matters </b></font></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><font style="color:#294c6c;"><b><i>Board</i></b>&#8217;<b><i>s Leadership Structure</i></b></font><i>. </i>Mr. Freiman has served as the Board&#8217;s independent Chairman since March 2019.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="13" data-prefix="- " data-suffix=" -" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">- 13 -</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><font style="color:#294c6c;"><b><i>Board</i></b>&#8217;<b><i>s Role in Risk Oversight</i></b></font>. One of the Board&#8217;s key functions is informed oversight of NovaBay&#8217;s risk management process. The Board does not have a formal risk management committee, but rather administers this oversight function through various standing committees of the Board that address risks inherent in their respective areas of oversight. Our Audit Committee is responsible for considering and discussing financial and enterprise risk exposures, including internal controls, and discusses with management, and the independent registered public accountants, our policies with respect to risk assessment and risk management, including risks related to fraud, liquidity, credit operations and regulatory compliance. In addition, under our whistleblower policy, employees wishing to report concerns or complaints they have related to accounting, auditing and internal controls submit such concerns in confidence, or anonymously if desired, to an outside administrator who forwards such complaints to our Audit Committee Chairman. Our Audit Committee monitors the effectiveness of the whistleblower policy. Our N&amp;CG Committee monitors the effectiveness of our compliance and ethics policies, including whether they are successful in preventing illegal or improper liability-creating conduct, and our compliance with legal and regulatory requirements. Our Compensation Committee monitors NovaBay&#8217;s compensation policies to ensure that the compensation packages offered to our executive officers do not present such individuals with the potential to engage in excessive or inappropriate risk-taking activities.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Management is responsible for the day-to-day management of the risks that we face, while our Board, as a whole and through its committees, has responsibility for the oversight of risk management. In its risk oversight role, the Board is responsible for satisfying itself that our risk management processes are adequate and functioning as designed. Our Board&#8217;s involvement in risk oversight includes receiving regular reports from members of management and evaluating areas of material risk, including operational, financial, legal, regulatory, strategic and reputational risks. As a smaller reporting company with a reasonably-sized Board, we believe it is appropriate to have the involvement and input of all of our directors in risk oversight matters.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><font style="color:#294c6c;"><b><i>Annual Meeting Attendance</i></b></font><i>. </i>We do not have a formal policy regarding attendance by members of our Board at the annual meetings of stockholders; however, directors are encouraged to attend all such meetings. In 2021, all<b> </b>six (6) of our directors then serving attended our 2021 Annual Meeting of Stockholders.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><font style="color:#294c6c;"><b><i>Director Selection</i></b></font>. The N&amp;CG Committee reviews the appropriate qualities and skills required of directors in the context of the current Board composition. This includes an assessment of each candidate&#8217;s independence, personal and professional integrity, financial literacy or other professional or business experience relevant to an understanding of our business, ability to think and act independently and with sound judgment, and ability to serve our stockholders&#8217; long-term interests. These factors, and others deemed appropriate by the N&amp;CG Committee in contributing to our Board&#8217;s heterogeneity, are reviewed in the context of an assessment of the perceived needs of the Board at a particular point in time. As a result, the priorities and emphasis of the N&amp;CG Committee and of the Board may change from time to time to take into account changes in business and other trends, rules and laws related to board criteria, and the portfolio of skills and experience of current and prospective directors. The N&amp;CG Committee leads the search for and selects, or recommends that the Board select, candidates for election to the Board. Consideration of new director candidates typically involves a series of committee discussions, review of information concerning candidates and interviews with selected candidates. Candidates for nomination to our Board typically have been suggested by other members of the Board or by our executive officers or by our large stockholders or investment partners.<i> </i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">From time to time, the N&amp;CG Committee may engage the services of a third-party search firm to identify director candidates. The Board strives to achieve a membership of qualified individuals with a combination of qualities that best serves the Company&#8217;s needs. The N&amp;CG Committee consults with the Board to determine the most appropriate mix of characteristics, skills and experiences for the Board as a whole to possess at any given time and will consider diversity in its process to the extent it deems appropriate. For example, the N&amp;CG Committee took into account (1) gender diversity in its determination to recommend that Ms. Sit be appointed to our Board in 2019 and that Dr. Audrey Kunin and Ms. Garlikov be appointed to our Board in 2022 and (2) ethnic diversity in its determination to recommend that Mr. Wu be appointed to our Board in 2016, that Dr. Jeff Zheng and Ms. Sit be appointed to our Board in 2019 and that Mr. Sean Zheng be appointed to our Board in 2022.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">To identify the best candidates for the Board&#8217;s needs, the N&amp;CG Committee considers the following as the minimum qualifications a nominee must have:</p>

<p style="margin: 0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px; font-family: Times New Roman; font-size: 10pt;">

		<tr style="vertical-align: top; font-family: Times New Roman; font-size: 10pt;">
			<td style="width: 45pt; font-family: Times New Roman; font-size: 10pt;">&nbsp;</td>
			<td style="width: 18pt; text-align: justify; font-family: Times New Roman; font-size: 10pt;"><img alt="a01.jpg" src="a01.jpg"></td>
			<td style="width: auto; font-family: Times New Roman; font-size: 10pt;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">experience at a strategic or policymaking level in a business, government, non-profit or academic organization;</p>
			</td>
		</tr>

</table>

<p style="margin: 0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px; font-family: Times New Roman; font-size: 10pt;">

		<tr style="vertical-align: top; font-family: Times New Roman; font-size: 10pt;">
			<td style="width: 45pt; text-align: justify; font-family: Times New Roman; font-size: 10pt;">&nbsp;</td>
			<td style="width: 18pt; text-align: justify; font-family: Times New Roman; font-size: 10pt;"><img alt="a01.jpg" src="a01.jpg"></td>
			<td style="width: auto; font-family: Times New Roman; font-size: 10pt;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">be highly accomplished in his or her respective field, with superior credentials and recognition;</p>
			</td>
		</tr>

</table>

<p style="font-family: Times New Roman; font-size: 10pt; margin: 0pt; text-align: left;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="14" data-prefix="- " data-suffix=" -" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">- 14 -</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px; font-family: Times New Roman; font-size: 10pt;">

		<tr style="vertical-align: top; font-family: Times New Roman; font-size: 10pt;">
			<td style="width: 45pt; font-family: Times New Roman; font-size: 10pt;">&nbsp;</td>
			<td style="width: 18pt; text-align: justify; font-family: Times New Roman; font-size: 10pt;"><img alt="a01.jpg" src="a01.jpg"></td>
			<td style="width: auto; font-family: Times New Roman; font-size: 10pt;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">be well regarded in the community and possess a long-term reputation for the highest ethical and moral standards;</p>
			</td>
		</tr>

</table>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px; font-family: Times New Roman; font-size: 10pt;">

		<tr style="vertical-align: top; font-family: Times New Roman; font-size: 10pt;">
			<td style="width: 45pt; text-align: justify; font-family: Times New Roman; font-size: 10pt;">&nbsp;</td>
			<td style="width: 18pt; text-align: justify; font-family: Times New Roman; font-size: 10pt;"><img alt="a01.jpg" src="a01.jpg"></td>
			<td style="width: auto; font-family: Times New Roman; font-size: 10pt;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">sufficient time and availability to devote to the affairs of the Company, particularly in light of the number of boards on which the nominee may serve; and</p>
			</td>
		</tr>

</table>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px; font-family: Times New Roman; font-size: 10pt;">

		<tr style="vertical-align: top; font-family: Times New Roman; font-size: 10pt;">
			<td style="width: 45pt; text-align: justify; font-family: Times New Roman; font-size: 10pt;">&nbsp;</td>
			<td style="width: 18pt; text-align: justify; font-family: Times New Roman; font-size: 10pt;"><img alt="a01.jpg" src="a01.jpg"></td>
			<td style="width: auto; font-family: Times New Roman; font-size: 10pt;">
			<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">to the extent such nominee serves or has previously served on other boards, a demonstrated history of actively contributing at board meetings.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The N&amp;CG Committee also considers industry experience or qualifications, such as generic, brand or biotech experience, general management or financial experience, and diverse experience in business, education, government, law, technology, regulatory compliance, medicine and science. When considering candidates for election (or re-election) to the Board, the N&amp;CG Committee considers the entirety of a candidate&#8217;s credentials and background in addition to the specific minimum qualifications outlined above. Moreover, the members of the N&amp;CG Committee believe that each member of the Board should have the highest character and integrity, a reputation for working constructively with others, and minimal conflicts of interest that might interfere with his or her performance as a director.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The N&amp;CG Committee will consider candidates for director recommended by our stockholders who meet the eligibility requirements for submitting stockholder proposals for inclusion in our next proxy statement, as described in the Bylaws and provided that such recommendations are received within the timeframe required under the caption &#8220;<i>Deadline for Receipt of Stockholder Proposals or Nominations</i>&#8221; below. Such stockholder&#8217;s notice shall set forth: (A) as to each nominee such stockholder proposes to nominate at the meeting: (1) the name, age, business address and residence address of such nominee, (2) the principal occupation or employment of such nominee, (3) the class and number of shares of each class of capital stock of the Company which are owned of record and beneficially by such nominee, (4) the date(s) on which such shares were acquired and the investment intent of such acquisition, (5) a statement of whether such nominee, if elected, intends to tender, promptly following such person&#8217;s failure to receive the required vote for election or re-election at the next meeting at which such person would face election or re-election, his or her resignation, and (6) such other information concerning such nominee as would be required to be disclosed in a proxy statement soliciting proxies for the election of such nominee as a director in an election contest (even if an election contest is not involved), or that is otherwise required to be disclosed pursuant to &#167; 14 of the Exchange Act and the rules and regulations promulgated thereunder (including such person&#8217;s written consent to being named as a nominee and to serving as a director if elected); and (B) as of the date of the notice and as to the stockholder giving the notice and the beneficial owner, if any, on whose behalf the nomination or proposal is made (each, a &#8220;<b><i>Proponent</i></b>&#8221; and collectively, the &#8220;<b><i>Proponents</i></b>&#8221;): (1) the name and address of each Proponent, as they appear on the Company&#8217;s books; (2) the class, series and number of shares of the Company that are owned beneficially and of record by each Proponent; (3) a description of any agreement, arrangement or understanding (whether oral or in writing) with respect to such nomination or proposal between or among any Proponent and any of its affiliates or associates, and any others (including their names) acting in concert, or otherwise under the agreement, arrangement or understanding, with any of the foregoing; (4) a representation that the Proponent(s) are holders of record or beneficial owners, as the case may be, of shares of the Company entitled to vote at the meeting and intend to appear in person or by proxy duly authorized at the meeting to nominate the person(s) specified in the notice; (5) a representation as to whether the Proponent(s) intend to deliver a proxy statement and form of proxy to holders of a sufficient number of holders of the Company&#8217;s voting shares to elect such nominee or nominees; (6) to the extent known by any Proponent, the name and address of any other stockholder supporting the proposal on the date of such stockholder&#8217;s notice; and (7) a description of any agreement, arrangement, interest or understanding entered into by, or on behalf or for the benefit of, any Proponent or any of its affiliates or associates, whether record or beneficial (each, a &#8220;<b><i>Derivative Transaction</i></b>&#8221;) by each Proponent during the previous 12-month period, including the date of the transactions and the class, series and number of securities involved in, and the material economic terms of, such Derivative Transactions.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The N&amp;CG Committee evaluates each candidate, including Board incumbents, based on the same criteria. After a candidate has been contacted and agrees to be considered as a nominee, the N&amp;CG Committee will review the candidate&#8217;s resume and other credentials and evaluate the expertise and experience that the candidate would provide to the Board and the Company.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Any potential candidates for director nominee, including candidates recommended by stockholders, are reviewed in the context of the current composition of the Board, our operating requirements and the long-term interests of stockholders. In conducting this assessment, the N&amp;CG Committee considers such factors as it deems appropriate given our current needs and those of our Board to maintain a balance of knowledge, experience and capability. The N&amp;CG Committee reviews directors&#8217; overall service during their term, including the number of meetings attended, level of participation and quality of performance. The N&amp;CG Committee also determines whether the nominee would be independent, which determination is based upon the Company Guide and applicable SEC rules and regulations. The N&amp;CG Committee then compiles a list of potential candidates from suggestions it may receive. The N&amp;CG Committee conducts any appropriate and necessary inquiries into the background and qualifications of possible candidates as it deems appropriate, then meets to discuss and consider such candidates&#8217; qualifications, and then selects a nominee for recommendation to the Board by majority vote.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="15" data-prefix="- " data-suffix=" -" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">- 15 -</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">No candidates for director nominations were submitted to the N&amp;CG Committee by any stockholder in connection with the election of directors at the Annual Meeting.<b> </b> Both of the director nominees standing for election at this Annual Meeting are current directors of NovaBay.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align: top; width: 101.6%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="color:#294c6c;"><b>Stockholder Communications to the Board </b></font></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Our Board has implemented a process by which stockholders may send written communications directly to the attention of the Board, any committee of the Board or any individual Board member, care of our Corporate Secretary, Mr. Justin M. Hall, Esq., at 2000 Powell Street, Suite 1150, Emeryville, California 94608. The name of any specific intended Board recipient should be noted in the communication. Our Corporate Secretary will be responsible for collecting, organizing and monitoring communications from stockholders and, where appropriate depending on the facts and circumstances outlined in the communication, providing copies of such communications to the intended recipients. Communications will be forwarded to directors if they relate to appropriate and important substantive corporate or Board matters. Communications that are primarily commercial in nature or related to an improper or irrelevant topic will not be forwarded to the Board.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="16" data-prefix="- " data-suffix=" -" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">- 16 -</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align: middle; width: 101.6%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:12pt;font-variant:small-caps;text-align:center;margin:0pt;"><font style="text-transform:uppercase;"><font style="color:#294c6c;"><b>Proposal Two: </b></font></font></p>

			<p style="font-family:Times New Roman;font-size:12pt;font-variant:small-caps;text-align:center;margin:0pt;"><font style="text-transform:uppercase;"><font style="color:#294c6c;"><b>Advisory, Non-Binding Vote to Approve Executive </b></font></font></p>

			<p style="font-family:Times New Roman;font-size:12pt;font-variant:small-caps;text-align:center;margin:0pt;"><font style="text-transform:uppercase;"><font style="color:#294c6c;"><b>Compensation</b></font></font></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;text-indent:9pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">In accordance with Section 14(a) of the Exchange Act, stockholders are being given the opportunity to vote on an advisory (non-binding) resolution to approve the compensation of the Company&#8217;s executive officers or NEOs, as described below under &#8220;<i>Executive Compensation and Other Information</i>,&#8221; which includes compensation tables and narrative discussions of the NEOs&#8217; compensation in this Proxy Statement. Consistent with the say-on-frequency voting results at the 2019 Annual Meeting, an advisory vote to approve executive compensation is conducted every three years.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">We are asking our stockholders to indicate their support for our NEO compensation as set forth in this Proxy Statement. This proposal, commonly known as a &#8220;Say-on-Pay&#8221; proposal, gives our stockholders the opportunity to express their views on our NEOs&#8217; compensation. This vote is not intended to address any specific item of compensation, but rather the overall compensation of our NEOs and the philosophies, policies and practices described in this Proxy Statement. We are asking our stockholders to vote &#8220;FOR&#8221; the following non-binding resolution at the Annual Meeting:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 27pt;">&#8220;RESOLVED, that the compensation of NovaBay Pharmaceuticals, Inc.&#8217;s named executive officers, as disclosed in NovaBay&#8217;s Proxy Statement for the 2022 Annual Meeting of Stockholders pursuant to Item 402 of Regulation S-K, including the &#8220;Executive Compensation and Other Information,&#8221; the compensation tables and related narrative disclosures, is hereby approved.&#8221;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:27pt;">The Say-on-Pay vote is advisory, and therefore not binding on NovaBay, the Compensation Committee or the Board. The Board and the Compensation Committee value the opinions of NovaBay&#8217;s stockholders and, to the extent there is any significant vote against the NEO compensation as disclosed in this Proxy Statement, the Board and the Compensation Committee will consider stockholders&#8217; concerns and evaluate whether any actions are necessary to address those concerns.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr style="background-color: rgb(230, 230, 230);">
			<td style="vertical-align: middle; width: 102.2%; border-top: 2px solid rgb(41, 76, 108); border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><font style="color:#294c6c;"><b><u>Recommendation of Our Board</u></b></font></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><font style="color:#294c6c;">Our Board recommends unanimously that you vote &#8220;FOR&#8221;&nbsp;the approval of the compensation of our executive officers.</font></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="17" data-prefix="- " data-suffix=" -" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">- 17 -</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 100%;">

		<tr>
			<td style="vertical-align: middle; width: 108%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:12pt;font-variant:small-caps;text-align:center;margin:0pt;"><font style="text-transform:uppercase;"><font style="color:#294c6c;"><b>Proposal Three: </b></font></font></p>

			<p style="font-family:Times New Roman;font-size:12pt;font-variant:small-caps;text-align:center;margin:0pt;"><font style="text-transform:uppercase;"><b><font style="color:#294c6c;">Advisory, Non-Binding Vote to Ratify the Selection of the</font> </b></font></p>

			<p style="font-family:Times New Roman;font-size:12pt;font-variant:small-caps;text-align:center;margin:0pt;"><font style="text-transform:uppercase;"><font style="color:#294c6c;"><b>Independent Registered Public Accounting Firm </b></font></font></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;text-indent:9pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Audit Committee of our Board has selected WithumSmith+Brown, PC (&#8220;<b><i>Withum</i></b>&#8221;) as our independent registered public accounting firm for the fiscal year ending December 31, 2022. After the 2021 Annual Meeting, as reported by us on a Form 8-K filed with the SEC on July 21, 2021, NovaBay was informed by OUM &amp; Co., LLP (&#8220;<b><i>OUM</i></b>&#8221;) that certain of its assets had been acquired by Withum, effective on July 15, 2021. As a result of the acquisition, OUM requested that NovaBay consent to the assignment and assumption of OUM&#8217;s engagement by NovaBay to Withum, which would provide for Withum to become our independent registered public accounting firm. Withum is registered with the Public Company Accounting Oversight Board (PCAOB) and the Center for Audit Quality and has over 20 years of experience representing public companies with over 200 SEC registrants for which they perform public company audits.&nbsp;After consideration of the request and the background and experience of Withum, the Audit Committee consented to the assignment, and Withum was engaged to serve as our independent registered public accounting firm for the fiscal year ending December 31, 2021. Our stockholders further ratified this engagement at the special meeting of stockholders held on December 17, 2021.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Prior to the acquisition by Withum, OUM served as the Company&#8217;s independent registered public accounting firm since 2011. We are asking our stockholders to ratify the selection by the Audit Committee of Withum as our independent registered public accounting firm to audit our consolidated financial statements for the fiscal year ending December 31, 2022, and to perform other appropriate services. Stockholder ratification of the selection of Withum as our independent registered public accounting firm is not required by the Bylaws or otherwise. In the event that stockholders fail to ratify the appointment, the Audit Committee will reconsider its selection. Even if the selection is ratified, the Audit Committee, in its sole discretion, may direct the appointment of a different independent registered public accounting firm at any time during the year if the Audit Committee feels that such a change would be in the Company&#8217;s best interests and our stockholders&#8217; best interests.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">A representative of Withum is expected to be present at the Annual Meeting, will have the opportunity to make a brief presentation to the stockholders if he or she so desires and is expected to be available to respond to appropriate questions from stockholders.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 100%;">

		<tr>
			<td style="vertical-align: top; width: 108%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="color:#294c6c;"><b>Fees Paid to Independent Registered Public Accounting Firm</b></font></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The following table sets forth the fees billed to us for the fiscal years ended December 31, 2021 and 2020, by Withum and OUM, as applicable, for such years:</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 2.5%; margin-left: 2.5%; width: 95%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.D2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td colspan="2" id=".amt.D2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>2021</b></b></p>
			</td>
			<td id=".trail.D2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td>
			<td id=".lead.D3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td colspan="2" id=".amt.D3" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>2020</b></b></p>
			</td>
			<td id=".trail.D3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(230, 230, 230);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 68%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Audit Fees</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.2" style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">221,550</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.3" style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">268,159</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Audit-Related Fees</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.2" style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">8,905</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">3,592</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(230, 230, 230);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Tax Fees</p>
			</td>
			<td id=".lead.D2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td colspan="2" id=".amt.D2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">&#8213;</p>
			</td>
			<td id=".trail.D2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.D3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td colspan="2" id=".amt.D3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: right;">&#8213;</p>
			</td>
			<td id=".trail.D3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">All Other Fees</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.2" style="width: 13%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);">98,800</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
			<td id=".amt.3" style="width: 13%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);">59,350</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(230, 230, 230);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Total Fees</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td>
			<td id=".amt.2" style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">329,255</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td>
			<td id=".amt.3" style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">331,101</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">&nbsp;</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><b><i>Audit Fees</i></b><i>.</i> Audit fees consisted of fees billed by Withum and OUM, as applicable, for professional services rendered in connection with the audit and quarterly reviews of our consolidated financial statements and other engagements, such as review of documents filed with the SEC.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><b><i>Audit-Related Fees. </i></b>Audit-related fees comprise fees for professional services rendered by Withum and OUM, as applicable that are reasonably related to the performance of the audit or review of our consolidated financial statements and internal controls over financial reporting that are not reported in &#8220;Audit Fees.&#8221;<b> </b>In 2021 and 2020, such audit-related fees were related to out-of-pocket expenses incurred in conjunction with the performance of audits and reviews.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="18" data-prefix="- " data-suffix=" -" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">- 18 -</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><b><i>Tax Fees. </i></b>These are fees for professional services with respect to tax compliance, tax advice and tax planning. There were no such services rendered by Withum or OUM in 2021 and<b> </b>2020 that meet the above category description.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><b><i>All Other Fees</i></b><i>.</i> All other fees consisted of fees associated with the review of registration statements, comfort letters and consents performed by Withum and OUM, as applicable.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 100%;">

		<tr>
			<td style="vertical-align: top; width: 108%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="color:#294c6c;"><b>Policy on Audit Committee Pre-Approval of Audit and Permissible Non-Audit Services</b></font></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">All engagements for services by Withum and OUM or other independent registered public accounting firms are subject to prior approval by the Audit Committee; however, <i>de minimis</i> non-audit services may be approved in accordance with applicable SEC rules. The Audit Committee approved all services provided by Withum and OUM for the fiscal years ended December 31, 2021 and December 31, 2020.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 100%;">

		<tr style="background-color: rgb(230, 230, 230);">
			<td style="vertical-align: middle; width: 108.6%; border-top: 2px solid rgb(41, 76, 108); border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><font style="color:#294c6c;"><b><u>Recommendation of Our Board</u></b></font></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><font style="color:#294c6c;">Our Board recommends unanimously that you vote &#8220;FOR&#8221;&nbsp;the ratification of the selection of </font></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><font style="color:#294c6c;">Withum as our independent registered public accounting firm for the fiscal year ending </font></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><font style="color:#294c6c;">December 31, 2022.</font></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 100%;">

		<tr>
			<td style="vertical-align: top; width: 108%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="color:#294c6c;"><b>Audit Committee Report</b></font></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The following is the report of the Audit Committee with respect to the audited consolidated financial statements of NovaBay Pharmaceuticals, Inc. for the fiscal year ended December 31, 2021, included in the Annual Report on Form 10-K for that year.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Audit Committee has reviewed and discussed the audited financial statements of NovaBay for the fiscal year ended December 31, 2021 with NovaBay&#8217;s management. The Audit Committee has discussed with NovaBay&#8217;s independent registered public accounting firm, Withum, the matters required to be discussed by Auditing Standard No. 61, <i>Communications with Audit Committees</i>, as adopted by the Public Company Accounting Oversight Board (&#8220;<b><i>PCAOB</i></b>&#8221;).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Audit Committee has received the written disclosures and the letter from Withum required by applicable requirements of the PCAOB regarding Withum&#8217;s communications with the Audit Committee concerning independence and has discussed with Withum the independence of Withum.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Based on the review and discussions referred to above in this report, the Audit Committee recommended to NovaBay&#8217;s Board that the audited financial statements be included in NovaBay&#8217;s Annual Report for filing with the SEC.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:99%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:18.7%;">&nbsp;</td>
			<td style="vertical-align:top;width:6.4%;">&nbsp;</td>
			<td style="vertical-align:top;width:3.2%;">&nbsp;</td>
			<td style="vertical-align:top;width:18.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Submitted by the Audit Committee</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">of the Board of Directors:</p>
			</td>
			<td style="vertical-align:top;width:6.4%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:18.7%;">&nbsp;</td>
			<td style="vertical-align:top;width:6.4%;">&nbsp;</td>
			<td style="vertical-align:top;width:3.2%;">&nbsp;</td>
			<td style="vertical-align:top;width:18.7%;">&nbsp;</td>
			<td style="vertical-align:top;width:6.4%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:18.7%;">&nbsp;</td>
			<td style="vertical-align:top;width:6.4%;">&nbsp;</td>
			<td style="vertical-align:top;width:3.2%;">&nbsp;</td>
			<td style="vertical-align:top;width:18.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Yenyou (Jeff) Zheng, Chair</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Paul E. Freiman</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Swan Sit</p>
			</td>
			<td style="vertical-align:top;width:6.4%;">&nbsp;</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="19" data-prefix="- " data-suffix=" -" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">- 19 -</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 100%;">

		<tr>
			<td style="vertical-align: middle; width: 108%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:12pt;font-variant:small-caps;text-align:center;margin:0pt;"><font style="text-transform:uppercase;"><font style="color:#294c6c;"><b>Executive Compensation and Other Information </b></font></font></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;text-indent:9pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 100%;">

		<tr>
			<td style="vertical-align: top; width: 108%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="color:#294c6c;"><b>Executive Officers </b></font></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The table below sets forth certain information regarding our executive officers. Our executive officers are elected by, and serve at the discretion of, our Board of Directors. The following provides the biographical information regarding our Chief Financial Officer and the President of DERMAdoctor. Information concerning the business experience of Mr. Hall and Dr. Audrey Kunin is provided in &#8220;<i>Class II Directors</i>&#8221; and &#8220;<i>Class I Directors</i>&#8221; above, respectively.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 100%;">

		<tr>
			<td style="vertical-align: middle; width: 17.2%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="color:#294c6c;"><b>Name</b></font></p>
			</td>
			<td style="vertical-align: middle; width: 1.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>&nbsp;</b></p>
			</td>
			<td style="vertical-align: middle; width: 4.1%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="color:#294c6c;"><b>Age</b></font></p>
			</td>
			<td style="vertical-align: middle; width: 1.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>&nbsp;</b></p>
			</td>
			<td style="vertical-align: middle; width: 29.6%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="color:#294c6c;"><b>Current Position(s)</b></font></p>
			</td>
		</tr>
		<tr style="background-color: rgb(230, 230, 230);">
			<td style="vertical-align:top;width:17.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Justin M. Hall, Esq.</p>
			</td>
			<td style="vertical-align:top;width:1.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:4.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">44</p>
			</td>
			<td style="vertical-align:top;width:1.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:29.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">CEO &amp; General Counsel and Chief Compliance Officer</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:top;width:17.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Andrew Jones</p>
			</td>
			<td style="vertical-align:top;width:1.4%;">&nbsp;</td>
			<td style="vertical-align:top;width:4.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">51</p>
			</td>
			<td style="vertical-align:top;width:1.4%;">&nbsp;</td>
			<td style="vertical-align:top;width:29.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Chief Financial Officer</p>
			</td>
		</tr>
		<tr style="background-color: rgb(230, 230, 230);">
			<td style="vertical-align:top;width:17.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Dr. Audrey Kunin</p>
			</td>
			<td style="vertical-align:top;width:1.4%;">&nbsp;</td>
			<td style="vertical-align:top;width:4.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">62</p>
			</td>
			<td style="vertical-align:top;width:1.4%;">&nbsp;</td>
			<td style="vertical-align:top;width:29.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Chief Product Officer</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align:top;width:17.2%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Dr. Jeff Kunin</p>
			</td>
			<td style="vertical-align:top;width:1.4%;">&nbsp;</td>
			<td style="vertical-align:top;width:4.1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">59</p>
			</td>
			<td style="vertical-align:top;width:1.4%;">&nbsp;</td>
			<td style="vertical-align:top;width:29.6%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">President, DERMAdoctor</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"><b><i>Andrew Jones </i></b>(&#8220;<b><i>Mr. Jones</i></b>&#8221;) Prior to joining the Company in May 2020, Mr. Jones served as the Vice President of Finance of MyoScience, Inc., a commercial stage company that produces pain management devices, from July 2017 until its acquisition by Pacira BioSciences, Inc. (Nasdaq: PCRX) in August 2019, during which time he was responsible for all financial, accounting, investor relations and risk management functions as well as leading debt and equity fundraising. Mr. Jones has served as Controller for various public and private life sciences companies including Armetheon, Inc. (May 2015 to July 2017), Asante Solutions, Inc. (Oct. 2014 to May 2015) and Genelabs Technologies, Inc. (then, Nasdaq: GNLB) (2005 to 2009) and began his career with PriceWaterhouseCoopers. Mr. Jones received a B.S. degree in Business Administration from the University of Washington in Seattle.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"><b><i>Dr. Jeff Kunin</i></b> co-founded DERMAdoctor and has served as the President and Chief Executive Officer of DERMAdoctor since March 2018. Dr. Jeff Kunin served as the Chairman of the Department of Radiology at Saint Luke&#8217;s Hospital in Kansas City from 2007 to 2017. He graduated college with a B.S. degree in Biochemistry and Cell Biology from the University of California, San Diego. He then graduated medical school and earned his M.D. from the University of Texas Medical Branch in Galveston, Texas. Then he completed a residency in diagnostic radiology at the Medical College of Virginia and Henry Ford Hospital. Subsequently, he completed a fellowship in body imaging at the University of Michigan Hospitals. Dr. Jeff Kunin received his MBA degree from Washington University in St. Louis Olin School of Business.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table cellpadding="0pt" cellspacing="0pt" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 100%; margin-left: 0pt; margin-right: 0pt;">

		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 108%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><font style="color:#294c6c;"><b>Business Highlights </b></font></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:18pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;"><img alt="a01.jpg" src="a01.jpg">&nbsp;</td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Completed the DERMAdoctor Acquisition in November 2021.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:18pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;"><img alt="a01.jpg" src="a01.jpg"></td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Company 2021 full year net product revenue of $8.4 million, which includes $0.6 million from the sale of DERMAdoctor products (since the completion of the DERMAdoctor Acquisition).</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width:100%;font-family:Times New Roman;font-size:10pt;">

		<tr>
			<td style="width:18pt;">&nbsp;</td>
			<td style="vertical-align:top;width:18pt;"><img alt="a01.jpg" src="a01.jpg"></td>
			<td style="vertical-align:top;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Gross profit of $5.6 million in 2021, with a gross profit margin of 67.0% as compared to 60.0% in 2020.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="20" data-prefix="- " data-suffix=" -" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">- 20 -</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table cellpadding="0pt" cellspacing="0pt" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 100%; margin-left: 0pt; margin-right: 0pt;">

		<tr style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<td style="vertical-align: top; width: 108%; border-bottom: 2px solid rgb(41, 76, 108); font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; font-variant: normal; margin: 0pt;"><font style="color:#294c6c;"><b>Summary Compensation Table </b></font></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The following table shows information regarding the compensation earned during the fiscal years ended December 31, 2021 and December 31, 2020 by (1) our Chief Executive Officer, General Counsel and Chief Compliance Officer, (2) our Chief Financial Officer, and (3) our Chief Product Officer. The individuals listed below are collectively referred to as the &#8220;<b><i>NEOs</i></b>&#8221; in this Proxy Statement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 2.5%; margin-left: 2.5%; width: 95%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 16%; border-top: 2px solid rgb(41, 76, 108); border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;"><font style="color:#294c6c;"><b>Name</b> <b>and</b> <b>principal</b> <b>position(s)</b></font></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%; border-top: 2px solid rgb(41, 76, 108);">&nbsp;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 4%; border-top: 2px solid rgb(41, 76, 108); border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><font style="color:#294c6c;"><b>Fiscal</b></font></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><font style="color:#294c6c;"><b>year</b></font></p>
			</td>
			<td id=".lead.D3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-top: 2px solid rgb(41, 76, 108); width: 1%;">&nbsp;</td>
			<td colspan="2" id=".amt.D3" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 2px solid rgb(41, 76, 108); width: 1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><font style="color:#294c6c;"><b><b>Salary</b></b></font></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><font style="color:#294c6c;"><b><b>($)</b></b></font></p>
			</td>
			<td id=".trail.D3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; border-top: 2px solid rgb(41, 76, 108); width: 1%;">&nbsp;</td>
			<td id=".lead.D4" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-top: 2px solid rgb(41, 76, 108); width: 1%;">&nbsp;</td>
			<td colspan="2" id=".amt.D4" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 2px solid rgb(41, 76, 108); width: 1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><font style="color:#294c6c;"><b><b>Bonus</b></b></font></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><font style="color:#294c6c;"><b><b>($)</b></b></font></p>
			</td>
			<td id=".trail.D4" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; border-top: 2px solid rgb(41, 76, 108); width: 1%;">&nbsp;</td>
			<td id=".lead.D5" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-top: 2px solid rgb(41, 76, 108); width: 1%;">&nbsp;</td>
			<td colspan="2" id=".amt.D5" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 2px solid rgb(41, 76, 108); width: 1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><font style="color:#294c6c;"><b><b>Stock </b></b></font></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><font style="color:#294c6c;"><b><b>awards</b></b></font></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><font style="color:#294c6c;"><b><b>($)</b></b></font></p>
			</td>
			<td id=".trail.D5" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; border-top: 2px solid rgb(41, 76, 108); width: 1%;">&nbsp;</td>
			<td id=".lead.D6" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-top: 2px solid rgb(41, 76, 108); width: 1%;">&nbsp;</td>
			<td colspan="2" id=".amt.D6" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 2px solid rgb(41, 76, 108); width: 1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><font style="color:#294c6c;"><b><b>Option </b></b></font></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><font style="color:#294c6c;"><b><b>awards</b><b><sup style="vertical-align:top;line-height:120%;font-size:pt">(1)</sup></b></b></font></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><font style="color:#294c6c;"><b><b>($)</b></b></font></p>
			</td>
			<td id=".trail.D6" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; border-top: 2px solid rgb(41, 76, 108); width: 1%;">&nbsp;</td>
			<td id=".lead.D7" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-top: 2px solid rgb(41, 76, 108); width: 1%;">&nbsp;</td>
			<td colspan="2" id=".amt.D7" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 2px solid rgb(41, 76, 108); width: 1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><font style="color:#294c6c;"><b><b>All other </b></b></font></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><font style="color:#294c6c;"><b><b>compensation</b><b><sup style="vertical-align:top;line-height:120%;font-size:pt">(2)</sup></b></b></font></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><font style="color:#294c6c;"><b><b>($)</b></b></font></p>
			</td>
			<td id=".trail.D7" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; border-top: 2px solid rgb(41, 76, 108); width: 1%;">&nbsp;</td>
			<td id=".lead.D8" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-top: 2px solid rgb(41, 76, 108); width: 1%;">&nbsp;</td>
			<td colspan="2" id=".amt.D8" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 2px solid rgb(41, 76, 108); width: 1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><font style="color:#294c6c;"><b><b>Total</b></b></font></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><font style="color:#294c6c;"><b><b>($)</b></b></font></p>
			</td>
			<td id=".trail.D8" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; border-top: 2px solid rgb(41, 76, 108); width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(230, 230, 230);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 16%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Justin M. Hall, Esq.</p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&nbsp;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2021</p>
			</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.3" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">328,667</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.4" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.4" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.4" style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">70,000</td>
			<td id=".trail.4" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.5" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.5" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.5" style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">395,000</td>
			<td id=".trail.5" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.6" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.6" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.6" style="width: 10%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8722;</td>
			<td id=".trail.6" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.7" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.7" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.7" style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">1,854</td>
			<td id=".trail.7" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.8" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.8" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.8" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">795,521</td>
			<td id=".trail.8" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 16%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;"><i>CEO, GC and Chief </i></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&nbsp;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2020</p>
			</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">286,000</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.4" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.4" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.4" style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">114,000</td>
			<td id=".trail.4" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.5" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.5" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.5" style="width: 10%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8722;</td>
			<td id=".trail.5" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.6" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.6" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.6" style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">346,500</td>
			<td id=".trail.6" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.7" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.7" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.7" style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">720</td>
			<td id=".trail.7" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.8" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.8" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.8" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">747,220</td>
			<td id=".trail.8" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(230, 230, 230);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 16%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;"><i>Compliance Officer</i></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&nbsp;</td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 4%;">&nbsp;</td>
			<td id=".lead.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&nbsp;</td>
			<td id=".symb.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;"><i>&nbsp;</i></td>
			<td id=".amt.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 7%;"><i>&nbsp;</i></td>
			<td id=".trail.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;"><i>&nbsp;</i></td>
			<td id=".lead.B4" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&nbsp;</td>
			<td id=".symb.B4" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;"><i>&nbsp;</i></td>
			<td id=".amt.B4" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 10%;"><i>&nbsp;</i></td>
			<td id=".trail.B4" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;"><i>&nbsp;</i></td>
			<td id=".lead.B5" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&nbsp;</td>
			<td id=".symb.B5" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;"><i>&nbsp;</i></td>
			<td id=".amt.B5" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 10%;"><i>&nbsp;</i></td>
			<td id=".trail.B5" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;"><i>&nbsp;</i></td>
			<td id=".lead.B6" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&nbsp;</td>
			<td id=".symb.B6" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;"><i>&nbsp;</i></td>
			<td id=".amt.B6" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 10%;"><i>&nbsp;</i></td>
			<td id=".trail.B6" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;"><i>&nbsp;</i></td>
			<td id=".lead.B7" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&nbsp;</td>
			<td id=".symb.B7" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;"><i>&nbsp;</i></td>
			<td id=".amt.B7" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 10%;"><i>&nbsp;</i></td>
			<td id=".trail.B7" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;"><i>&nbsp;</i></td>
			<td id=".lead.B8" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&nbsp;</td>
			<td id=".symb.B8" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;"><i>&nbsp;</i></td>
			<td id=".amt.B8" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 7%;"><i>&nbsp;</i></td>
			<td id=".trail.B8" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;"><i>&nbsp;</i></td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="width: 16%;">&nbsp;</td>
			<td style="width: 1%;">&nbsp;</td>
			<td style="width: 4%;">&nbsp;</td>
			<td id=".lead.B3" style="width: 1%;">&nbsp;</td>
			<td id=".symb.B3" style="width: 1%;">&nbsp;</td>
			<td id=".amt.B3" style="width: 7%;">&nbsp;</td>
			<td id=".trail.B3" style="width: 1%;">&nbsp;</td>
			<td id=".lead.B4" style="width: 1%;">&nbsp;</td>
			<td id=".symb.B4" style="width: 1%;">&nbsp;</td>
			<td id=".amt.B4" style="width: 10%;">&nbsp;</td>
			<td id=".trail.B4" style="width: 1%;">&nbsp;</td>
			<td id=".lead.B5" style="width: 1%;">&nbsp;</td>
			<td id=".symb.B5" style="width: 1%;">&nbsp;</td>
			<td id=".amt.B5" style="width: 10%;">&nbsp;</td>
			<td id=".trail.B5" style="width: 1%;">&nbsp;</td>
			<td id=".lead.B6" style="width: 1%;">&nbsp;</td>
			<td id=".symb.B6" style="width: 1%;">&nbsp;</td>
			<td id=".amt.B6" style="width: 10%;">&nbsp;</td>
			<td id=".trail.B6" style="width: 1%;">&nbsp;</td>
			<td id=".lead.B7" style="width: 1%;">&nbsp;</td>
			<td id=".symb.B7" style="width: 1%;">&nbsp;</td>
			<td id=".amt.B7" style="width: 10%;">&nbsp;</td>
			<td id=".trail.B7" style="width: 1%;">&nbsp;</td>
			<td id=".lead.B8" style="width: 1%;">&nbsp;</td>
			<td id=".symb.B8" style="width: 1%;">&nbsp;</td>
			<td id=".amt.B8" style="width: 7%;">&nbsp;</td>
			<td id=".trail.B8" style="width: 1%;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(230, 230, 230);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 16%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Andrew Jones<sup style="vertical-align:top;line-height:120%;font-size:pt">(3)</sup></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&nbsp;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2021</p>
			</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.3" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">291,667</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.4" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.4" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.4" style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">73,500</td>
			<td id=".trail.4" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.5" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.5" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.5" style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">197,500</td>
			<td id=".trail.5" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.6" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.6" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.6" style="width: 10%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8722;</td>
			<td id=".trail.6" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.7" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.7" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.7" style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">1,854</td>
			<td id=".trail.7" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.8" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.8" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.8" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">564,521</td>
			<td id=".trail.8" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 16%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;"><i>Chief Financial Officer</i></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&nbsp;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2020</p>
			</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">182,452</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.4" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.4" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.4" style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">54,669</td>
			<td id=".trail.4" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.5" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.5" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.5" style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">164,800</td>
			<td id=".trail.5" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.6" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.6" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.6" style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">333,750</td>
			<td id=".trail.6" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.7" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.7" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.7" style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">1,104</td>
			<td id=".trail.7" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.8" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.8" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.8" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">736,775</td>
			<td id=".trail.8" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(230, 230, 230);">
			<td style="width: 16%;">&nbsp;</td>
			<td style="width: 1%;">&nbsp;</td>
			<td style="width: 4%;">&nbsp;</td>
			<td id=".lead.B3" style="width: 1%;">&nbsp;</td>
			<td id=".symb.B3" style="width: 1%;">&nbsp;</td>
			<td id=".amt.B3" style="width: 7%;">&nbsp;</td>
			<td id=".trail.B3" style="width: 1%;">&nbsp;</td>
			<td id=".lead.B4" style="width: 1%;">&nbsp;</td>
			<td id=".symb.B4" style="width: 1%;">&nbsp;</td>
			<td id=".amt.B4" style="width: 10%;">&nbsp;</td>
			<td id=".trail.B4" style="width: 1%;">&nbsp;</td>
			<td id=".lead.B5" style="width: 1%;">&nbsp;</td>
			<td id=".symb.B5" style="width: 1%;">&nbsp;</td>
			<td id=".amt.B5" style="width: 10%;">&nbsp;</td>
			<td id=".trail.B5" style="width: 1%;">&nbsp;</td>
			<td id=".lead.B6" style="width: 1%;">&nbsp;</td>
			<td id=".symb.B6" style="width: 1%;">&nbsp;</td>
			<td id=".amt.B6" style="width: 10%;">&nbsp;</td>
			<td id=".trail.B6" style="width: 1%;">&nbsp;</td>
			<td id=".lead.B7" style="width: 1%;">&nbsp;</td>
			<td id=".symb.B7" style="width: 1%;">&nbsp;</td>
			<td id=".amt.B7" style="width: 10%;">&nbsp;</td>
			<td id=".trail.B7" style="width: 1%;">&nbsp;</td>
			<td id=".lead.B8" style="width: 1%;">&nbsp;</td>
			<td id=".symb.B8" style="width: 1%;">&nbsp;</td>
			<td id=".amt.B8" style="width: 7%;">&nbsp;</td>
			<td id=".trail.B8" style="width: 1%;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 16%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Dr. Audrey Kunin<sup style="vertical-align:top;line-height:120%;font-size:pt">(4)</sup></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&nbsp;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">2021</p>
			</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.3" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">31,538</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.4" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.4" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.4" style="width: 10%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8722;</td>
			<td id=".trail.4" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.5" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.5" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.5" style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">177,000</td>
			<td id=".trail.5" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.6" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.6" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.6" style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">86,715</td>
			<td id=".trail.6" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.7" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.7" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.7" style="width: 10%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8722;</td>
			<td id=".trail.7" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.8" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.8" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.8" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">295,253</td>
			<td id=".trail.8" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(230, 230, 230);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 2px solid rgb(41, 76, 108); width: 16%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;"><i>Chief Product Officer</i></p>
			</td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 2px solid rgb(41, 76, 108); width: 1%;">&nbsp;</td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 2px solid rgb(41, 76, 108); width: 4%;">&nbsp;</td>
			<td id=".lead.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 2px solid rgb(41, 76, 108); width: 1%;">&nbsp;</td>
			<td id=".symb.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 2px solid rgb(41, 76, 108); width: 1%;"><i>&nbsp;</i></td>
			<td id=".amt.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 2px solid rgb(41, 76, 108); width: 7%;"><i>&nbsp;</i></td>
			<td id=".trail.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 2px solid rgb(41, 76, 108); width: 1%;"><i>&nbsp;</i></td>
			<td id=".lead.B4" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 2px solid rgb(41, 76, 108); width: 1%;">&nbsp;</td>
			<td id=".symb.B4" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 2px solid rgb(41, 76, 108); width: 1%;"><i>&nbsp;</i></td>
			<td id=".amt.B4" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 2px solid rgb(41, 76, 108); width: 10%;"><i>&nbsp;</i></td>
			<td id=".trail.B4" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 2px solid rgb(41, 76, 108); width: 1%;"><i>&nbsp;</i></td>
			<td id=".lead.B5" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 2px solid rgb(41, 76, 108); width: 1%;">&nbsp;</td>
			<td id=".symb.B5" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 2px solid rgb(41, 76, 108); width: 1%;"><i>&nbsp;</i></td>
			<td id=".amt.B5" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 2px solid rgb(41, 76, 108); width: 10%;"><i>&nbsp;</i></td>
			<td id=".trail.B5" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 2px solid rgb(41, 76, 108); width: 1%;"><i>&nbsp;</i></td>
			<td id=".lead.B6" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 2px solid rgb(41, 76, 108); width: 1%;">&nbsp;</td>
			<td id=".symb.B6" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 2px solid rgb(41, 76, 108); width: 1%;"><i>&nbsp;</i></td>
			<td id=".amt.B6" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 2px solid rgb(41, 76, 108); width: 10%;"><i>&nbsp;</i></td>
			<td id=".trail.B6" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 2px solid rgb(41, 76, 108); width: 1%;"><i>&nbsp;</i></td>
			<td id=".lead.B7" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 2px solid rgb(41, 76, 108); width: 1%;">&nbsp;</td>
			<td id=".symb.B7" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 2px solid rgb(41, 76, 108); width: 1%;"><i>&nbsp;</i></td>
			<td id=".amt.B7" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 2px solid rgb(41, 76, 108); width: 10%;"><i>&nbsp;</i></td>
			<td id=".trail.B7" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 2px solid rgb(41, 76, 108); width: 1%;"><i>&nbsp;</i></td>
			<td id=".lead.B8" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 2px solid rgb(41, 76, 108); width: 1%;">&nbsp;</td>
			<td id=".symb.B8" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 2px solid rgb(41, 76, 108); width: 1%;"><i>&nbsp;</i></td>
			<td id=".amt.B8" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 2px solid rgb(41, 76, 108); width: 7%;"><i>&nbsp;</i></td>
			<td id=".trail.B8" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 2px solid rgb(41, 76, 108); width: 1%;"><i>&nbsp;</i></td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&nbsp;</p>

<hr style="text-align: left; height: 1px; color: #000000; background-color: #000000; width: 10%; border: none; margin: 3pt auto 3pt 0">
<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt">(1)</sup></p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">These amounts represent the aggregate grant date fair value of the equity awards granted to the Company&#8217;s NEOs during the fiscal year. The aggregate grant date fair value is computed in accordance with FASB ASC Topic 718, excluding the effect of estimated forfeitures. See Note 15, &#8220;Equity-Based Compensation&#8221; to the Company&#8217;s consolidated financial statements in our Annual Report, regarding assumptions underlying the valuation of the Company&#8217;s equity awards. These amounts do not correspond to the actual value that may be recognized by the Company&#8217;s NEOs.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt">(2)</sup></p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">These amounts include individual life insurance premiums paid for by the Company.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt">(3)</sup></p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">Mr. Jones was appointed our Chief Financial Officer effective May 4, 2020, and therefore 2020 compensation only reflects a partial year.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt">(4)</sup></p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">Dr. Audrey Kunin was appointed our Chief Product Officer effective November 5, 2021, and therefore 2021 compensation only reflects a partial year.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="color:#294c6c;"><b><i>Compensation Peer Survey</i></b></font></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company&#8217;s most recent formal compensation peer survey conducted by a third party was in 2021. The Compensation Committee retained Pay Governance LLC (the &#8220;<b><i>Compensation Consultant</i></b>&#8221;) to conduct a survey (the &#8220;<b><i>Pay Governance Survey</i></b>&#8221;) of the Company&#8217;s executive compensation program and Board compensation program and recommend any appropriate changes for 2021. The Pay Governance Survey benchmarked the Company&#8217;s compensation practices as compared to the Company&#8217;s peer group. The Company&#8217;s peer group was approved by the Compensation Committee on May 4, 2021 and is comprised of the following 17 comparably-sized pharmaceutical companies:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 100%;">

		<tr>
			<td style="vertical-align: top; width: 37.9%; background-color: rgb(230, 230, 230); border-top: 2px solid rgb(41, 76, 108); border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">AcelRx Pharmaceuticals, Inc.</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Adamis Pharmaceuticals Corporation</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Alimera Sciences, Inc.</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Anika Therapeutics, Inc.</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Aytu BioScience, Inc.</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">BioDelivery Sciences International, Inc.</p>
			</td>
			<td style="vertical-align: top; width: 34%; border-top: 2px solid rgb(41, 76, 108); border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Cipher Pharmaceuticals Inc.</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Cumberland Pharmaceuticals Inc.</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">DURECT Corporation</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">EyeGate Pharmaceuticals, Inc.</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">EyePoint Pharmaceuticals, Inc.</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Harrow Health, Inc.</p>
			</td>
			<td style="vertical-align: top; width: 30.4%; background-color: rgb(230, 230, 230); border-top: 2px solid rgb(41, 76, 108); border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Jaguar Health, Inc.</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Neos Therapeutics, Inc.</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Otonomy, Inc.</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Plus Therapeutics, Inc.</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Sonoma Pharmaceuticals, Inc.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Pay Governance Survey found that while the Company is positioned slightly above the 25th percentile of the peer group on a revenue basis, the Company&#8217;s overall compensation to Messrs. Hall and Jones was below the peer median, particularly (1) the Company&#8217;s base salary amount and target bonus amount for Mr. Hall, which was below the market 25th percentile, (2) the Company&#8217;s base salary amount and target bonus amount for Mr. Jones, which was below the regressed revenue median, and (3) the Company&#8217;s long-term incentive equity grants for both Messrs. Hall and Jones, which were below the market 25th percentile.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="21" data-prefix="- " data-suffix=" -" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">- 21 -</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">As a result of the Pay Governance Survey and based on the Compensation Consultant&#8217;s recommendations, the Compensation Committee approved increases to Messrs. Hall&#8217;s and Jones&#8217; annual base salary and target bonus amounts to be effective as of May 1, 2021. The base salary of Mr. Justin Hall, the Company&#8217;s Chief Executive Officer and General Counsel, increased from $286,000 to $350,000 and his target bonus percentage of base salary increased from 40% to 50%. The base salary of Mr. Andrew Jones, the Company&#8217;s Chief Financial Officer, increased from $275,000 to $300,000 and his target bonus percentage of base salary increased from 30% to 35%.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="color:#294c6c;"><b><i>2021 and 2020 Cash Bonuses </i></b></font></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Board, upon the recommendation of the Compensation Committee, established Mr. Hall and Mr. Jones would receive a bonus of $70,000 and $73,500, respectively, for fiscal year 2021 performance. Dr. Audrey Kunin was not granted a bonus for fiscal year 2021 due to her beginning date of service on November 5, 2021.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Board, upon the recommendation of the Compensation Committee, established Mr. Hall and Mr. Jones would receive a bonus of $114,000 and $54,669, respectively, for fiscal year 2020 performance (with Mr. Jones&#8217; bonus only reflecting his partial year of service in 2020).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="color:#294c6c;"><b><i>2021 Equity Awards </i></b></font></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">On May 4, 2021, the Compensation Committee granted performance restricted stock units (&#8220;<b><i>Performance RSUs</i></b>&#8221;) to Messrs. Hall and Jones in the amount of 500,000 Performance RSUs and 250,000 Performance RSUs, respectively. Subsequently, on November 5, 2021, Dr. Audrey Kunin was granted 300,000 Performance RSUs in relation to her Executive Employment Agreement (as described in more detail below).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Performance RSUs are designed to align each executive&#8217;s total direct compensation with the long-term interests of the Company and its stockholders by further linking compensation to performance. The Performance RSUs represent the right to receive a number of shares of the Company&#8217;s common stock on a one-to-one basis with the number of Performance RSUs granted, subject to the Company's achievement of certain performance goals set forth in the award agreement. Under the Performance RSUs, the awards will vest based on the achievement of three performance goals as determined by the Compensation Committee at the end of the performance period ending December 31, 2023.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Performance RSUs are tied to three categories of performance goals to be achieved during the performance period, which will be equally weighted at the end of the performance period: (1) 1/3 of the Performance RSUs will be earned if the Company&#8217;s revenue meets a threshold amount for a trailing 12 month period; (2) 1/3 of the Performance RSUs will be earned if the Company achieves a threshold amount of cash flow for at least two consecutive quarters; and (3) 1/3 of the Performance RSUs will be earned if the Company achieves a threshold market capitalization for twenty consecutive trading days.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Performance RSUs will only vest upon the achievement of the performance goals as determined by the Compensation Committee at the end of the performance period, subject, in general, to the executive's continuous employment with the Company through the end of the performance period; provided, however, an executive will be entitled to a pro-rated portion of the award in the event that his employment ceases upon his death or permanent disability. Further, if a change in control of the Company occurs, the Performance RSUs will immediately vest, even if the performance goals have not been met, and be settled in the form of consideration consistent with the terms of the change in control.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">On November 5, 2021, Dr. Audrey Kunin was also granted 150,000 stock options in relation to her Executive Employment Agreement (as described in more detail below). Such stock options will vest over a two (2) year period (with 50% of the options vesting on the one-year anniversary of Dr. Audrey Kunin&#8217;s first day of employment and the remaining 50% of the Options vesting on the two (2) year anniversary of Dr. Audrey Kunin&#8217;s employment immediately prior to the expiration of the term of her Employment Agreement).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="22" data-prefix="- " data-suffix=" -" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">- 22 -</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="color:#294c6c;"><b><i>2020 Equity Awards</i></b></font></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">On August 20, 2020, Mr. Hall and Mr. Jones were awarded 350,000 and 75,000 stock options, respectively, to vest over four years. In 2020, Mr. Jones was also granted 160,000 restricted stock units and 300,000 stock options in relation to his Executive Employment Agreement (as described in more detail below). Such restricted stock units will fully vest on the one year anniversary of his first day of employment and such stock options will vest over four years.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="color:#294c6c;"><b><i>Federal Income Tax Law </i></b></font></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Federal income tax law prohibits publicly held companies, such as the Company, from deducting compensation paid to a NEO that exceeds $1 million during the tax year. Prior to the adoption of the Tax Cuts and Jobs Act of 2017 (&#8220;<b><i>Tax Act</i></b>&#8221;), to the extent that compensation was based upon the attainment of performance goals set by the Compensation Committee pursuant to plans approved by the stockholders, the compensation was exempted from the $1 million deduction limit. The Tax Act repealed this exemption, and now compensation paid to NEOs in excess of $1 million is no longer deductible, even if performance-based. The Compensation Committee intends to continue to use performance metrics in compensation when it is in the best interests of the Company and its stockholders even if such compensation is not deductible for tax purposes.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 100%;">

		<tr>
			<td style="vertical-align: top; width: 108%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="color:#294c6c;"><b>Outstanding Equity Awards at Fiscal Year End</b></font></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The following table presents the outstanding equity awards, as of December 31, 2021, held by each of our NEOs. Stock options were granted pursuant to our 2002 Stock Option Plan (&#8220;<b><i>2002 Plan</i></b>&#8221;) and 2005 Stock Option Plan (&#8220;<b><i>2005 Plan</i></b>&#8221;) prior to our initial public offering in October 2007, pursuant to our 2007 Plan thereafter until its expiration in March 2017, and all awards since then have been pursuant to our 2017 Omnibus Incentive Plan (&#8220;<b><i>2017 Plan</i></b>&#8221;). All options granted under our 2002 Plan and 2005 Plan were immediately exercisable and subject to a right of repurchase for any shares exercised prior to vesting. The options granted under our 2007 Plan and 2017 Plan are not exercisable until they have vested.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 12%; border-top: 2px solid rgb(41, 76, 108);">&nbsp;</td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%; border-top: 2px solid rgb(41, 76, 108);">&nbsp;</td>
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 7%; border-top: 2px solid rgb(41, 76, 108);">&nbsp;</td>
			<td id=".lead.D6" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%; border-top: 2px solid rgb(41, 76, 108);">&nbsp;</td>
			<td colspan="14" id=".amt.D6" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 31%; border-top: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b><b>Option Awards</b></b></b></p>
			</td>
			<td id=".trail.D6" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; width: 1%; border-top: 2px solid rgb(41, 76, 108);">&nbsp;</td>
			<td id=".lead.D10" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%; border-top: 2px solid rgb(41, 76, 108);">&nbsp;</td>
			<td colspan="14" id=".amt.D10" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); width: 31%; border-top: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b><b>Stock Awards</b></b></b></p>
			</td>
			<td id=".trail.D10" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; width: 1%; border-top: 2px solid rgb(41, 76, 108);">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 12%; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;"><font style="color:#294c6c;"><b>Name</b></font></p>
			</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 1%;">&nbsp;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 7%; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><font style="color:#294c6c;"><b>Grant date</b></font></p>
			</td>
			<td id=".lead.D3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%; padding-bottom: 1px;">&nbsp;</td>
			<td colspan="2" id=".amt.D3" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><font style="color:#294c6c;"><b><b>Number of securities underlying unexercised options</b></b></font></b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><font style="color:#294c6c;"><b><b>(#)</b></b></font></b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><font style="color:#294c6c;"><b><b>exercisable</b><sup style="vertical-align:top;line-height:120%;font-size:pt">(1)</sup></b></font></b></p>
			</td>
			<td id=".trail.D3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%; padding-bottom: 1px;">&nbsp;</td>
			<td id=".lead.D4" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%; padding-bottom: 1px;">&nbsp;</td>
			<td colspan="2" id=".amt.D4" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><font style="color:#294c6c;"><b><b>Number of securities underlying unexercised options</b></b></font></b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><font style="color:#294c6c;"><b><b>(#)</b></b></font></b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><font style="color:#294c6c;"><b><b>unexercisable</b><sup style="vertical-align:top;line-height:120%;font-size:pt">(1)</sup></b></font></b></p>
			</td>
			<td id=".trail.D4" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%; padding-bottom: 1px;">&nbsp;</td>
			<td id=".lead.D5" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%; padding-bottom: 1px;">&nbsp;</td>
			<td colspan="2" id=".amt.D5" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><font style="color:#294c6c;"><b><b>Option exercise price</b></b></font></b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><font style="color:#294c6c;"><b><b>($)</b></b></font></b></p>
			</td>
			<td id=".trail.D5" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%; padding-bottom: 1px;">&nbsp;</td>
			<td id=".lead.D6" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%; padding-bottom: 1px;">&nbsp;</td>
			<td colspan="2" id=".amt.D6" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><font style="color:#294c6c;"><b><b>Option expiration date</b></b></font></b></p>
			</td>
			<td id=".trail.D6" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%; padding-bottom: 1px;">&nbsp;</td>
			<td id=".lead.D7" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%; padding-bottom: 1px;">&nbsp;</td>
			<td colspan="2" id=".amt.D7" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><font style="color:#294c6c;"><b><b>Number of shares or units of stock that have not vested</b><b><sup style="vertical-align:top;line-height:120%;font-size:pt"> </sup></b><b>(#)</b></b></font></b></p>
			</td>
			<td id=".trail.D7" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%; padding-bottom: 1px;">&nbsp;</td>
			<td id=".lead.D8" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%; padding-bottom: 1px;">&nbsp;</td>
			<td colspan="2" id=".amt.D8" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><font style="color:#294c6c;"><b><b>Market value of shares or units of stock that have not vested ($)</b></b></font></b></p>
			</td>
			<td id=".trail.D8" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%; padding-bottom: 1px;">&nbsp;</td>
			<td id=".lead.D9" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%; padding-bottom: 1px;">&nbsp;</td>
			<td colspan="2" id=".amt.D9" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><font style="color:#294c6c;"><b><b>Equity incentive plan awards: number of unearned shares, units or other rights that have not vested</b><b><sup style="vertical-align:top;line-height:120%;font-size:pt"> </sup></b></b></font></b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><font style="color:#294c6c;"><b><b>(#)</b></b></font></b></p>
			</td>
			<td id=".trail.D9" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%; padding-bottom: 1px;">&nbsp;</td>
			<td id=".lead.D10" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%; padding-bottom: 1px;">&nbsp;</td>
			<td colspan="2" id=".amt.D10" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 1%; border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><font style="color:#294c6c;"><b><b>Equity incentive plan awards: market or payout value of unearned shares, units or other rights that have not vested</b></b></font></b></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><font style="color:#294c6c;"><b><b>($)</b></b></font></b></p>
			</td>
			<td id=".trail.D10" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%; padding-bottom: 1px;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(230, 230, 230);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Justin M. Hall, Esq.</p>
			</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 1%;">&nbsp;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">05/04/21</p>
			</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#8211;</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.4" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.4" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.4" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#8211;</td>
			<td id=".trail.4" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.5" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.5" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.5" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#8211;</td>
			<td id=".trail.5" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.6" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.6" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.6" style="width: 7%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: center;">&nbsp; &nbsp; &nbsp;&#8211;</td>
			<td id=".trail.6" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.7" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.7" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.7" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#8211;</td>
			<td id=".trail.7" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.8" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.8" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.8" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#8211;</td>
			<td id=".trail.8" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.9" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.9" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.9" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">500,000</td>
			<td id=".trail.9" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; vertical-align: middle;"><sup style="vertical-align:top;line-height:120%;font-size:pt">(2)</sup></td>
			<td id=".lead.10" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.10" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.10" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">395,000</td>
			<td id=".trail.10" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 12%;">&nbsp;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 1%;">&nbsp;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">08/20/20</p>
			</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">109,375</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.4" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.4" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.4" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">240,625</td>
			<td id=".trail.4" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.5" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.5" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.5" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">0.99</td>
			<td id=".trail.5" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.D6" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&nbsp;</td>
			<td colspan="2" id=".amt.D6" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">08/20/30</p>
			</td>
			<td id=".trail.D6" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&nbsp;</td>
			<td id=".lead.7" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.7" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.7" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#8211;</td>
			<td id=".trail.7" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.8" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.8" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.8" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#8211;</td>
			<td id=".trail.8" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.9" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.9" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.9" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#8211;</td>
			<td id=".trail.9" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.10" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.10" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.10" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#8211;</td>
			<td id=".trail.10" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(230, 230, 230);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 12%;">&nbsp;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 1%;">&nbsp;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">05/31/18</p>
			</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">166,250</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.4" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.4" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.4" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">23,750</td>
			<td id=".trail.4" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.5" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.5" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.5" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">2.20</td>
			<td id=".trail.5" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.D6" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&nbsp;</td>
			<td colspan="2" id=".amt.D6" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">05/31/28</p>
			</td>
			<td id=".trail.D6" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&nbsp;</td>
			<td id=".lead.7" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.7" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.7" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#8211;</td>
			<td id=".trail.7" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.8" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.8" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.8" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#8211;</td>
			<td id=".trail.8" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.9" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.9" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.9" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#8211;</td>
			<td id=".trail.9" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.10" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.10" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.10" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#8211;</td>
			<td id=".trail.10" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 12%;">&nbsp;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 1%;">&nbsp;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">01/25/17</p>
			</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">21,450</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; vertical-align: top;"><sup style="vertical-align:top;line-height:120%;font-size:pt">(3)</sup></td>
			<td id=".lead.4" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.4" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.4" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#8211;</td>
			<td id=".trail.4" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.5" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.5" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.5" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">3.60</td>
			<td id=".trail.5" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.D6" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&nbsp;</td>
			<td colspan="2" id=".amt.D6" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">01/25/27</p>
			</td>
			<td id=".trail.D6" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&nbsp;</td>
			<td id=".lead.7" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.7" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.7" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#8211;</td>
			<td id=".trail.7" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.8" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.8" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.8" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#8211;</td>
			<td id=".trail.8" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.9" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.9" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.9" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#8211;</td>
			<td id=".trail.9" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.10" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.10" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.10" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#8211;</td>
			<td id=".trail.10" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(230, 230, 230);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 12%;">&nbsp;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 1%;">&nbsp;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">06/06/16</p>
			</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">130,000</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; vertical-align: top;"><sup style="vertical-align:top;line-height:120%;font-size:pt">(4)</sup></td>
			<td id=".lead.4" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.4" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.4" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#8211;</td>
			<td id=".trail.4" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.5" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.5" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.5" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">2.78</td>
			<td id=".trail.5" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.D6" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&nbsp;</td>
			<td colspan="2" id=".amt.D6" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">06/06/26</p>
			</td>
			<td id=".trail.D6" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&nbsp;</td>
			<td id=".lead.7" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.7" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.7" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#8211;</td>
			<td id=".trail.7" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.8" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.8" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.8" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#8211;</td>
			<td id=".trail.8" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.9" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.9" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.9" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#8211;</td>
			<td id=".trail.9" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.10" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.10" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.10" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#8211;</td>
			<td id=".trail.10" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 12%;">&nbsp;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 1%;">&nbsp;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">10/01/15</p>
			</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">2,000</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.4" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.4" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.4" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#8211;</td>
			<td id=".trail.4" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.5" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.5" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.5" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">6.75</td>
			<td id=".trail.5" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.D6" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&nbsp;</td>
			<td colspan="2" id=".amt.D6" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">10/01/25</p>
			</td>
			<td id=".trail.D6" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&nbsp;</td>
			<td id=".lead.7" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.7" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.7" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#8211;</td>
			<td id=".trail.7" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.8" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.8" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.8" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#8211;</td>
			<td id=".trail.8" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.9" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.9" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.9" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#8211;</td>
			<td id=".trail.9" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.10" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.10" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.10" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#8211;</td>
			<td id=".trail.10" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(230, 230, 230);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 12%;">&nbsp;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 1%;">&nbsp;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">09/26/14</p>
			</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">1,200</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.4" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.4" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.4" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#8211;</td>
			<td id=".trail.4" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.5" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.5" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.5" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">18.75</td>
			<td id=".trail.5" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.D6" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&nbsp;</td>
			<td colspan="2" id=".amt.D6" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">09/26/24</p>
			</td>
			<td id=".trail.D6" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&nbsp;</td>
			<td id=".lead.7" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.7" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.7" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#8211;</td>
			<td id=".trail.7" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.8" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.8" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.8" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#8211;</td>
			<td id=".trail.8" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.9" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.9" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.9" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#8211;</td>
			<td id=".trail.9" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.10" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.10" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.10" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#8211;</td>
			<td id=".trail.10" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 12%;">&nbsp;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 1%;">&nbsp;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">09/26/13</p>
			</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">760</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.4" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.4" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.4" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#8211;</td>
			<td id=".trail.4" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.5" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.5" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.5" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">42.75</td>
			<td id=".trail.5" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.D6" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&nbsp;</td>
			<td colspan="2" id=".amt.D6" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">09/26/23</p>
			</td>
			<td id=".trail.D6" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&nbsp;</td>
			<td id=".lead.7" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.7" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.7" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#8211;</td>
			<td id=".trail.7" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.8" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.8" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.8" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#8211;</td>
			<td id=".trail.8" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.9" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.9" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.9" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#8211;</td>
			<td id=".trail.9" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.10" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.10" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.10" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#8211;</td>
			<td id=".trail.10" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(230, 230, 230);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 12%;">&nbsp;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 1%;">&nbsp;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">02/01/13</p>
			</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">1,200</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.4" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.4" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.4" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#8211;</td>
			<td id=".trail.4" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.5" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.5" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.5" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">30.50</td>
			<td id=".trail.5" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.D6" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&nbsp;</td>
			<td colspan="2" id=".amt.D6" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">02/01/23</p>
			</td>
			<td id=".trail.D6" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&nbsp;</td>
			<td id=".lead.7" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.7" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.7" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#8211;</td>
			<td id=".trail.7" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.8" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.8" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.8" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#8211;</td>
			<td id=".trail.8" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.9" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.9" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.9" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#8211;</td>
			<td id=".trail.9" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.10" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.10" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.10" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#8211;</td>
			<td id=".trail.10" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="width: 12%;">&nbsp;</td>
			<td style="width: 1%;">&nbsp;</td>
			<td style="width: 7%;">&nbsp;</td>
			<td id=".lead.B3" style="width: 1%;">&nbsp;</td>
			<td id=".symb.B3" style="width: 1%;">&nbsp;</td>
			<td id=".amt.B3" style="width: 7%;">&nbsp;</td>
			<td id=".trail.B3" style="width: 1%;">&nbsp;</td>
			<td id=".lead.B4" style="width: 1%;">&nbsp;</td>
			<td id=".symb.B4" style="width: 1%;">&nbsp;</td>
			<td id=".amt.B4" style="width: 7%;">&nbsp;</td>
			<td id=".trail.B4" style="width: 1%;">&nbsp;</td>
			<td id=".lead.B5" style="width: 1%;">&nbsp;</td>
			<td id=".symb.B5" style="width: 1%;">&nbsp;</td>
			<td id=".amt.B5" style="width: 7%;">&nbsp;</td>
			<td id=".trail.B5" style="width: 1%;">&nbsp;</td>
			<td id=".lead.B6" style="width: 1%;">&nbsp;</td>
			<td id=".symb.B6" style="width: 1%;">&nbsp;</td>
			<td id=".amt.B6" style="width: 7%;">&nbsp;</td>
			<td id=".trail.B6" style="width: 1%;">&nbsp;</td>
			<td id=".lead.B7" style="width: 1%;">&nbsp;</td>
			<td id=".symb.B7" style="width: 1%;">&nbsp;</td>
			<td id=".amt.B7" style="width: 7%;">&nbsp;</td>
			<td id=".trail.B7" style="width: 1%;">&nbsp;</td>
			<td id=".lead.B8" style="width: 1%;">&nbsp;</td>
			<td id=".symb.B8" style="width: 1%;">&nbsp;</td>
			<td id=".amt.B8" style="width: 7%;">&nbsp;</td>
			<td id=".trail.B8" style="width: 1%;">&nbsp;</td>
			<td id=".lead.B9" style="width: 1%;">&nbsp;</td>
			<td id=".symb.B9" style="width: 1%;">&nbsp;</td>
			<td id=".amt.B9" style="width: 7%;">&nbsp;</td>
			<td id=".trail.B9" style="width: 1%;">&nbsp;</td>
			<td id=".lead.B10" style="width: 1%;">&nbsp;</td>
			<td id=".symb.B10" style="width: 1%;">&nbsp;</td>
			<td id=".amt.B10" style="width: 7%;">&nbsp;</td>
			<td id=".trail.B10" style="width: 1%;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(230, 230, 230);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Andrew Jones</p>
			</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 1%;">&nbsp;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">05/04/21</p>
			</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#8211;</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.4" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.4" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.4" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#8211;</td>
			<td id=".trail.4" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.5" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.5" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.5" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#8211;</td>
			<td id=".trail.5" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.6" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.6" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.6" style="width: 7%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: center;">&nbsp; &nbsp; &nbsp;&#8211;</td>
			<td id=".trail.6" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.7" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.7" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.7" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#8211;</td>
			<td id=".trail.7" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.8" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.8" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.8" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#8211;</td>
			<td id=".trail.8" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.9" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.9" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.9" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">250,000</td>
			<td id=".trail.9" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; vertical-align: top;"><sup style="vertical-align:top;line-height:120%;font-size:pt">(2)</sup></td>
			<td id=".lead.10" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.10" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.10" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">197,500</td>
			<td id=".trail.10" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 12%;">&nbsp;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 1%;">&nbsp;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">08/20/20</p>
			</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">25,000</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.4" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.4" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.4" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#8211;</td>
			<td id=".trail.4" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.5" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.5" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.5" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">0.99</td>
			<td id=".trail.5" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.D6" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&nbsp;</td>
			<td colspan="2" id=".amt.D6" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">08/20/30</p>
			</td>
			<td id=".trail.D6" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&nbsp;</td>
			<td id=".lead.B7" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&nbsp;</td>
			<td id=".symb.B7" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&nbsp;</td>
			<td id=".amt.B7" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 7%;">&nbsp;</td>
			<td id=".trail.B7" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&nbsp;</td>
			<td id=".lead.B8" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&nbsp;</td>
			<td id=".symb.B8" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&nbsp;</td>
			<td id=".amt.B8" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 7%;">&nbsp;</td>
			<td id=".trail.B8" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&nbsp;</td>
			<td id=".lead.B9" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&nbsp;</td>
			<td id=".symb.B9" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&nbsp;</td>
			<td id=".amt.B9" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 7%;">&nbsp;</td>
			<td id=".trail.B9" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&nbsp;</td>
			<td id=".lead.B10" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&nbsp;</td>
			<td id=".symb.B10" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&nbsp;</td>
			<td id=".amt.B10" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 7%;">&nbsp;</td>
			<td id=".trail.B10" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(230, 230, 230);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 12%;">&nbsp;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 1%;">&nbsp;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">05/04/20</p>
			</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">300,000</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.4" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.4" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.4" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#8211;</td>
			<td id=".trail.4" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.5" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.5" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.5" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">1.03</td>
			<td id=".trail.5" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.D6" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&nbsp;</td>
			<td colspan="2" id=".amt.D6" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 1%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">05/04/30</p>
			</td>
			<td id=".trail.D6" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&nbsp;</td>
			<td id=".lead.B7" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&nbsp;</td>
			<td id=".symb.B7" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&nbsp;</td>
			<td id=".amt.B7" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 7%;">&nbsp;</td>
			<td id=".trail.B7" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&nbsp;</td>
			<td id=".lead.B8" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&nbsp;</td>
			<td id=".symb.B8" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&nbsp;</td>
			<td id=".amt.B8" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 7%;">&nbsp;</td>
			<td id=".trail.B8" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&nbsp;</td>
			<td id=".lead.B9" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&nbsp;</td>
			<td id=".symb.B9" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&nbsp;</td>
			<td id=".amt.B9" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 7%;">&nbsp;</td>
			<td id=".trail.B9" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&nbsp;</td>
			<td id=".lead.B10" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&nbsp;</td>
			<td id=".symb.B10" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&nbsp;</td>
			<td id=".amt.B10" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 7%;">&nbsp;</td>
			<td id=".trail.B10" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 1%;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="width: 12%;">&nbsp;</td>
			<td style="width: 1%;">&nbsp;</td>
			<td style="width: 7%;">&nbsp;</td>
			<td id=".lead.B3" style="width: 1%;">&nbsp;</td>
			<td id=".symb.B3" style="width: 1%;">&nbsp;</td>
			<td id=".amt.B3" style="width: 7%;">&nbsp;</td>
			<td id=".trail.B3" style="width: 1%;">&nbsp;</td>
			<td id=".lead.B4" style="width: 1%;">&nbsp;</td>
			<td id=".symb.B4" style="width: 1%;">&nbsp;</td>
			<td id=".amt.B4" style="width: 7%;">&nbsp;</td>
			<td id=".trail.B4" style="width: 1%;">&nbsp;</td>
			<td id=".lead.B5" style="width: 1%;">&nbsp;</td>
			<td id=".symb.B5" style="width: 1%;">&nbsp;</td>
			<td id=".amt.B5" style="width: 7%;">&nbsp;</td>
			<td id=".trail.B5" style="width: 1%;">&nbsp;</td>
			<td id=".lead.B6" style="width: 1%;">&nbsp;</td>
			<td id=".symb.B6" style="width: 1%;">&nbsp;</td>
			<td id=".amt.B6" style="width: 7%;">&nbsp;</td>
			<td id=".trail.B6" style="width: 1%;">&nbsp;</td>
			<td id=".lead.B7" style="width: 1%;">&nbsp;</td>
			<td id=".symb.B7" style="width: 1%;">&nbsp;</td>
			<td id=".amt.B7" style="width: 7%;">&nbsp;</td>
			<td id=".trail.B7" style="width: 1%;">&nbsp;</td>
			<td id=".lead.B8" style="width: 1%;">&nbsp;</td>
			<td id=".symb.B8" style="width: 1%;">&nbsp;</td>
			<td id=".amt.B8" style="width: 7%;">&nbsp;</td>
			<td id=".trail.B8" style="width: 1%;">&nbsp;</td>
			<td id=".lead.B9" style="width: 1%;">&nbsp;</td>
			<td id=".symb.B9" style="width: 1%;">&nbsp;</td>
			<td id=".amt.B9" style="width: 7%;">&nbsp;</td>
			<td id=".trail.B9" style="width: 1%;">&nbsp;</td>
			<td id=".lead.B10" style="width: 1%;">&nbsp;</td>
			<td id=".symb.B10" style="width: 1%;">&nbsp;</td>
			<td id=".amt.B10" style="width: 7%;">&nbsp;</td>
			<td id=".trail.B10" style="width: 1%;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(230, 230, 230);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 12%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Dr. Audrey Kunin</p>
			</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 1%;">&nbsp;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">11/05/21</p>
			</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#8211;</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.4" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.4" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.4" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#8211;</td>
			<td id=".trail.4" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.5" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.5" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.5" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#8211;</td>
			<td id=".trail.5" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.6" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.6" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.6" style="width: 7%; text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp; &nbsp; &nbsp;&#8211;</td>
			<td id=".trail.6" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.7" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.7" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.7" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#8211;</td>
			<td id=".trail.7" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.8" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.8" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.8" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&#8211;</td>
			<td id=".trail.8" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.9" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.9" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.9" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">300,000</td>
			<td id=".trail.9" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; vertical-align: top;"><sup style="vertical-align:top;line-height:120%;font-size:pt">(2)</sup></td>
			<td id=".lead.10" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.10" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.10" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">177,000</td>
			<td id=".trail.10" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 12%; border-bottom: 2px solid rgb(41, 76, 108);">&nbsp;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 1%; border-bottom: 2px solid rgb(41, 76, 108);">&nbsp;</td>
			<td style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 7%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">11/05/21</p>
			</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 2px solid rgb(41, 76, 108);">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 2px solid rgb(41, 76, 108);">&nbsp;</td>
			<td id=".amt.3" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 2px solid rgb(41, 76, 108);">&#8211;</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 2px solid rgb(41, 76, 108);">&nbsp;</td>
			<td id=".lead.4" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 2px solid rgb(41, 76, 108);">&nbsp;</td>
			<td id=".symb.4" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 2px solid rgb(41, 76, 108);">&nbsp;</td>
			<td id=".amt.4" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 2px solid rgb(41, 76, 108);">150,000</td>
			<td id=".trail.4" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 2px solid rgb(41, 76, 108); vertical-align: top;"><sup style="vertical-align:top;line-height:120%;font-size:pt">(5)</sup></td>
			<td id=".lead.5" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 2px solid rgb(41, 76, 108);">&nbsp;</td>
			<td id=".symb.5" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 2px solid rgb(41, 76, 108);">$</td>
			<td id=".amt.5" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 2px solid rgb(41, 76, 108);">0.56</td>
			<td id=".trail.5" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 2px solid rgb(41, 76, 108);">&nbsp;</td>
			<td id=".lead.6" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 2px solid rgb(41, 76, 108);">&nbsp;</td>
			<td id=".symb.6" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 2px solid rgb(41, 76, 108);">&nbsp;</td>
			<td id=".amt.6" style="width: 7%; text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 2px solid rgb(41, 76, 108);">&nbsp; &nbsp; &nbsp;&#8211;</td>
			<td id=".trail.6" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 2px solid rgb(41, 76, 108);">&nbsp;</td>
			<td id=".lead.7" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 2px solid rgb(41, 76, 108);">&nbsp;</td>
			<td id=".symb.7" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 2px solid rgb(41, 76, 108);">&nbsp;</td>
			<td id=".amt.7" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 2px solid rgb(41, 76, 108);">&#8211;</td>
			<td id=".trail.7" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 2px solid rgb(41, 76, 108);">&nbsp;</td>
			<td id=".lead.8" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 2px solid rgb(41, 76, 108);">&nbsp;</td>
			<td id=".symb.8" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 2px solid rgb(41, 76, 108);">&nbsp;</td>
			<td id=".amt.8" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 2px solid rgb(41, 76, 108);">&#8211;</td>
			<td id=".trail.8" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 2px solid rgb(41, 76, 108);">&nbsp;</td>
			<td id=".lead.9" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 2px solid rgb(41, 76, 108);">&nbsp;</td>
			<td id=".symb.9" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 2px solid rgb(41, 76, 108);">&nbsp;</td>
			<td id=".amt.9" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 2px solid rgb(41, 76, 108);">&#8211;</td>
			<td id=".trail.9" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 2px solid rgb(41, 76, 108);">&nbsp;</td>
			<td id=".lead.10" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 2px solid rgb(41, 76, 108);">&nbsp;</td>
			<td id=".symb.10" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 2px solid rgb(41, 76, 108);">&nbsp;</td>
			<td id=".amt.10" style="width: 7%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 2px solid rgb(41, 76, 108);">&#8211;</td>
			<td id=".trail.10" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 2px solid rgb(41, 76, 108);">&nbsp;</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">_________________</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt">(1)</sup></p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">Unless otherwise noted, each option vests as to 25% of the shares underlying the option on the first anniversary of the grant date, with the remainder vesting in 12 equal installments thereafter at the end of each calendar quarter. Options expire ten (10) years from the date of grant.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt">(2)</sup></p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">Under the Performance RSUs, the awards will vest based on the achievement of three performance goals as determined by the Compensation Committee at the end of the performance period ending December 31, 2023, as described in further detail above.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt">(3)</sup></p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">Mr. Hall was granted 143,000 stock options to vest on January 31, 2018, in direct proportion to the percentage achievement of the stated 2017 corporate goals, as approved and determined by the Board. Such determination resulted in a 15% payout, or 21,450 shares vesting.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt">(4)</sup></p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">Mr. Hall was granted 130,000 stock options to vest on January 31, 2017, in direct proportion to the percentage achievement of the stated 2016 corporate goals, as approved and determined by the Board, which was 100%.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt">(5)</sup></p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">Dr. Audrey Kunin was granted 150,000 stock options to vest in two equal tranches on November 5, 2022 and November 5, 2023.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="23" data-prefix="- " data-suffix=" -" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">- 23 -</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 100%;">

		<tr>
			<td style="vertical-align: top; width: 108%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="color:#294c6c;"><b>Employment-Related Agreements and Potential Payments upon Termination or Change in Control </b></font></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">On January 31, 2020, May 4, 2020 and November 5, 2021, the Company entered into an employment agreement with each of Mr. Hall, Mr. Jones and Dr. Audrey Kunin, respectively, in connection with their respective appointments to serve as an executive officer. Mr. Hall&#8217;s employment agreement was subsequently amended on January 26, 2022.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The principal terms of our NEOs employment agreements are summarized below.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><font style="color:#294c6c;"><b><i>Justin Hall </i></b></font></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Mr. Hall&#8217;s employment agreement, as amended, provides for at-will employment and a term commencing on January 31, 2020 and ending on December 31, 2023 unless earlier terminated. Mr. Hall&#8217;s employment agreement originally provided for an annual base salary of two hundred eighty-six thousand dollars ($286,000), subject to annual review and increases determined by the Compensation Committee and/or Board (such amount, the &#8220;<b><i>Hall Base Salary</i></b>&#8221;).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">In addition, Mr. Hall shall be eligible for any bonus plan that is deemed appropriate by the Board. The bonus amount shall be determined by the Board, in its sole discretion, based upon factors, including: (i) the fulfillment, during the relevant year, of specific milestones and tasks delegated, for such year, to the executive as set by the executive and the Company&#8217;s Board, before the end of the first calendar quarter; (ii) the evaluation of the executive by the Company&#8217;s Board; (iii) the Company&#8217;s financial, product and expected progress and (iv) other pertinent matters relating to the Company&#8217;s business and valuation. Any bonus will be payable within two and a half (2<sup style="vertical-align:top;line-height:120%;font-size:pt">1</sup>/<sub>2</sub>) months following the end of the year for which the bonus was earned. The Compensation Committee of the Board of Directors shall have the sole discretion to pay any or all of the annual bonus in the form of equity compensation. Any such equity compensation shall be issued from the Company&#8217;s equity incentive plan, and shall be fully vested upon issuance.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">In the event the Company terminates Mr. Hall for cause (as defined in the employment agreement), he shall be entitled to any earned but unpaid wages or other compensation (including reimbursements of his outstanding expenses and unused vacation) earned through the termination date.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">In the event the Company terminates Mr. Hall without cause (including death, disability or for constructive termination) (each as defined in the employment agreement) which is not in connection with a change of control, provided such termination constitutes a &#8220;separation from service&#8221; as such term is defined in Section 409A of the Code and, subject to his execution of a release of claims in favor of the Company, he shall be entitled to an amount equal to the Hall Base Salary in effect on the date of separation from service plus the full target annual bonus percentage for the current fiscal year (the &#8220;<b><i>Hall Severance Amount</i></b>&#8221;). The Hall Severance Amount will be paid in twelve (12) equal consecutive monthly installments at the monthly rate of the Hall Base Salary rate in effect at the time of his termination, with such installments commencing within sixty (60) days following the executive&#8217;s separation from service. The Hall Severance Amount shall be in addition to Mr. Hall&#8217;s earned wages and other compensation (including reimbursements of his outstanding expenses and unused vacation) through the date his employment is terminated from the Company.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">In the event the Company terminates Mr. Hall without cause in connection with a change of control (as defined in the employment agreement), he shall be entitled to a Change of Control Severance (the &#8220;<b><i>Hall CoC Severance Amount</i></b>&#8221;) in place of the Hall Severance Amount described above. The Hall CoC Severance Amount shall be: (i) an amount equal to twice the Hall Base Salary and (ii) an amount equal to the cash portion of his target Annual Bonus for the fiscal year in which the termination occurs (with it deemed that all performance goals have been met at one hundred percent (100%) of budget or plan) multiplied by one hundred fifty percent (150%). For a period of eighteen (18) months, Mr. Hall may elect coverage for, and the Company shall reimburse him for, the amount of his premium payments for group health coverage, if any, elected by the executive pursuant to the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended ("<b><i>COBRA</i></b>"); provided, however, that Mr. Hall shall be solely responsible for all matters relating to his continuation of coverage pursuant to COBRA, including (without limitation) his election of such coverage and his timely payment of premiums.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Moreover, all outstanding equity awards held by Mr. Hall will be subject to full accelerated vesting on the date of termination without cause, in both the standard Hall Severance Amount and the Hall CoC Severance Amount, and the exercise period shall be extended to three (3) years from the date of termination. In order to terminate Mr. Hall for cause (or for Mr. Hall to resign for constructive termination), the acting party shall give notice to the other party specifying the reason for termination and providing a period of thirty (30) days to cure the reason specified. If there is no cure within thirty (30) days or the notified party earlier refuses to effect the cure, the termination shall then be deemed effective.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><font style="color:#294c6c;"><b><i>Andrew Jones</i></b></font></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Mr. Jones&#8217; employment agreement provides for at-will employment and a term commencing on May 4, 2020 and continuing until terminated in accordance with the terms of the employment agreement. The employment agreement included an original annual base salary of two hundred seventy-five thousand dollars ($275,000), subject to annual review and increases determined by the Compensation Committee (such amount, the &#8220;<b><i>Jones</i></b> <b><i>Base Salary</i></b>&#8221;), as well as an initial equity grant of 160,000 restricted stock units and an initial stock option award of 300,000 shares, as further described above.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="24" data-prefix="- " data-suffix=" -" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">- 24 -</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">In addition, Mr. Jones shall have the opportunity to earn an annual performance bonus in an amount up to thirty percent (30%) of the Jones Base Salary, with such maximum amount subject to increases determined by the Compensation Committee and/or Board (the &#8220;<b><i>Annual Bonus</i></b>&#8221;). The bonus amount shall be determined by the Board, in its sole discretion, based upon the following factors: (i) the fulfillment, during the relevant year, of specific milestones and tasks delegated, for such year, to Mr. Jones as set by Mr. Jones and the Company&#8217;s CEO and/or the Board, before the end of the first calendar quarter (or the first three months of his employment, as appropriate); (ii) the evaluation of Mr. Jones by the Company&#8217;s CEO and/or the Board; (iii) the Company&#8217;s financial, product and expected progress and (iv) other pertinent matters relating to the Company&#8217;s business and valuation. Any bonus will be payable within two and a half (2 &#189;) months following the end of the year for which the bonus was earned. The Committee shall have the sole discretion to pay any or all of the Annual Bonus in the form of equity compensation, except to the extent that the Annual Bonus is paid in connection with a Jones Severance Amount (as defined below) or a Jones CoC Severance Amount (as defined below). Any such equity compensation shall be issued from the Company&#8217;s equity incentive plan, and shall be fully vested upon payment.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">In the event the Company terminates Mr. Jones for cause (as defined in the employment agreement), he shall be entitled to any earned but unpaid wages or other compensation (including reimbursements of his outstanding expenses and unused vacation) earned through the termination date. In the event the Company terminates Mr. Jones without cause (including death, disability, or for constructive termination) (each as defined in the employment agreement), which is not in connection with a change of control, he shall, subject to his execution of a release of claims in favor of the Company, be entitled to an amount equal to the Jones Base Salary in effect on the date of separation from service plus the full target Annual Bonus percentage of the then current fiscal year (with it deemed that all performance goals have been met at 100% of budget or plan) (the &#8220;<b><i>Jones Severance Amount</i></b>&#8221;), which will be paid in twelve (12) equal consecutive monthly installments. The Jones Severance Amount shall be in addition to Mr. Jones&#8217; earned wages and other compensation (including reimbursements of his outstanding expenses and unused vacation) through the date his employment is terminated from the Company.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">In the event the Company terminates Mr. Jones without cause in connection with a change of control (as defined in the employment agreement), he shall be entitled to a Change of Control Severance (the &#8220;<b><i>Jones CoC Severance Amount</i></b>&#8221;) in place of the Jones Severance Amount described above. The Jones CoC Severance Amount shall be: (i) an amount equal to twice the Jones Base Salary in effect on the date of separation from service and (ii) an amount equal to the cash portion of Mr. Jones&#8217; target Annual Bonus for the fiscal year in which the termination occurs (with it deemed that all performance goals have been met at one hundred percent (100%) of budget or plan) multiplied by one hundred fifty percent (150%). For a period of eighteen (18) months, Mr. Jones may elect coverage for, and the Company shall reimburse Mr. Jones for, the amount of his premium payments for group health coverage, if any, elected by Mr. Jones pursuant to the COBRA; provided, however, that Mr. Jones shall be solely responsible for all matters relating to his continuation of coverage pursuant to COBRA, including (without limitation) his election of such coverage and his timely payment of premiums.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Moreover, in the event of either a termination without cause or a termination in connection with a change of control, all outstanding equity awards held by Mr. Jones will be subject to full accelerated vesting on the date of termination, and the exercise period shall be extended to three (3) years from the date of termination. In order for Mr. Jones to resign for constructive termination, Mr. Jones shall give notice to the Company within thirty (30) days of the initial existence of such grounds for constructive termination and providing a period of thirty (30) days to cure the reason specified. Mr. Jones must then terminate his employment within thirty (30) days of the expiration of the cure period.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><font style="color:#294c6c;"><b><i>Dr. Audrey Kunin</i></b></font></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Dr. Audrey Kunin&#8217;s employment agreement provides for at-will employment and a two-year term commencing on November 5, 2021. Her Employment Agreement provides for an annual base salary of $200,000 (&#8220;<b><i>Kunin Base Salary</i></b>&#8221;). Additionally, Dr. Audrey Kunin&#8217;s employment agreement includes an equity grant of 300,000 Performance RSUs and a stock option award of 150,000 shares, as further described above.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="25" data-prefix="- " data-suffix=" -" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">- 25 -</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Dr. Audrey Kunin&#8217;s employment agreement also provides her with the opportunity to earn an annual performance bonus (&#8220;<b><i>Kunin Annual Bonus</i></b>&#8221;) in an amount up to one hundred percent (100%) of the Kunin Base Salary. For the Kunin Annual Bonus, sixty percent (60%) of the total amount of the Kunin Annual Bonus shall be determined by the Board in its sole discretion, based upon the following factors: (i) the fulfillment, during the relevant year, of specific milestones and tasks delegated, for such year, to Dr. Audrey Kunin as set by Dr. Audrey Kunin and NovaBay and/or its authorized representative; (ii) the evaluation of Dr. Audrey Kunin by NovaBay and/or its authorized representative; (iii) DERMAdoctor&#8217;s financial, product and expected progress and (iv) other pertinent matters relating to DERMAdoctor&#8217;s business and valuation. Dr. Audrey Kunin shall also be entitled to the remaining portion of the Kunin Annual Bonus of up to forty percent (40%) of the Kunin Base Salary, as considered and approved by NovaBay&#8217;s Board of Directors in its sole discretion, upon meeting certain performance metrics related to the Membership Unit Purchase Agreement entered into in connection with the DERMAdoctor Acquisition. Any bonus to Dr. Audrey Kunin will be payable within seventy-four (74) days following the end of the year for which the such bonus was earned. Upon the mutual agreement of Dr. Audrey Kunin and NovaBay&#8217;s Board of Directors, any or all of the Kunin Annual Bonus may be paid in the form of equity compensation. Any such equity compensation shall be issued from NovaBay&#8217;s equity incentive plan, and shall be fully vested upon payment.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">In the event that Dr. Audrey Kunin is terminated for cause (as defined in the her employment agreement) or such employment is terminated due to her death or disability, she shall be entitled to any earned but unpaid wages or other compensation (including reimbursements of her outstanding expenses and unused vacation) earned through the termination date. In the event that Dr. Audrey Kunin is terminated without cause (as defined in her employment agreement), she shall execute a release of claims in favor of NovaBay, be entitled to an amount equal to the Kunin Base Salary in effect on the date of separation from service plus the full target Annual Bonus percentage of the then current fiscal year (with it deemed that all performance goals have been met at 100% of budget or plan) (the &#8220;<b><i>Kunin Severance Amount</i></b>&#8221;), which will be paid in twelve (12) equal consecutive monthly installments. The Kunin Severance Amount shall be in addition to Dr. Audrey Kunin&#8217;s earned wages and other compensation (including reimbursements of her outstanding expenses and unused vacation) through the date her employment is terminated. Further, in the event that Dr. Audrey Kunin is terminated for cause, she and the other applicable parties will no longer be entitled to the earn out payments provided for in the Membership Unit Purchase Agreement entered into in connection with the DERMAdoctor Acquisition; however, if Dr. Audrey Kunin is terminated without cause or terminated as a result of death or disability, her and the other applicable parties will remain entitled to the earn out payments.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Moreover, in the event of either a termination without cause, and subject to her execution of a release, all outstanding equity awards then held by Dr. Audrey Kunin will be subject to full accelerated vesting on the date of termination, and the exercise period shall be extended to three (3) years from the date of termination.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 100%;">

		<tr>
			<td style="vertical-align: top; width: 108%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="color:#294c6c;"><b>Director Compensation </b></font></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The compensation and benefits for services as non-employee members of our Board is determined by our Board. Directors employed by us, such as Mr. Hall and Dr. Audrey Kunin, are not compensated for service on the Board or any committee of the Board; however, we reimburse all directors for any out-of-pocket expenses incurred in connection with attending meetings of our Board and committees of our Board.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Board, upon the recommendation of the Compensation Committee, approved the Non-Employee Director Compensation Program, effective January 1, 2021 (the &#8220;<b><i>2021 Non-Employee Director Compensation Plan</i></b>&#8221;). Subsequently, the Pay Governance Survey found that the Company&#8217;s 2021 Non-Employee Director Compensation Plan was below the market 25th percentile of the Company&#8217;s peers. As a result, the Board, upon the recommendation of the Compensation Committee, revised the previously adopted 2021 Non-Employee Director Compensation Plan to increase certain cash retainer amounts and alter the director&#8217;s annual equity grant from stock options to restricted stock units, effective as of July 1, 2021.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Under the 2021 Non-Employee Director Compensation Plan, each director receives his or her annual retainer compensation in cash and an annual grant of 30,000 restricted stock units. All cash compensation is payable quarterly on the first (1<sup style="vertical-align:top;line-height:120%;font-size:pt">st</sup>) business day of the quarter.<b> </b>Approved non-employee director compensation for 2021 was as follows:</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="26" data-prefix="- " data-suffix=" -" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">- 26 -</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 34.2%; border-top: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><font style="color:#294c6c;"><b>Board Meetings</b></font></p>
			</td>
			<td style="vertical-align:bottom;width:1.8%;">&nbsp;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 34.2%; border-top: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><font style="color:#294c6c;"><b>Chairman of Committee for</b><br>
			<b>Committee Meetings</b></font></p>
			</td>
			<td style="vertical-align:bottom;width:1.8%;">&nbsp;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 34.2%; border-top: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><font style="color:#294c6c;"><b>All Other Members for</b><br>
			<b>Committee Meetings</b></font></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 34.2%; background-color: rgb(230, 230, 230); border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Chairman of the Board</i>: Annual cash compensation of $52,000 per year.</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&nbsp;</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Member of the Board</i>: The annual fee consists of: (i) $40,000 in cash and (ii) 30,000 restricted stock units granted. The restricted stock units are granted at the Company&#8217;s Annual Meeting of Stockholders, and vest on the one year anniversary of the grant date.</p>
			</td>
			<td style="vertical-align:top;width:1.8%;">&nbsp;</td>
			<td style="vertical-align: top; width: 34.2%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Chairman of the Audit Committee</i>: Annual cash compensation of $17,500 per year.</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&nbsp;</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Chairman of the Compensation Committee</i>: Annual cash compensation of $13,000 per year.</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&nbsp;</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Chairman of the N&amp;CG Committee</i>: Annual cash compensation of $10,000 per year.</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&nbsp;</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Lead Independent Director (if different from Chairman of the Board)</i>: Annual cash compensation of $30,000 per year.</p>
			</td>
			<td style="vertical-align:top;width:1.8%;">&nbsp;</td>
			<td style="vertical-align: top; width: 34.2%; background-color: rgb(230, 230, 230); border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Member of the Audit Committee</i>: Annual cash compensation of $7,500 per year.</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&nbsp;</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Member of the Compensation Committee</i>: Annual cash compensation of $6,000 per year for each committee.</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&nbsp;</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Member of the N&amp;CG Committee</i>: Annual cash compensation of $5,000 per year for each committee.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Non-employee directors also may be granted additional awards under our equity incentive plans at the discretion of our Board.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The compensation received during 2021 by each non-employee director is set forth below. Due to their nominations to the Board that occurred after the end of the 2021 fiscal year on January 27, 2022, Dr. Audrey Kunin, Ms. Garlikov and Mr. Sean Zheng are not included in the below.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 7.5%; margin-left: 7.5%; width: 85%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 46%; border-top: 2px solid rgb(41, 76, 108); border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;"><font style="color:#294c6c;"><b>Name</b></font></p>
			</td>
			<td id=".lead.D2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-top: 2px solid rgb(41, 76, 108);">&nbsp;</td>
			<td colspan="2" id=".amt.D2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><font style="color:#294c6c;"><b><b>Fees </b></b></font></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><font style="color:#294c6c;"><b><b>Earned or </b></b></font></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><font style="color:#294c6c;"><b><b>Paid in</b></b></font></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><font style="color:#294c6c;"><b><b>Cash ($)</b></b></font></p>
			</td>
			<td id=".trail.D2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; border-top: 2px solid rgb(41, 76, 108);">&nbsp;</td>
			<td id=".lead.D3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-top: 2px solid rgb(41, 76, 108);">&nbsp;</td>
			<td colspan="2" id=".amt.D3" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><font style="color:#294c6c;"><b><b>Stock </b></b></font></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><font style="color:#294c6c;"><b><b>Awards</b><b><sup style="vertical-align:top;line-height:120%;font-size:pt">(1)</sup></b></b></font></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><font style="color:#294c6c;"><b><b>($)</b></b></font></p>
			</td>
			<td id=".trail.D3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; border-top: 2px solid rgb(41, 76, 108);">&nbsp;</td>
			<td id=".lead.D4" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-top: 2px solid rgb(41, 76, 108);">&nbsp;</td>
			<td colspan="2" id=".amt.D4" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><font style="color:#294c6c;"><b><b>Total</b></b></font></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><font style="color:#294c6c;"><b><b>($)</b></b></font></p>
			</td>
			<td id=".trail.D4" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; border-top: 2px solid rgb(41, 76, 108); border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(230, 230, 230);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Paul E. Freiman, Ph.D.</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.2" style="width: 15%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">74,250</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.3" style="width: 15%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">20,400</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.4" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.4" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.4" style="width: 15%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">94,650</td>
			<td id=".trail.4" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td>&nbsp;</td>
			<td id=".lead.B2">&nbsp;</td>
			<td id=".symb.B2">&nbsp;</td>
			<td id=".amt.B2">&nbsp;</td>
			<td id=".trail.B2">&nbsp;</td>
			<td id=".lead.B3">&nbsp;</td>
			<td id=".symb.B3">&nbsp;</td>
			<td id=".amt.B3">&nbsp;</td>
			<td id=".trail.B3">&nbsp;</td>
			<td id=".lead.B4">&nbsp;</td>
			<td id=".symb.B4">&nbsp;</td>
			<td id=".amt.B4">&nbsp;</td>
			<td id=".trail.B4">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(230, 230, 230);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Xinzhou (Paul) Li<sup style="vertical-align:top;line-height:120%;font-size:pt">(2)</sup></p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.2" style="width: 15%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.3" style="width: 15%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">20,400</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.4" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.4" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.4" style="width: 15%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">20,400</td>
			<td id=".trail.4" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td>&nbsp;</td>
			<td id=".lead.B2">&nbsp;</td>
			<td id=".symb.B2">&nbsp;</td>
			<td id=".amt.B2">&nbsp;</td>
			<td id=".trail.B2">&nbsp;</td>
			<td id=".lead.B3">&nbsp;</td>
			<td id=".symb.B3">&nbsp;</td>
			<td id=".amt.B3">&nbsp;</td>
			<td id=".trail.B3">&nbsp;</td>
			<td id=".lead.B4">&nbsp;</td>
			<td id=".symb.B4">&nbsp;</td>
			<td id=".amt.B4">&nbsp;</td>
			<td id=".trail.B4">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(230, 230, 230);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Swan Sit</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.2" style="width: 15%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">52,250</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.3" style="width: 15%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">20,400</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.4" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.4" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.4" style="width: 15%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">72,650</td>
			<td id=".trail.4" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td>&nbsp;</td>
			<td id=".lead.B2">&nbsp;</td>
			<td id=".symb.B2">&nbsp;</td>
			<td id=".amt.B2">&nbsp;</td>
			<td id=".trail.B2">&nbsp;</td>
			<td id=".lead.B3">&nbsp;</td>
			<td id=".symb.B3">&nbsp;</td>
			<td id=".amt.B3">&nbsp;</td>
			<td id=".trail.B3">&nbsp;</td>
			<td id=".lead.B4">&nbsp;</td>
			<td id=".symb.B4">&nbsp;</td>
			<td id=".amt.B4">&nbsp;</td>
			<td id=".trail.B4">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(230, 230, 230);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Mijia (Bob) Wu, M.B.A.<sup style="vertical-align:top;line-height:120%;font-size:pt"> </sup><sub> </sub></p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.2" style="width: 15%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">35,000</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.3" style="width: 15%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">20,400</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.4" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.4" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.4" style="width: 15%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">55,400</td>
			<td id=".trail.4" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td>&nbsp;</td>
			<td id=".lead.B2">&nbsp;</td>
			<td id=".symb.B2">&nbsp;</td>
			<td id=".amt.B2">&nbsp;</td>
			<td id=".trail.B2">&nbsp;</td>
			<td id=".lead.B3">&nbsp;</td>
			<td id=".symb.B3">&nbsp;</td>
			<td id=".amt.B3">&nbsp;</td>
			<td id=".trail.B3">&nbsp;</td>
			<td id=".lead.B4">&nbsp;</td>
			<td id=".symb.B4">&nbsp;</td>
			<td id=".amt.B4">&nbsp;</td>
			<td id=".trail.B4">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(230, 230, 230);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Yenyou (Jeff) Zheng, Ph.D.</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 2px solid rgb(41, 76, 108);">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 2px solid rgb(41, 76, 108);">$</td>
			<td id=".amt.2" style="width: 15%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 2px solid rgb(41, 76, 108);">64,250</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 2px solid rgb(41, 76, 108);">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 2px solid rgb(41, 76, 108);">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 2px solid rgb(41, 76, 108);">$</td>
			<td id=".amt.3" style="width: 15%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 2px solid rgb(41, 76, 108);">20,400</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 2px solid rgb(41, 76, 108);">&nbsp;</td>
			<td id=".lead.4" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 2px solid rgb(41, 76, 108);">&nbsp;</td>
			<td id=".symb.4" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 2px solid rgb(41, 76, 108);">$</td>
			<td id=".amt.4" style="width: 15%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 2px solid rgb(41, 76, 108);">84,650</td>
			<td id=".trail.4" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 2px solid rgb(41, 76, 108);">&nbsp;</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&nbsp;</p>

<hr style="text-align: left; height: 1px; color: #000000; background-color: #000000; width: 10%; border: none; margin: 3pt auto 3pt 0">
<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt">(1)</sup></p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">These amounts represent the aggregate grant date fair value of $0.68 per share for the 30,000 restricted stock awards granted to each director as part of his or her annual fee in fiscal year 2021. The assumptions used to determine the value of restricted stock units are described in Note 15 &#8220;Equity-Based Compensation&#8221; to the Company&#8217;s consolidated financial statements in our Annual Report. At December 31, 2021, each of Mr. Freiman, Mr. Li, Ms. Sit, Mr. Wu and Dr. Jeff Zheng had an aggregate of 30,000 unvested restricted stock units. At December 31, 2021, the aggregate number of vested stock options for each of the non-employee directors who served in 2021 and held stock options was as follows (with no such director holding any unvested stock options at such time): Mr. Freiman, 122,097; Mr. Li, 65,248; Ms. Sit, 20,000; Mr. Wu, 55,244; and Mr. Zheng, 20,000.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt">(2)</sup></p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">Mr. Li elected to forgo any compensatory cash fees during 2021.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="27" data-prefix="- " data-suffix=" -" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">- 27 -</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 100%;">

		<tr>
			<td style="vertical-align: middle; width: 108%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:12pt;font-variant:small-caps;text-align:center;margin:0pt;"><font style="text-transform:uppercase;"><font style="color:#294c6c;"><b>Security Ownership of Certain Beneficial Owners and Management </b></font></font></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">The following table indicates information as of March 16, 2022 regarding the beneficial ownership of our securities by:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;">each person who is known by us to beneficially own more than five percent (5%) of our securities;</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;">our current executive officers;</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;">each of our directors; and</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;">&#9679;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;">all of our directors and executive officers as a group.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">The percentage of shares beneficially owned is based on 51,018,364&nbsp;shares of our Common Stock outstanding as of March 16, 2022. Except as indicated in the footnotes to this table, and as affected by applicable community property laws, all persons listed have sole voting and investment power for all shares shown as beneficially owned by them and no shares are pledged.&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 70%; border-top: 2px solid rgb(41, 76, 108); border-bottom: 1px solid rgb(0, 0, 0);">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;"><font style="color:#294c6c;"><b>Name and Address of Beneficial Owner (1)</b></font></p>
			</td>
			<td id=".lead.D2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-top: 2px solid rgb(41, 76, 108);">&nbsp;</td>
			<td colspan="2" id=".amt.D2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><font style="color:#294c6c;"><b><b>Number of</b><br>
			<b>Shares</b><br>
			<b>Beneficially</b><br>
			<b>Owned</b></b></font></p>
			</td>
			<td id=".trail.D2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; border-top: 2px solid rgb(41, 76, 108);">&nbsp;</td>
			<td id=".lead.D3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-top: 2px solid rgb(41, 76, 108);">&nbsp;</td>
			<td colspan="2" id=".amt.D3" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><font style="color:#294c6c;"><b><b>Percent</b><br>
			<b>of Class</b></b></font></p>
			</td>
			<td id=".trail.D3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; border-top: 2px solid rgb(41, 76, 108);">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Beneficial Owners Holding More Than 5%</p>
			</td>
			<td id=".lead.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td>&nbsp;</td>
			<td id=".lead.B2">&nbsp;</td>
			<td id=".symb.B2">&nbsp;</td>
			<td id=".amt.B2">&nbsp;</td>
			<td id=".trail.B2">&nbsp;</td>
			<td id=".lead.B3">&nbsp;</td>
			<td id=".symb.B3">&nbsp;</td>
			<td id=".amt.B3">&nbsp;</td>
			<td id=".trail.B3">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(230, 230, 230);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Pioneer Pharma (Hong Kong) Company Ltd. (&#8220;<b><i>Pioneer Hong Kong</i></b>&#8221;) (2)</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">5,188,421</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">10.2</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p>
			</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(230, 230, 230);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">682 Castle Peak Road</p>
			</td>
			<td id=".lead.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(230, 230, 230);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Lai Chi Kok, Kowloon, Hong Kong</p>
			</td>
			<td id=".lead.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td>&nbsp;</td>
			<td id=".lead.B2">&nbsp;</td>
			<td id=".symb.B2">&nbsp;</td>
			<td id=".amt.B2">&nbsp;</td>
			<td id=".trail.B2">&nbsp;</td>
			<td id=".lead.B3">&nbsp;</td>
			<td id=".symb.B3">&nbsp;</td>
			<td id=".amt.B3">&nbsp;</td>
			<td id=".trail.B3">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(230, 230, 230);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">FGP Protective Opportunity Master Fund SP (3)</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">5,605,790</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">9.9</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p>
			</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(230, 230, 230);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">94 Solaris Ave, 2<sup style="vertical-align:top;line-height:120%;font-size:pt">nd</sup> Floor</p>
			</td>
			<td id=".lead.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(230, 230, 230);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Camana Bay</p>
			</td>
			<td id=".lead.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(230, 230, 230);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">P.O. Box 30 745 Grand Cayman</p>
			</td>
			<td id=".lead.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td>&nbsp;</td>
			<td id=".lead.B2">&nbsp;</td>
			<td id=".symb.B2">&nbsp;</td>
			<td id=".amt.B2">&nbsp;</td>
			<td id=".trail.B2">&nbsp;</td>
			<td id=".lead.B3">&nbsp;</td>
			<td id=".symb.B3">&nbsp;</td>
			<td id=".amt.B3">&nbsp;</td>
			<td id=".trail.B3">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(230, 230, 230);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Hudson Bay Master Fund Ltd. (4)</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">4,971,292</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">8.9</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p>
			</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(230, 230, 230);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">c/o Hudson Bay Capital Management LP</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">28 Havemeyer Place, 2<sup style="vertical-align:top;line-height:120%;font-size:pt">nd</sup> Floor</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Greenwich, CT 06830</p>
			</td>
			<td id=".lead.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom;">
			<td>&nbsp;</td>
			<td id=".lead.B2">&nbsp;</td>
			<td id=".symb.B2">&nbsp;</td>
			<td id=".amt.B2">&nbsp;</td>
			<td id=".trail.B2">&nbsp;</td>
			<td id=".lead.B3">&nbsp;</td>
			<td id=".symb.B3">&nbsp;</td>
			<td id=".amt.B3">&nbsp;</td>
			<td id=".trail.B3">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(230, 230, 230);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Jian Ping Fu (&#8220;<b><i>Mr. Fu</i></b>&#8221;) (5)</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">4,000,000</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">7.8</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p>
			</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(230, 230, 230);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">11 Williams Road</p>
			</td>
			<td id=".lead.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(230, 230, 230);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Mt. Eliza, Melbourne VIC 3930, Australia</p>
			</td>
			<td id=".lead.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td>&nbsp;</td>
			<td id=".lead.B2">&nbsp;</td>
			<td id=".symb.B2">&nbsp;</td>
			<td id=".amt.B2">&nbsp;</td>
			<td id=".trail.B2">&nbsp;</td>
			<td id=".lead.B3">&nbsp;</td>
			<td id=".symb.B3">&nbsp;</td>
			<td id=".amt.B3">&nbsp;</td>
			<td id=".trail.B3">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(230, 230, 230);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;"><u>Executive Officers and Directors</u></p>
			</td>
			<td id=".lead.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".lead.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".trail.B3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Justin M. Hall, Esq. (6)</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">471,657</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">*</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(230, 230, 230);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Andrew Jones (7)</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">268,086</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">*</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Dr. Audrey Kunin (8)</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">500,000</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">1.0</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p>
			</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(230, 230, 230);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Dr. Jeff Kunin (9)</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">500,000</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">1.0</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p>
			</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Paul E. Freiman, Ph.D. (10)</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">124,409</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">*</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(230, 230, 230);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Julie Garlikov</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">*</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Swan Sit (11)</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">20,000</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">*</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(230, 230, 230);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Mijia (Bob) Wu, M.B.A. (12)</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">55,244</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">*</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Yenyou (Jeff) Zheng, Ph.D. (13)</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">20,000</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">*</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(230, 230, 230);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Yongxiang (Sean) Zheng</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">*</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">All directors and executive officers as a group (10 persons)</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 2px solid rgb(41, 76, 108);">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 2px solid rgb(41, 76, 108);">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 2px solid rgb(41, 76, 108);">1,459,396</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 2px solid rgb(41, 76, 108);">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 2px solid rgb(41, 76, 108);">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 2px solid rgb(41, 76, 108);">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 2px solid rgb(41, 76, 108);">2.8</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="28" data-prefix="- " data-suffix=" -" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">- 28 -</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<hr style="text-align: left; height: 1px; color: #000000; background-color: #000000; width: 10%; border: none; margin: 3pt auto 3pt 0">
<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">*</p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">Less than one percent (1%).</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<p style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">(1)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">The address for each director and officer of NovaBay listed is c/o NovaBay Pharmaceuticals, Inc., 2000 Powell Street, Suite 1150, Emeryville, CA 94608. Number of shares beneficially owned and percent of class is calculated in accordance with SEC rules. A beneficial owner is deemed to beneficially own shares the beneficial owner has the right to acquire within 60 days of March 16, 2022. For purposes of calculating the percent of class held by a single beneficial owner, the shares that such beneficial owner has the right to acquire within 60 days of March 16, 2022 are also deemed to be outstanding; however, such shares are not deemed to be outstanding for purposes of calculating the percentage ownership of any other beneficial owner.</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<p style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">(2)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">Based upon information contained in the Schedule 13D/A filed by Pioneer Hong Kong and China Pioneer Pharma Holdings Limited, the parent company of Pioneer Hong Kong, with the SEC on January 13, 2017, Pioneer Hong Kong beneficially owned 5,188,421 shares of Common Stock as of December 9, 2016, with shared voting and dispositive power of all shares and sole voting and dispositive power of no shares.</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<p style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">(3)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">Based upon the Company&#8217;s records, as of March 16, 2022, FGP Protective Opportunity Master Fund SP owned at least 5,605,790 shares of Common Stock issuable upon the exercise of warrants and/or the conversion of shares of the Preferred Stock (with such number of shares of Common Stock representing the maximum amount exercisable and/or convertible up to a beneficial ownership threshold of 9.9%).</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<p style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">(4)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">Based upon information contained in the Schedule 13G filed by Hudson Bay Capital Management LP and Sander Gerber with the SEC on February 4, 2022, Hudson Bay Capital Management LP beneficially owned 4,971,292 shares of Common Stock (including 4,804,326 shares of Common Stock issuable upon exercise of warrants and/or conversion of shares of the Preferred Stock) as of December 31, 2021, with shared voting and dispositive power of all shares and sole voting and dispositive power of no shares.</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<p style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">(5)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">Based upon information contained in the Schedule 13D/A filed by Mr. Fu with the SEC on August 24, 2020, Mr. Fu beneficially owned 4,000,000 shares of Common Stock as of August 1, 2020, with sole voting power over 4,000,000 shares, shared voting power over no shares, sole dispositive power over 4,000,000 shares and shared dispositive power over no shares.</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<p style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">(6)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">Includes (i) 73,172 shares of Common Stock held directly by Mr. Hall and (ii) 398,485 shares issuable upon the exercise of outstanding options which are exercisable as of March 16, 2022 or within 60 days after such date. Does not include 500,000 performance restricted stock units granted to Mr. Hall on May 4, 2021 that will vest based on the achievement of three performance goals at the end of a three-year performance period ending December 31, 2023.</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<p style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">(7)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">Includes (i) 127,461 shares of Common Stock held directly by Mr. Jones and (ii) 140,625 shares issuable upon exercise of outstanding options which are exercisable as of March 16, 2022 or within 60 days after such date. Does not include 250,000 performance restricted stock units granted to Mr. Jones on May 4, 2021 that will vest based on the achievement of three performance goals at the end of a three-year performance period ending December 31, 2023.</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<p style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">(8)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">Consists of 500,000 shares held by The Audrey G. Kunin Trust of which Dr. Audrey Kunin serves as the trustee (with sole voting and investment power). Does not include 300,000 performance restricted stock units granted to Dr. Audrey Kunin on November 8, 2021 that will vest based on the achievement of three performance goals at the end of a three-year performance period ending December 31, 2023.</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<p style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">(9)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">Consists of 500,000 shares held by The Audrey G. Kunin Trust of which Dr. Jeff Kunin's spouse (Dr. Audrey Kunin) serves as the trustee (with sole voting and investment power).</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<p style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">(10)&nbsp;</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">Includes (i) 2,311 shares held by the Paul Freiman and Anna Mazzuchi Freiman Trust, of which Mr. Freiman and his spouse are trustees (with sole voting power over 625 shares, shared voting power over 1,061 shares, sole investment power over no shares and shared investment power over 1,686 shares), and (ii) 122,097 shares issuable upon exercise of outstanding options which are exercisable as of March 16, 2022, or within 60 days after such date.</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<p style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">(11)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">Reflects 20,000 shares issuable upon exercise of outstanding options which are exercisable as of March 16, 2022, or within 60 days after such date.</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<p style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">(12)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">Reflects 55,244 shares issuable upon exercise of outstanding options which are exercisable as of March 16, 2022, or within 60 days after such date. As Non-Executive Director of China Pioneer, the parent company of Pioneer Hong Kong. Mr. Wu disclaims beneficial ownership of the shares of the Common Stock held by China Pioneer Pharma and Pioneer Hong Kong.</p>
			</td>
		</tr>
		<tr style="vertical-align: top;">
			<td style="width: 36pt;">
			<p style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">(13)</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">Reflects 20,000 shares issuable upon exercise of outstanding options which are exercisable as of March 16, 2022, or within 60 days after such date.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="29" data-prefix="- " data-suffix=" -" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">- 29 -</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 100%;">

		<tr>
			<td style="vertical-align: middle; width: 108%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:12pt;font-variant:small-caps;text-align:center;margin:0pt;"><font style="text-transform:uppercase;"><font style="color:#294c6c;"><b>Equity Compensation Plan Information </b></font></font></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">The following table provides information as of December 31, 2021 with respect to shares of our common stock that may be issued under existing equity compensation plans.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;">

		<tr style="vertical-align: bottom;">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 55%; border-bottom: 1px solid rgb(0, 0, 0); border-top: 2px solid rgb(41, 76, 108);">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;"><b>Plan category</b></p>
			</td>
			<td id=".lead.D2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; border-top: 2px solid rgb(41, 76, 108);">&nbsp;</td>
			<td colspan="2" id=".amt.D2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Number of Securities to be Issued Upon Exercise of Outstanding Options and Rights</b></b></p>
			</td>
			<td id=".trail.D2" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; border-top: 2px solid rgb(41, 76, 108);">&nbsp;</td>
			<td id=".lead.D3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; border-top: 2px solid rgb(41, 76, 108);">&nbsp;</td>
			<td colspan="2" id=".amt.D3" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Weighted Average Exercise Price of Outstanding Options and Rights</b></b></p>
			</td>
			<td id=".trail.D3" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; border-top: 2px solid rgb(41, 76, 108);">&nbsp;</td>
			<td id=".lead.D4" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; border-top: 2px solid rgb(41, 76, 108);">&nbsp;</td>
			<td colspan="2" id=".amt.D4" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Number of Securities Remaining Available For Future Issuance under Equity Compensation Plans (excluding some securities reflected in first column)</b></b></p>
			</td>
			<td id=".trail.D4" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; border-top: 2px solid rgb(41, 76, 108);">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(230, 230, 230);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Equity compensation plans approved by security holders<sup style="vertical-align:top;line-height:120%;font-size:pt">(1)</sup></p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">4,449,048</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">1.39</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.4" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.4" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.4" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">1,842,993</td>
			<td id=".trail.4" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Equity compensation plans not approved by security holders</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.3" style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
			<td id=".lead.4" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".symb.4" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td>
			<td id=".amt.4" style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;">&#8212;</td>
			<td id=".trail.4" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td>
		</tr>
		<tr style="vertical-align: bottom; background-color: rgb(230, 230, 230);">
			<td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Total</p>
			</td>
			<td id=".lead.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 2px solid rgb(41, 76, 108);">&nbsp;</td>
			<td id=".symb.2" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 2px solid rgb(41, 76, 108);">&nbsp;</td>
			<td id=".amt.2" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 2px solid rgb(41, 76, 108);">4,449,048</td>
			<td id=".trail.2" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 2px solid rgb(41, 76, 108);">&nbsp;</td>
			<td id=".lead.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 2px solid rgb(41, 76, 108);">&nbsp;</td>
			<td id=".symb.3" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 2px solid rgb(41, 76, 108);">$</td>
			<td id=".amt.3" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 2px solid rgb(41, 76, 108);">1.39</td>
			<td id=".trail.3" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 2px solid rgb(41, 76, 108);">&nbsp;</td>
			<td id=".lead.4" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 2px solid rgb(41, 76, 108);">&nbsp;</td>
			<td id=".symb.4" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 2px solid rgb(41, 76, 108);">&nbsp;</td>
			<td id=".amt.4" style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 2px solid rgb(41, 76, 108);">1,842,993</td>
			<td id=".trail.4" nowrap="true" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt; border-bottom: 2px solid rgb(41, 76, 108);">&nbsp;</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<hr style="text-align: left; height: 1px; color: #000000; background-color: #000000; width: 10%; border: none; margin: 3pt auto 3pt 0">
<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 27pt;">
			<p style="margin: 0pt; text-align: justify; font-size: 10pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt">(1)</sup></p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: justify; font-size: 10pt;">Consists of the 2007 Plan and 2017 Plan. No additional option grants are being made under the 2002 Plan, 2005 Plan or 2007 Plan. The 2017 Plan became effective on June 2, 2017, and 1,842,993 shares were reserved for issuance under that plan at December 31, 2021.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="30" data-prefix="- " data-suffix=" -" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">- 30 -</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 100%;">

		<tr>
			<td style="vertical-align: middle; width: 108%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:12pt;font-variant:small-caps;text-align:center;margin:0pt;"><font style="text-transform:uppercase;"><font style="color:#294c6c;"><b>Certain Relationships and Related Party Transactions </b></font></font></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">NovaBay&#8217;s Audit Committee has the responsibility of reviewing any possible related party transactions. In conducting its review, the Audit Committee applies the principles of the Code of Ethics and its Conflict of Interest Policy to: (i) the relationship of the related persons to the transaction; (ii) the relationship between the Company and the related persons; (iii) the importance of the interest to the related persons; and (iv) the amount involved in the transaction. Since December 31, 2019, there has not been any transaction, nor is there any proposed transaction, in which NovaBay was a participant, and in which a &#8220;related party&#8221; of NovaBay had or is expected to have a direct or indirect material interest, in which the amount involved exceeded or will exceed the lesser of $120,000 or one percent (1%) of the average of NovaBay&#8217;s total assets at the end of the last two (2) completed fiscal years, that would require disclosure, except for the following:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><font style="color:#294c6c;"><b><i>November 2021 DERMAdoctor Acquisition</i></b></font></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">On November 5, 2021, pursuant to a membership unit purchase agreement, dated as of September 27, 2021 (the &#8220;<b><i>Purchase Agreement</i></b>&#8221;), NovaBay acquired 100% of the membership units of DERMAdoctor from Papillon Partners, Inc., a Missouri corporation indirectly owned by Dr. Audrey Kunin and Dr. Jeff Kunin (&#8220;<b><i>Papillon</i></b>&#8221;) and (v) Midwest Growth Partners, L.L.L.P., an Iowa limited liability limited partnership (together with Papillon, the &#8220;<b><i>Sellers</i></b>&#8221;) for a closing purchase price of $12.0 million (as adjusted for certain indebtedness, transaction expenses and cash of DERMAdoctor at closing as set forth in the Purchase Agreement, the &#8220;<b><i>Closing Cash Consideration</i></b>&#8221;) and potential future earn out payments of up to an aggregate of $3.0 million over a period of two calendar years post-closing. The earn out payments are for up to $1.5 million after closing for each of the 2022 and 2023 calendar years (or an aggregate $3.0 million) if the legacy business of DERMAdoctor achieves certain contribution margin targets each year conditioned upon Dr. Audrey Kunin&#8217;s and Dr. Jeff Kunin&#8217;s continued employment with DERMAdoctor (except if either are terminated without cause or terminated as a result of death or disability). Such earn out payments are to be paid in cash or unregistered shares of NovaBay&#8217;s common stock, subject to certain restrictions. Under the terms of the Purchase Agreement, Papillon and Midwest Growth Partners, L.L.L.P. received approximately 82.2% and 17.8%, respectively, of the Closing Cash Consideration and will subsequently receive such proportion of the earn out payments, if any. An aggregate amount of $1.2 million of the Closing Cash Consideration is being held in escrow for 12 months after the closing to secure certain payment and indemnification obligations of DERMAdoctor and the Sellers, as applicable and in accordance with the terms of the Purchase Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">Both Dr. Audrey Kunin and Dr. Jeff Kunin are parties to executive employment agreements, as described above and in the Current Report on Form 8-K filed with the SEC on November 12, 2021, which is incorporated by reference. Further, in connection with the closing of the DERMAdoctor Acquisition, NovaBay also entered into a Side Letter with Dr. Audrey Kunin to provide for her appointment to the Board, which occurred on January 27, 2022.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><font style="color:#294c6c;"><b><i>June 2020 Reprice of August 2019 Preferred Private Placement Warrants</i></b></font></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">On August 8, 2019, we entered into a securities purchase agreement (the &#8220;<b><i>2019 Securities</i></b>&nbsp;<b><i>Purchase Agreement</i></b>&#8221;) for the sale to accredited investors of (i) 2,700,000 shares of NovaBay&#8217;s Series A Non-Voting Convertible Preferred Stock that automatically converted into 2,700,000 shares of Common Stock upon the approval of our stockholders at the special meeting of stockholders on October 9, 2019 and (ii) Common Stock purchase warrants exercisable for 2,700,000 shares of Common Stock for an aggregate purchase price of $2,700,000 (the &#8220;<b><i>August Private Placement</i></b>&#8221;). China Kington agreed to serve as placement agent in exchange for a commission equal to six percent (6%) of the gross proceeds received by us in the August Private Placement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">In July 2020, the Common Stock purchase warrants issued in the August Private Placement were exercised in full as consideration for the issuance of an equivalent number of new warrants to the same investor with a reduced exercise price (the &#8220;<b><i>June 2020 Reprice</i></b>&#8221;). China Kington did not participate and did not receive any commission for the June 2020 Reprice. Our Audit Committee recommended to our Board and our Board approved the 2019 Securities Purchase Agreement on August 8, 2019 and then further approved the June 2020 Reprice, upon the Audit Committee&#8217;s recommendation, on July 20, 2020. Mr. Wu, who serves as a director on our Board, also serves as the Managing Director of China Kington.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><font style="color:#294c6c;"><b><i>February 2019 Promissory Note Amended June 25, 2019 and May 14, 2020</i></b></font></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">On February 27, 2019, NovaBay issued a promissory note payable to Pioneer Hong Kong, which was amended on June 25, 2019 and May 14, 2020, pursuant to which Pioneer Hong Kong loaned us $1,000,000 (the &#8220;<b><i>Promissory Note</i></b>&#8221;). The interest payment in the Promissory Note was amended from a payment of $300,000 (initially $150,000) to the delivery of 65,178 units of NeutroPhase (40ml) to Pioneer Hong Kong, or an affiliate of Pioneer Hong Kong. We repaid the Promissory Note in full in May 2020 using proceeds raised through certain at-the-market equity offerings pursuant to the At the Market Offering Agreement, dated April 27, 2020, with Ladenburg Thalmann &amp; Co. Inc. The loan was facilitated by China Kington which, until repaid in full, had a perfected security interest in all tangible and intangible assets of NovaBay. In connection with the Promissory Note, we paid China Kington a 2% fee for brokering the transaction and entered into a consulting agreement with China Kington for a term of one year. Mr. Mijia (Bob) Wu, acting in a dual role as a member of the Board and as principal of China Kington, was paid $100,000 pursuant to this consulting agreement. The Board, upon the recommendation of the Audit Committee, approved the loan and related documents on February 24, 2019, as well as the First Amendment to the Promissory Note and Second Amendment to the Promissory Note on May 30, 2019 and May 14, 2020, respectively.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="31" data-prefix="- " data-suffix=" -" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">- 31 -</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 100%;">

		<tr>
			<td style="vertical-align: middle; width: 108%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:12pt;font-variant:small-caps;text-align:center;margin:0pt;"><font style="text-transform:uppercase;"><font style="color:#294c6c;"><b>Other Proxy Matters </b></font></font></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 100%;">

		<tr>
			<td style="vertical-align: top; width: 108%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="color:#294c6c;"><b>Delinquent Section 16(a) Reports </b></font></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Under the federal securities laws, our directors and officers and any persons holding more than ten percent (10%) of our common stock are required to report their ownership of our common stock and any changes in that ownership to the SEC. Specific due dates for these reports have been established, and we are required to report in this Proxy Statement any failure to file by these dates.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">In making this statement, we have relied upon examination of the copies of Forms 3, 4 and 5, and amendments to these forms, provided to us and the written representations of our directors, executive officers and ten percent (10%) stockholders. Based solely on our review of copies of the reports on the Section 16(a) forms filed with the SEC with respect to the fiscal year ended December 31, 2021, and the written representations received from the reporting persons that no other reports were required, we believe that all directors, executive officers and persons who own more than ten percent (10%) of our common stock have complied with the reporting requirements of Section 16(a) and have filed all reports required by such section, except for: (i) the initial Forms 3 for Dr. Audrey Kunin and Dr. Jeff Kunin, both reflecting current holdings of one stock option grant to Dr. Audrey Kunin and (ii) one Form 4 for Mr. Jones, representing one disposition of common stock for the payment of tax liability due to the vesting of restricted stock units.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 100%;">

		<tr>
			<td style="vertical-align: top; width: 108%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="color:#294c6c;"><b>Annual Report </b></font></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Our Company&#8217;s Internet address, located at <u>www.novabay.com</u>, includes electronic files of this Proxy Statement and our Annual Report, as well as our other SEC filings. For those stockholders who do not participate in electronic delivery of proxy materials, a copy of our Annual Report (excluding the exhibits thereto) accompanies this Proxy Statement, the Notice, the proxy card and other proxy materials being mailed to all stockholders. The Annual Report (including the exhibits thereto) is also available on the SEC&#8217;s website at <u>www.sec.gov</u>. Information found on, or accessible through, our website is not a part of, and is not incorporated into, this Proxy Statement, and you should not consider it part of this Proxy Statement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 100%;">

		<tr>
			<td style="vertical-align: top; width: 108%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="color:#294c6c;"><b>Deadline for Receipt of Stockholder Proposals and Nominations </b></font></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><font style="color:#294c6c;"><b><i>Due Date for Stockholder Proposals and Nominations for Next Year</i></b>&#8217;<b><i>s Annual Meeting</i></b></font></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Under applicable SEC rules, to be considered for inclusion in our proxy materials next year, your proposal must be submitted by November 30, 2022; however, if NovaBay&#8217;s 2023 Annual Meeting of Stockholders is held on a date more than 30 calendar days from May 11, 2023, then the deadline will be a reasonable time prior to the time we begin to print, mail or electronically deliver our proxy materials. If notice is received after November 30, 2022 it will be considered untimely, and we will not be required to present the matter at the stockholders meeting. All stockholder proposals must comply with applicable rules and regulations adopted by the SEC.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Pursuant to our Bylaws, if you wish to submit a proposal to be included in next year&#8217;s proxy materials or nominate a director, you must do so no earlier than the close of business on the 120<sup style="vertical-align:top;line-height:120%;font-size:pt">th</sup> day, and not later than the close of business on the 90<sup style="vertical-align:top;line-height:120%;font-size:pt">th</sup> day, prior to the first anniversary of the preceding year&#8217;s annual meeting (for next year&#8217;s 2023 Annual Meeting, these dates would be January 11, 2023 and February 10, 2023, respectively); <u>provided</u>, <u>however</u>, that in the event that the date of the 2023 Annual Meeting of Stockholders is held more than 30 days prior to or more than 30 days after May 11, 2023, your notice must be delivered not earlier than the close of business on the 120<sup style="vertical-align:top;line-height:120%;font-size:pt">th</sup> day prior to the 2023 Annual Meeting of Stockholders and not later than the close of business on the later of the 90<sup style="vertical-align:top;line-height:120%;font-size:pt">th</sup> day prior to the 2023 Annual Meeting of Stockholders or the 10<sup style="vertical-align:top;line-height:120%;font-size:pt">th</sup> day following the day on which public announcement of the date of the 2023 Annual Meeting of Stockholders is first made. Stockholders are also advised to review the Bylaws, which contain additional requirements with respect to advance notice of stockholder proposals and director nominations.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="32" data-prefix="- " data-suffix=" -" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">- 32 -</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Stockholder proposals must be in writing and should be addressed to our Corporate Secretary, at our principal executive offices at 2000 Powell Street, Suite 1150, Emeryville, California 94608. It is recommended that stockholders submitting proposals direct them to our Corporate Secretary and utilize certified mail, return receipt requested, to provide proof of timely receipt. The presiding officer of the Annual Meeting reserves the right to reject, rule out of order, or take other appropriate action with respect to any proposal that does not comply with these and other applicable requirements, including conditions set forth in the Bylaws and conditions established by the SEC.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 100%;">

		<tr>
			<td style="vertical-align: top; width: 108%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="color:#294c6c;"><b>Householding of Proxy Materials </b></font></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The SEC has adopted rules that permit companies and intermediaries (<i>e.g.</i>, brokers, banks or other nominees) to satisfy the delivery requirements for proxy statements and annual reports with respect to two (2) or more stockholders sharing the same address (and who do not receive electronic delivery of proxy materials) by delivering a single proxy statement addressed to those stockholders. This process, which is commonly referred to as &#8220;householding,&#8221; potentially means extra convenience for stockholders and cost savings for companies.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">For those who receive proxy materials by mail, a single proxy statement may be delivered to multiple stockholders sharing an address unless contrary instructions have been received from the affected stockholders. Once you have received notice from your broker, bank or other nominee or NovaBay that it will be &#8220;householding&#8221; communications to your address, &#8220;householding&#8221; will continue until you are notified otherwise or until you notify your broker, bank or other nominee or NovaBay that you no longer wish to participate in &#8220;householding.&#8221; If, at any time, you no longer wish to participate in &#8220;householding&#8221; and would prefer to receive a separate proxy statement and annual report in the future, you may (1) notify your broker, bank or other nominee or (2) direct your written request to our Corporate Secretary, NovaBay Pharmaceuticals, Inc., 2000 Powell Street, Suite 1150, Emeryville, California 94608, (510) 899-8800. Stockholders who currently receive multiple copies of the proxy statement at their address and would like to request &#8220;householding&#8221; of their communications should likewise contact their broker, bank or other nominee or NovaBay using the above information. In addition, NovaBay will promptly deliver, upon written or oral request to the address or telephone number above, a separate copy of the Annual Report and this Proxy Statement to a stockholder at a shared address to which a single copy of the documents was delivered.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 100%;">

		<tr>
			<td style="vertical-align: top; width: 108%; border-bottom: 2px solid rgb(41, 76, 108);">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="color:#294c6c;"><b>Other Business </b></font></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Board is not aware of any other matter which will be presented for action at the Annual Meeting other than the matters set forth in this Proxy Statement. If any other matter requiring a vote of the stockholders arises, it is intended that the proxy holders will vote the shares they represent as the Board may recommend. The proxy grants the proxy holders discretionary authority to vote on any such other matters properly brought before the Annual Meeting.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:18.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">March 30, 2022</p>
			</td>
			<td style="vertical-align:top;width:6.4%;">&nbsp;</td>
			<td style="vertical-align:top;width:0.6%;">&nbsp;</td>
			<td style="vertical-align: top; width: 21.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">By Order of the Board of Directors,</p>

			<div><img alt="sig01.jpg" src="sig01.jpg"></div>
			</td>
			<td style="vertical-align:top;width:6.4%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:18.7%;">&nbsp;</td>
			<td style="vertical-align:top;width:6.4%;">&nbsp;</td>
			<td style="vertical-align:top;width:0.6%;">&nbsp;</td>
			<td style="vertical-align:top;width:21.3%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Paul E. Freiman</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Chairman of the Board</p>
			</td>
			<td style="vertical-align:top;width:6.4%;">&nbsp;</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="33" data-prefix="- " data-suffix=" -" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">- 33 -</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<div style="text-align: center;"><img alt="card01.jpg" src="card01.jpg"></div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="34" data-prefix="- " data-suffix=" -" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">- 34 -</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<div style="text-align: center;"><img alt="card02.jpg" src="card02.jpg"></div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="35" data-prefix="- " data-suffix=" -" style="text-align: center; font-size: 10pt; font-family: Times New Roman;">- 35 -</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>a01.jpg
<TEXT>
begin 644 a01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0 L17AI9@  34T *@    @  0$Q  (
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..CDG7K2;CHDM28WZG_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>a02.jpg
<TEXT>
begin 644 a02.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0 L17AI9@  34T *@    @  0$Q  (
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M]2NUM+.:XD^Y"A<_@*T)Y$0?.ZK_ +S 5QGCW4%A\.21QR*6N'6/"L#QU/\
M*JIPYYJ/<FI/D@Y=CS*>=[FXDGE.7E<NQ]R<TRBBOIMCYP**** "BBGPQ/<3
MQPQ#+R,%4>YH V_"OAUM=OBTX*V<)'F,/XS_ '1_6O6[6U2&)(XD5$0 *JC
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M7H\%KI]M';P(O"(,<^I]3[FMN.+ I+6#R;=$/51BK(%+<-A%7%.HHH ****
M"BBB@ HHHH **** $(IC)FBB@"-HLU"UO110!!+:+(I610Z^C#(K+N/"VDW!
MS+IT!/JJ;3^E%%5&4H[,EQC+=%!_ NBMTM77_=E:IK?PAIMM'Y<44FW.<&0F
MBBJE5G)6DVR8TX1=XJQ;C\-Z>O6WW?[S$U=ATJV@_P!5;QI]$%%%9FA;6WJ5
;8<444 2K'BGA:** '4444 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>a03.jpg
<TEXT>
begin 644 a03.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0 L17AI9@  34T *@    @  0$Q  (
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MB1I)9#EG8\DTRBBO</%"BBB@ HHHH **** *VH?\@NZ_ZXM_*O/ATKT'4/\
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MMPP<^N:YKQOJDW_"$W<,ACV8"1C8,KN89 /8>U735YI$3=H-GBEO_P ?$O\
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"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>a04.jpg
<TEXT>
begin 644 a04.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0 L17AI9@  34T *@    @  0$Q  (
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MP(X((YS4E<UX;46OB;Q)86J!+..YBG1%^ZDLL>Z0 =LG#D>KD]ZZ6@ HHHH
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M_J4?_)JNUHK+VGDC7D\V>>Z7I?Q*TFU:*%_"LLDLAEGGF:Y:2>0]78],\ 8
M"J %4!0 +O\ Q='_ *E'_P FJ[6BCVGD@Y/-G%?\71_ZE'_R:KH= _M[[ __
M  E/]G?:_-.S^SO,\OR\#&=_.[.[VQBM2BDY75K#4;/<Y?QGX^TOP/\ 8O[6
M@O)OMF_R_LR*V-FW.=S#^\/UKE_^%^^%_P#GPU?_ +\Q?_'*Q?VA_P#F7?\
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MSQ=_X*O_ +*C_A9/_4F>+O\ P5?_ &5=K17F\T/Y3T.6?<XK_A9/_4F>+O\
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MP01Z@@C\*MQM'F:=B5*[Y4]2E_PEFG?\^^K_ /@EO/\ XU1_PEFG?\^^K_\
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M)I'_ ('Q?_%5\BT5K]2CW,_KDNQ]=?\ ":>%_P#H9-(_\#XO_BJ/^$T\+_\
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M@'H1U -5]4A>UR?K4[7L?5__  FGA?\ Z&32/_ ^+_XJC_A-/"__ $,FD?\
M@?%_\57R1%&LC,'E2(!2P+@\D#(7@'D]!V]2*M:?IDFHQ7CPRQ(;2W-PRN3E
MU! .W (SR.N*;P<5U$L7)]#ZM_X33PO_ -#)I'_@?%_\51_PFGA?_H9-(_\
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M\51_PFGA?_H9-(_\#XO_ (JC_A"_"_\ T+>D?^ $7_Q-'_"%^%_^A;TC_P
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MX<5;%[J\L4F5;@0Q7!56S@AL*<9X'N"/:HH_$6MPW$T\6L7Z33D&61;IPTA
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ML[C4+@RZPO\ :6\SV@4/"F]"&'^M7?@MP7'3C&?F'LO_  K;_J<_%W_@U_\
ML:/^%;?]3GXN_P#!K_\ 8TY5Z;_K_@!&C47]?\$\7?Q=I\[3^9>ZDMM-9RP1
MV8M(V6U,D:KL1_,!,8*@@8 X!QDDU8U/QAH5Y8M#'-J\CK93VJ2742R.^\H5
M+N93TVG. !SP!TKV#_A6W_4Y^+O_  :__8T?\*V_ZG/Q=_X-?_L:GVU+^O\
MAA^RJ?U_PYX!97>@/H=A::K+J&ZWNIKB6."V0K('$:[ YD!'$77;_%TXR=JY
M\>0WXB-U-?Q+.UVEY;P@;!#,,*%.[YBN >0 23^/LO\ PK;_ *G/Q=_X-?\
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MU6,$X!;6[L9/I_K:?_PB>G?\_&K_ /@ZO/\ X[1:(7D;5%8O_")Z=_S\:O\
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M *#G_DI!_P#$4?\ "W_'/_0<_P#)2#_XBCZG4[H7UNGV9]/T5\P?\+?\<_\
M0<_\E(/_ (BC_A;_ (Y_Z#G_ )*0?_$4?4ZG=!];I]F?3]%?,'_"W_'/_0<_
M\E(/_B*/^%O^.?\ H.?^2D'_ ,11]3J=T'UNGV9]/T5\P?\ "W_'/_0<_P#)
M2#_XBC_A;_CG_H.?^2D'_P 11]3J=T'UNGV9]/T5\P?\+?\ '/\ T'/_ "4@
M_P#B*/\ A;_CG_H.?^2D'_Q%'U.IW0?6Z?9GT_17S!_PM_QS_P!!S_R4@_\
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MW (7HN#CICICI7I5*,_9<NFAY].M#VG-KJ?1]%%%>8>B%%%% !1110 4444
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M*/\ G_TC_O\ 2_\ QNC_ (4%XH_Y_P#2/^_TO_QNMO;TOYC'V-3L>845Z?\
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M_A?OA?\ Y\-7_P"_,7_QRC_A?OA?_GPU?_OS%_\ '*/85>P>WI]SU"BO+_\
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M )\-7_[\Q?\ QRC_ (7[X7_Y\-7_ ._,7_QRCV%7L'MZ?<]0HKR__A?OA?\
MY\-7_P"_,7_QRC_A?OA?_GPU?_OS%_\ '*/85>P>WI]SU"BO+_\ A?OA?_GP
MU?\ [\Q?_'*/^%^^%_\ GPU?_OS%_P#'*/85>P>WI]SU"BO+_P#A?OA?_GPU
M?_OS%_\ '*/^%^^%_P#GPU?_ +\Q?_'*/85>P>WI]SU"BO+_ /A?OA?_ )\-
M7_[\Q?\ QRC_ (7[X7_Y\-7_ ._,7_QRCV%7L'MZ?<]0HKR__A?OA?\ Y\-7
M_P"_,7_QRC_A?OA?_GPU?_OS%_\ '*/85>P>WI]SU"BO+_\ A?OA?_GPU?\
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M_&Z/;TNX>PJ=CS"BO3_^%!>*/^?_ $C_ +_2_P#QNC_A07BC_G_TC_O]+_\
M&Z/;TNX>PJ=CS"BO3_\ A07BC_G_ -(_[_2__&Z/^%!>*/\ G_TC_O\ 2_\
MQNCV]+N'L*G8\PHKT_\ X4%XH_Y_](_[_2__ !NC_A07BC_G_P!(_P"_TO\
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5YQVS5ZD5510J *JC  & !2T ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>a05.jpg
<TEXT>
begin 644 a05.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0 L17AI9@  34T *@    @  0$Q  (
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=6XXTAB6.)%2- %55& H'0 5K*<7%)(A1:;;9_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>a06.jpg
<TEXT>
begin 644 a06.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0 L17AI9@  34T *@    @  0$Q  (
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M&Y1A<=7K3QN/HR5:I*<)Q<*4W!:T^:R4;<W+RI6;_&C]E3_@KE\<OVA/C_\
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M/$Y'B,7*E6R;"5<94IXC#4_:8V4JDJE2:K3A*524/9\TDN5Z+=-'ZA_L%_\
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M3J?ACPO>3BX\Z]!)DLWO(TA$-E)MDB3?O120#R/_  5S_97^/_A#]HGX%_\
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DA=[=#3J)884<R)%&KMG<ZQHK'/7+!0Q_$GWHHI 2T444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>card01.jpg
<TEXT>
begin 644 card01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X@I(24-#7U!23T9)3$4  0$   HX041"
M10(0  !M;G1R4D="(%A96B 'X@ #  D "@ O #5A8W-P35-&5     !$14Q,
M                        ]M8  0    #3+41%3$P
M                                              ID97-C    _
M 'EC<')T   !>    #=W='!T   !L    !1R6%E:   !Q    !1G6%E:   !
MV    !1B6%E:   ![    !1R5%)#   "    " QG5%)#   "    " QB5%)#
M   "    " QC:&%D   *#    "QD97-C         #%$14Q,(% R-#$Y2"!#
M;VQO<B!0<F]F:6QE+$0V-3 P
M
M            =&5X=     !#;W!Y<FEG:'0@*&,I(#(P,3@@1&5L;"!);F,N
M                          !865H@        ]MP  0    #3.EA96B
M      !R&0  .LX   (96%E:(        & 4  "VE   %*E865H@
M)*\   Z>  "\>&-U<G8        $      4 "@ / !0 &0 > ", *  M #(
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M(@LY"U$+:0N "Y@+L O("^$+^0P2#"H,0PQ<#'4,C@RG#, ,V0SS#0T-)@U
M#5H-= V.#:D-PPW>#?@.$PXN#DD.9 Y_#IL.M@[2#NX/"0\E#T$/7@]Z#Y8/
MLP_/#^P0"1 F$$,081!^$)L0N1#7$/41$Q$Q$4\1;1&,$:H1R1'H$@<2)A)%
M$F02A!*C$L,2XQ,#$R,30Q-C$X,3I!/%$^44!A0G%$D4:A2+%*T4SA3P%1(5
M-!56%7@5FQ6]%> 6 Q8F%DD6;!:/%K(6UA;Z%QT701=E%XD7KA?2%_<8&QA
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M.N\[+3MK.ZH[Z#PG/&4\I#SC/2(]83VA/> ^(#Y@/J ^X#\A/V$_HC_B0"-
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M# P/#@X,# P.#A,.# P,$1$1%!$,$1$1$1$1$1$1$1$1$1$1$1$1$1$1_\
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M  P#   !$0(1 #\ _?R@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M^"OQ-^)VA> _BC?_ !Z\1FTDO_M=QH<\U]<Q3Q:=J,D+V\DKZB%9)U@(;,)
M#D%7 Y 9=\,^)/BU^WE?^(-6\*^-KKX<^ M*NEM-/:S&[4[N\B0,3.UM<02C
M,4X>1?/$"$PHB3NDDZ@!XF\2?%K]@V_\/ZMXJ\;77Q&\!:K=-::@UX-NIVEY
M*A8&!KFXGE.(H"\:^>8'(F1T@=XYV /U@H$% !0!\;?\% O^2!^//^X/_P"G
M:RH&C%M_"/Q4_9@ATF'PG=W7Q%\"V6R&?1;R. >(M)L(('8M87*- E[\Y.VW
M>/>$2"VA4*6E0 ^B_A/\:_"OQFM+^;P]=RB[TR5+;5=,O;>2TU#3;HKEH+JW
ME 975@R%EW1L\<BK(Q1L CUB@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
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M?Z;K/AO69?%\,6FZ?=6$NEZ@NH7#6.K6NR;R[E&FG>2V5)I94WH7,IRI5T0
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
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MP2+*$$C 7/LF@04 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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MW/HKXQ_"3_A;/_"#_P#$U_L__A&?%&D^)/\ CV\_[3_9WF_Z/_K8_+\SS/\
M6?/MQ]QL\ CP[5/V,M+L+C5AX*UB+0-.O/!%_P""H+":RGU%;:+4=2DO[FZ$
MLM]'([L)I51&;".RON9%\H@[G3:?^R;HWA?6?ACKGASQ!JD5SX(\RWC35[Z\
MU>WN;&XL_L4\:PS721VDIC ,;VRQPHPPUM(BQH@%S&_X9)_XL'_PH_\ X2O_
M +C']G?]1;^U/^/7[3_VS_UW^W_LT!<N>//V;/$/Q>UWP]J?C?QI82VFD6'B
M73A;:-H$VGRRQ>(-.;3YV\ZZU2_57C4AT/E$9!!!!X ,;XC_ +*?B'XDZ/X
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M&DPZ'X4T2UTFPCVGR;6()YCK&D7FRM]^65D10TLC-(^ 68GF@1V5 !0 4 %
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M!DEFB2.-03\SNRHHR68 $T@N?U:#@4R1: "@ H * "@ H * "@ H * "@ H
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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MV=E%N[A)C&X*@ ]8H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M98IHI5#I)&Z$JR,I!5@2"""#B@"[0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % ',^-+#1=5\/:]9>)6B71;FP
MO(=3:><V\0LI(76X,DP9#&@C+;G#+M&6W#&: /ES2#H&CV'A34-'^(NEZ3XA
MTVU\1V]Y+XETR:U-Y+>O:ZUKES+I-S>:==6TIEBCO,;Q%!;3%A$8)()$!E*?
MP7X/\3Z%>62?$6PBDN_"7C\W4TL:0AK;Q5J,5U=ZS%!-<(ZZ;%<02>0Y:2*6
M!XV%W( )I0#LAX/L?B7\/)/ 6F?$.PU'5+.71M2EU&SN[Z]:)?[0BUFR=P^L
MSWZ)/%$HBD_M .4/F0R(JHJ@' ?![Q'\,;SQ9X&\/Z;XG\[7-!T'4M/MM/O_
M  _?:5+<BUN!;1-;'4(HW/\ 9:1:A:0QL]Q<I%->"2=W%W)* =-\3OA[X/\
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MY,GD[<^;Y;[-VUL '94 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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M+%8XTC"HH(Z:@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * .-^(WA'_A/_  GXG\+_ &O[)_;>EZAIOVCR_-\G
M[9;O!YGE[DW[-^=NY<XQN'6@#YHF_9&2.:+4;+Q==)JLMK%]NO;EM0N3-J=C
M/<7FEWNPZF@N/L-S,GEQZE_:)-M;6UN)$*232@[FSK?[*UA>OIVG:9K']G^'
M;+5-&U8:6;5[AY'T[3[?0Y+.6XDN,26%SI4+6\L$D3R-)(TCSR1%K9@+G?\
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MH+Z6YEC:24KY5PT$L4YB@EB N?:U @H * "@ H * "@ H * "@ H * "@ H
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MHY[>X@D66*:*50Z21NA*LC*058$@@@@XH NT 8UQXCTFUAU:YGU2UCATG?\
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M!.$=4F179!+$75=\3[=T4JYCEC*RQL\;JS &S0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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ME[_3+_[*\$987)\Z%P8/G8 \ST#]D9;K48/#8\0Z-?Q^&I?"HO\ 3;>ZM/\
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MX*N9]>UW4UEDO+;3[2TU&_GO)M-DM-0N]+D(ELK9EC7R;6VNBL2&"\M4@*3
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MI&MHM,T\Z5:QR)!;I!Y2N]_%+(T2%$(GDN#(92T;@CUB@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M2I:ZW_8]U]LO-'UNZ1M,U%)8KI?L$LMOIR1+:V<MRDMHJZ<(T%I;QK!#A7B
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MWDL&L:=)?O+MMI&^SRLLTL\K6['89)7C8[@0#F3^S#JPO8=7NK'0=7^SVME
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M!2?4;2*[@L'NHENYXIIXK<R*)9(H&C2614)W,B-+&&8#"ET!(++D NT % !0
M 4 % !0 4 % !0 4 4M.U&TUBTM;^PNHKJTNHHY[>X@D66*:*50Z21NA*LC*
M058$@@@@XH NT % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % 'D_QMTG5-<\)7%GI.F2ZI(U_HCW.GPR01M>Z?%JEI)J%L?M4L,+)-:+-
M&\<DBI*C-&V0Y! /#G\)>/OAW92:KX-\,YMI?[;O-,\'V5S:6UMI5_<65E;:
M:MP!=V=L]JIAO)[R&"5D6[O=\:73PK>@&<9X9^$GQ$T30-'TK5&U[5)IM+\.
M3ZCJ<FOQRZU:WGG7FIZ]96EZ;N"9(KLV.FZ>J17,4"B5+G>[17+N ;/[/\OC
M74_%D=CXHUBZUR]T&UU-?$VL6&K++H%UK7VB.#3K:VMX)T6*6ULVNDO+8V=L
M!-Y-Q-')(;.X(!S7BW]FW5'^(?BGQEX>\+Q66HM+KMWH.JV=Q!9M#JM]I_AN
MUM+NY$4R/+;I<+JDMQ%*DJR)]H)MYGN$2< [+PQ\-_B?=^#/$FC>,-1EU2XU
MF_T2PU"T<*D4UE)>PQZ_=6T\NJ7C+;WEE+*L<<::?Y(BW06%K-)@@'&V?PE^
M,LMC;:E=ZE*/$&F^')-#:5]1-RL\"WVCQS+9NMU;.]Q>P:7>73W$KV%PKZC:
M6YNU:U,UH ;/ACX9?&R.^U!=2\52SQOHUZ-/^U+<6UL([BQ,5MI=Y):>(+B:
M&XMKN3S'O88;J\>*$?\ $X<RM"H!YGI_PU\<_![P?X8,5Y+X2TC0[#0;+7+>
M?Q'#!97%EL-[K@@FDO!%;ZEJ5_J)MK:4&'R/L+,FH6T5Q"C 'U[\'K/Q9<^$
M-(OI9+K2[J]U2YO9K7Q&EQJ%\FB_:)8[*U8?;Q]FNOL"6H=V>4B82R3Q37,L
MSL".9\6>#/$FK>.8+R;PG8:VL>LZ5=:9JVJV]K=V6C:/!# ;N"W1[R&YM=2:
MYCGFCN(;6X63=:12R>7&ILP9S5K\*/'?C+P)\0?"OB*[NH;G6=!AL%DO-7E=
M+CQ%Y5T+[4()+6662#2[J1K7R[4"%%CCF1M/A21DF .E^&.E^,/"VHWVJ:]!
MK,&EVUAJDEW'>W[ZQ)<J;F*;1X[.W@N;Z7[186"RVUZ41'O+IED#:BQ%R #Y
M<A\3^/+_ %R73=4OO&2>&IM4ETLR6>@>+$N(] L+NWUC3+H2#3DNVNI8_M6D
M7LJW$<SJ]O<,MSY#3R@&-I'BSXMZS#LU_5_%%K?O:W.HBYMO#'B:.SBU_2X+
MW2;-/)@TA'^P:@DECJ4D;"6'S[6YCDLHQ=>4 #OOAG\2O%:7=W/X\L_&\]E=
M6!9;.R\.>(Q)%<^)FL'U"W$D=G \*:)<6]T;:19IY19W:QV\[20>6X!S4'Q
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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MSQ33Q6YD42R10-&DLBH3N9$:6,,P&%+H"067(!=H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M-JY@EDN-L4?E>'BB)"?)7S%2-?-U!9 #&\+_  J^,-UJVA1ZQXGU2WT&?DP
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M\LEYK*-%X(\06L8'B,JMWXWFBAA_M&V6.\VQV5PK$V44@ABLWCDD%G92,C2
M'93>%/BM9:1XPTQ8+^]M;B6V&G[M9DDO8XH-7U:)&MY(]6T^=G.FP:2)%?4;
M0/NGN'>>\:ZAN0#R?0O@_P#%K1/$6F:SJ5OKU[9:O:_VGXPMM-\3_9IKZ\GT
MG1K5;:V']I6R074&HVUQ.SP/;P"PVVL=P\>VR ![]X!\$_$O1M>TW5_$.IW5
M[>2:I96NK2IJC/IDNEQ^$X5GEM[!Y$@AWZY&6#1VT5S@MP+=W! /K"@04 %
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M#I-UITUQ$-)@F34?#5C9P7E_=13PVBQMK-W=QS6,5JDL0,<BR+9PKB]0 N>
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M,7:V5;65_P!X!(]J6MQ*)(T;*,J@CIJ "@ H * "@ H * "@ H * "@ H *
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M)-<FXGMY=4C@G1)4, \BWC?380BFUN9VDN5B!'N- !0 4 % !0 4 % !0 4
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M7A.ZN-+CA2U\23/I*12#5]._LC4K*QM)KJ1KD@Q:C#.UU #:PXB:/:\R@RN
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M[2UTS3=;T'PW>P:=J%A'&^BW%TE[)J#W%S?ZGI44_P!GECMK6<236BI)?6(
M2;]S?@'OWQ9\>:_X8^'%CXC>:U\*:K)=>%5OC?-#?6FF?;]4L+>]2=P\,<L4
M4<TB.ZR194%TDB.UU!',^"OB]XP\3^(?"VFR:78-IVJ17<_VV)747EEIDVJV
MEUJ-J&N&"V\\G]B36ZGS<P7[E);E(WGB!GU)0(* "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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MVA:Q+I=W8?V]%X8'V2PN+2X%V/"\7B&2],DE[<(8F<20K;^6&161S<N8V60
M\!\=^._'WP]UNVCMO&]UK,G_  L;0_!MHFM6EI]DAAU?0[6[:[FAT>+2Y+B6
M*2ZD"1R3?9]NUC%Y\<<Z '9-^U)K]YX 3Q3!HMK;32:IIEK+<NT+V>GVFJ:'
M:Z_#+<"]O]-A/EB[BL"TE];++.5G0!I([$@6/3-:^,7B72=<\*:7>:+:Z;<Z
MA:^'Y;C2)I#=7EY<:K=O:W\%A<0R)&W]B1J+J[=8;A9('4G[(A$S 'F>E_&[
MQWK_ (.LIGO=+M=<U"U^&>L6][:Z;*+2"W\7:PME):2VD]W,\OE)#(&E6XA:
M190$6W>,2L < O[0NM>&&M;C3M.B\+Z3>V&MW@L;VV%[&NNS7>A:AJ4MU>7]
M]I4,:07.K7UB8Y+JTCBO(9(BTD[P6,0!]%_LW_&+Q+\9["[U?6M%M=,MA:V$
ML<4$AE>*XOGNKZ.!Y#(1)C2IM*FWK&BF2XE7Y75X( #R?6_BOXS\/^&;1SXB
MEEN[:7XA):7D]K9"76M7T#6FL=%T:14MTB=[^(2!H;6.&[G,!,$D967< >L?
M'3XI:9X7TGPYJVF_$:UT>ZU7>=#CDNM+72=7=XTF26]GNX7=;"),/-+;3PR-
M%)LB:2YEM8V /&O%OQPO-%U/4QXA^(5UX?@CNM?BN;6RCT:.XL+BSU2.QT*S
M0ZI:RK%_;%G))>EKQ]KK";J*:UL8KB@#O]&^,EO#XMT"ROOBAHUS=RZ-!JGB
M+3EOM-31;.V.EM<F?2Y3%'?2/))']I7S9YXH[#SI9?),EEO #XX?%[Q;X%N_
MB=;:)I=_>QZ7X(M-6L[FT72_*TF]D;7%:ZN!?7$,DJ$6L+;(TN,"%OW0+XD
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0!YG\9KOQ+I_@3Q?>>#9-FO6VEWL^G8LC?.UQ%$TBI%;AEWROMVQ9#J)"
MK-%*H,3@'R?HO[1/C71O#=SJ=W=Z7XL^W_\ "4W.FWVFV2VD-O::/XFM]&:Y
MDWZ@T%Q:K!>K=*S7%HL=O;,LUV_F/>1@SL_A'\=O&OB[5;+_ (2&PTN"PO\
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M0!C>(/#]AXJL+C2M5M_M%E<;!/ 7=4F175S%*$9=\3[=LL39CEC+12*\;LK
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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M1_V)A;1)$3_3_#VD:M)D222'B:^D5>>(P@.6#.P(]^H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M<?G)<75TC320":VBM@9H+B^D_<4#L=-??M'7OA+P.GBCQ%I%K+?PZIXFAO\
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M*YTVZ\,_V#J%UX7O+A%L?$-Q9Z/OMXDM;&>:ZCL41)(+&2:$QK:Q17=PA"H
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@"EJ.G6FL6EU87]K%=6EU%)!<6\\:RQ312J4>.1'!5D920RD$$$@C%
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M66'PK8Z-XL^WZ"-(ET2*_MI;_2"VG-%=0VPMWGD1[A8IECBOA \$K"TN)Y5
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M;;RM6TV-H%:ZMQ!<321(!=6[;+I+>8B9<1$I*(P#UB@ H * "@ H * "@ H
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M>&M&F\/Z%%#8M:RQZ?*UD6-]*US.MS<;;"W DBCM4SYQ\DB1%B!'N- !0 4
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MYK2W\F,Q1>5#(C1ILC8HNU1M4E1@'% '&?\ #.?PG_Z)AX7_ /"?T_\ ^,4
M=GX1^'/A/P!]K_X1?PQI>B?:_+^T?V;I]O9^=Y6[R_,\A$W[-[;<YQN;'4T
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M5G2WU&SANXEE5602*DZ.H<*[ ,!D!B,X)H X#_AG/X3_ /1,/"__ (3^G_\
MQB@#O_"O@OP]X%M)+#PUH-AHUI)*T[V^G6<-I$TK*J&1D@1%+E44%B,D*!G
M% ' ?\,Y_"?_ *)AX7_\)_3_ /XQ0!L^'_@M\/?"5_;ZMH?@30=,O[??Y-W9
M:/9V]Q'O1HVV2Q1*Z[D9E.",J2#P30!=\5?"CP1XZNX[_P 2^#M&UF[CB6!+
MC4=+M;N58E9G$:O/&[! SL0H. 6)QDF@#F?^&<_A/_T3#PO_ .$_I_\ \8H
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M,TZ2(^UF>*W4^6^H6:R 'W?0(* "@ H * "@ H * "@ H * "@ H * "@ H
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M\=^'YO"7@&VT/PE;W5O9Z9_8=D8;%YWNX]#M[NUBOD@9&:Y:5=/68(8F-T6
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M\(^"M%T;5(])\$>"[2ZEO+^;1%>6*\\0!KA(K;3]0#/<2&667<RD.<[I"[,
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M0 3X+V6GZ3X0T[1=?U32+GPOI:Z+8ZE:FRENVL#';))#*MY9W%LWFFTMW9Q
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MT:;0=+MM1&FB*ULI6LF8*;*PMI'?%E"H:1WX![L30![C0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 4K73K2QEO)K:UBADO)1/<O'&J-/*L4< DD
M*@%W$<2(&;)V(JYPH  +M !0 4 % %*_TZTU6)8;VUBN8UE@G5)HUD42V\JS
MPR ," \<B*Z-U5U5@00#0!=H * "@ H * "@ H * "@ H * "@ H * "@ H
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M^$__ $,/BC_P-T__ .5U 7#_ (=7?"?_ *&'Q1_X&Z?_ /*Z@+A_PZN^$_\
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MG_\ RNH"X?\ #J[X3_\ 0P^*/_ W3_\ Y74!</\ AU=\)_\ H8?%'_@;I_\
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MJ[X3_P#0P^*/_ W3_P#Y74!</^'5WPG_ .AA\4?^!NG_ /RNH"X?\.KOA/\
M]##XH_\  W3_ /Y74!</^'5WPG_Z&'Q1_P"!NG__ "NH"X?\.KOA/_T,/BC_
M ,#=/_\ E=0%P_X=7?"?_H8?%'_@;I__ ,KJ N'_  ZN^$__ $,/BC_P-T__
M .5U 7#_ (=7?"?_ *&'Q1_X&Z?_ /*Z@+A_PZN^$_\ T,/BC_P-T_\ ^5U
M7#_AU=\)_P#H8?%'_@;I_P#\KJ N'_#J[X3_ /0P^*/_  -T_P#^5U 7#_AU
M=\)_^AA\4?\ @;I__P KJ N'_#J[X3_]##XH_P# W3__ )74!</^'5WPG_Z&
M'Q1_X&Z?_P#*Z@+A_P .KOA/_P!##XH_\#=/_P#E=0%P_P"'5WPG_P"AA\4?
M^!NG_P#RNH"X?\.KOA/_ -##XH_\#=/_ /E=0%P_X=7?"?\ Z&'Q1_X&Z?\
M_*Z@+A_PZN^$_P#T,/BC_P #=/\ _E=0%P_X=7?"?_H8?%'_ (&Z?_\ *Z@+
MA_PZN^$__0P^*/\ P-T__P"5U 7#_AU=\)_^AA\4?^!NG_\ RNH"X?\ #J[X
M3_\ 0P^*/_ W3_\ Y74!</\ AU=\)_\ H8?%'_@;I_\ \KJ N'_#J[X3_P#0
MP^*/_ W3_P#Y74!</^'5WPG_ .AA\4?^!NG_ /RNH"X?\.KOA/\ ]##XH_\
M W3_ /Y74!</^'5WPG_Z&'Q1_P"!NG__ "NH"X?\.KOA/_T,/BC_ ,#=/_\
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0!^:/\ P51_Y)/X>_[&BR_]-^HT#1^EU @H * "@ H * /S1_X)7?\
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ME+B9=Y);;+*,XD;(!V5 !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@#\T?^"J/_ "2?P]_V-%E_Z;]1H&C]+J!!0!^:/_!5
M'_DD_A[_ +&BR_\ 3?J- T?I=0(* "@ H * "@#\T?\ @E=_R2?Q#_V-%[_Z
M;].H&S]+J!!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@#\T?\ @JC_ ,DG\/?]C19?^F_4:!H_2Z@04 ?FC_P51_Y)/X>_[&BR_P#3
M?J- T?I=0(* "@ H * "@#\T?^"5W_))_$/_ &-%[_Z;].H&S]+J!!0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % 'Y[_\%)_!?B'QU\,M"L/#6@W^LW<?B.TG>WTZ
MSFNY5B6QOT,C) CL$#.H+$8!8#.2*!H_0B@04 ?FC_P51_Y)/X>_[&BR_P#3
M?J- T?I=0(* "@ H * "@#\T?^"5W_))_$/_ &-%[_Z;].H&S]+J!!0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M7_A5M)T9M>DU#Q%#HLMU?E;N[CECN_L.VQ%E91QPO=_97CG,=W:9NK.0,;@
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M?#GPG8?V]]F\,:7#_P )!YG]L>7I]NG]I>9YF_[7M0>?N\V3=YF[.]\_>.0
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MQ1*CNH1"%"LPQ@G(!<F\%^'KF*:&70;"2.:+48)$:SA97BU.43WT; I@I=2
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M!Z90!C:7X@L-9N=7L[.X\R;2;I+*]78Z^5</;07BIEE ;,-Q$V5)7YMN=P8
M N/J-I%=P6#W42W<\4T\5N9%$LD4#1I+(J$[F1&EC#,!A2Z D%ER ":C:2W<
M]@EU$UW!%#/+;B13+'%.TB12,@.Y4=HI K$88HX!)5L %V@#F?$OB_2_"*V1
MU*656OI9X+6."UGNI9Y8+2XOGCCBMHY'9_(MI650N7*A%#2,BL 8WASXG^&_
M%=W;:?I][+]MGBO9A9W-E=6=U$MBUHLXG@NH8I(' O;9U254>2.:.5%:-M]
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MXOTOQI:27FERRE8I6@GAN;6>SNK>4*K^7/;7<<4\+E'215DC4M&\<B@QNC,
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M9Q?LR3>#M6MI;M=!\56 ^T:!H/ASQ)?3QV3:9')-JNG'==6VIO)?Z8DM_:Q
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MJVB>%_$^E:'X7T;PG::/JM_<?9+[^RY+AHM8G232KF.WNDCD,<<"QW&Q;FX
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MX9(K2Y@&HWAFN(H]L27#27;D03.UWOG8S@CUB@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@#\T?^"J/_
M "2?P]_V-%E_Z;]1H&C]+J!!0 4 % !0 4 ?FC_P2N_Y)/XA_P"QHO?_ $WZ
M=0-GZ74""@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * /S1_P""J/\ R2?P
M]_V-%E_Z;]1H&C]+J!!0 4 % !0 4 ?FC_P2N_Y)/XA_[&B]_P#3?IU V?I=
M0(* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * /D+P3\4?%L;:N;BUO\ 5KW5_%NN:#H4>J3Z78:*
M%TV[UI\0S:=;SWR)'::>4D:Z@E=[@1B/$;R2J#._\ _&+5O'_B.71;;PY:P6
MVFVI?6+F35)#+#=KJ.KZ4\5I"MEBXB%SI4A6626V8Q2(YA5P8J!'OU !0 4
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M % !0!^:/_!*[_DD_B'_ +&B]_\ 3?IU V?I=0(* "@ H * "@ H * "@ H
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M\.?">NVSV6I>&-+O+9_M6^&XT^WEB;[7<QWMQE'0@^=<QI-)Q\\J+(V74,
MU+X<^$]9L+;2=0\,:7=V%M:BQ@M)]/MY;>*T#P2"!(G0HL0>WA;8 %W11'&8
MUP ;/A_PYI/A*PM])T/2[73+"WW^3:65O';V\>]VD;9%$JHNYV9C@#+$D\DT
M ;- !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % 'YH_P#!5'_D
MD_A[_L:++_TWZC0-'Z74""@ H * "@ H _-'_@E=_P DG\0_]C1>_P#IOTZ@
M;/TNH$% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M]&N=+@O]2TZ.;4_$5U8W4DNF7<UA<,T$&CWB*AG@D\LB=BT>QV$;,8T ._\
M /B[_A-M&34FM/LLT=UJ-A=0B3S42[TR\GL+D12;4,D7G0/Y3LD;/'M9HXV)
M10#LJ "@ H * "@ H * /#K/Q_XW\4M?7?A;PGHUSI<%_J6G1S:GXBNK&ZDE
MTR[FL+AF@@T>\14,\$GED3L6CV.PC9C&@!W_ (!\7?\ ";:,FI-:?99H[K4;
M"ZA$GFHEWIEY/87(BDVH9(O.@?RG9(V>/:S1QL2B@'94 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * /S1_X*H_\DG\/?\
M8T67_IOU&@:/TNH$% !0 4 % !0!^:/_  2N_P"23^(?^QHO?_3?IU V?I=0
M(* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H _-'_@JC_R2?P]_V-%E_P"F
M_4:!H_2Z@04 % !0 4 % 'YH_P#!*[_DD_B'_L:+W_TWZ=0-GZ74""@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M"% !>21V=VZL[,Q)))H NT % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M79C\\TSMC.U<[5 4   _.K_@JC_R2?P]_P!C19?^F_4:!H_2Z@04 % !0 4
M% 'YH_\ !*[_ ))/XA_[&B]_]-^G4#9^EU @H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M#XT\/7,4,T6O6$D<T6G3QNMY"RO%J<I@L9%(?!2ZD!2!AQ,X*H6(Q0!=\/\
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MZ'XT\/>)[O5;#1M>L-1N]*E\C4+>TO(9Y;.7<Z>7<)&[-$^Z-QM< Y5AC*G
M!P%W^T#\/8_[!6Q\6Z7JDFNZI'H^GI8:E9S^==GRVD4/YPC'DQR([@MN.^.)
M%DGG@BE #QO\=?#7P^O]?TS5A=+<Z1H)\0L$A!2ZMU2_D:WMY&=8VNO+T^>0
M0NR,\:M(A9(IVB .SLOB-X3U.;4K:S\3Z7<3:9=06-]%%J%N[VEW<3FVA@G5
M7)CEDF!B1&PS2#8 6XH Q?$WQ?\ "?AFP\07K:U:WLVB:7J>L75A975O-?&T
MTQY8KEDA\U3\DT+PDL559E,;,K @ !HGQ7T/4(6.JR?\(_>IJD6B26&KW%I%
M<+J<\$5U!:J\-Q-!-+-!-'+&L$TI*OM.)%D1 "[J'Q-\/6"Z=,FH175I=1)=
MRWEM-#+:V.GRVEY>1:A=RB0+%92K9R)'.<H\A50<;BH!=UGXC>$_#NDV.O:M
MXGTNPTJ_\G[)?W6H6\-I<>=&98O*FD=8WWQJ77:QW*"PR!F@"Y)XT\/0RZY#
M)KU@LFA1)/JR->0AM.BDB:=)+L%\P(T:EPTFT% 6!P": ,:P^*_@C58FFLO&
M.C7,:V$^JL\.J6LBC3[>5H)KLE9"!;QR(R/+]Q75E+ @B@#&\2_'#P1X8;0X
M9O$=A<7>N2Z.FF6=M?6LEU>1:M=Q6=O<P1&96EM]TF]I$W#RTD9=Q7! .RU'
MQIX>T>[NK"_UZPM;NUL)-5N+>>\ABEAT^)BCW<B.X9;=6!#2D! 006S0 /XT
M\/1:I!H;Z]8+JD\LT$5B;R$74DL$$=U+&L)?>SI!+'*RA<K&Z.0%920"GIOQ
M&\)ZS?W.DZ?XGTN[O[:Z-C/:0:A;RW$5V$GD,#Q(Y=90EO,VP@-MBE.,1M@
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M$:ML1YHE9L*9$!+  ]^H * /S1_X*H_\DG\/?]C19?\ IOU&@:/TNH$% !0
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M.?PCKUG$]U>6LD$*R7%UI\4$*%W4-)+(D:#+.ZJ"0#/J2@04 ?FC_P %4?\
MDD_A[_L:++_TWZC0-'Z74""@ H * "@ H _-'_@E=_R2?Q#_ -C1>_\ IOTZ
M@;/TNH$% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 ?FC_ ,%4?^23^'O^
MQHLO_3?J- T?I=0(* "@ H * "@#\T?^"5W_ "2?Q#_V-%[_ .F_3J!L_2Z@
M04 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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MN6XGD BM[BT -G5=9^+%A!KNI6VH:S<21Q>/=6M+$Z/9M%YF@:K]GT735"6
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M.O7?A[2_[8TF)Y;2T2WU*6:QTC4;>>\%K8Q(</+?PK<1K#$C6<-ON6>:=;T
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MBVO[H:UXMLK2:S>R5[6'2QX7T][G5[:1+&XN#<1/:F",[;N!I!Y(L+FY98V
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M4P21QL#&LLMQ;@'FFE?$3XN6+>!OM-A?WL=YK,,+RFQNW$^EW5W:VDYU!/\
MA&K&2*XLP;F9'=-(@\@V[AM2*W"@ ^E_A1%XDG@U[4O$FJW\\ESK.N0VMC=V
MMK;Q6=E9ZK>V]H;<0VL,S)-;+"^^:2;>-KHP#'<"/6* /&OVC/\ DD_Q/_[%
M?Q!_Z;YZ #]HS_DD_P 3_P#L5_$'_IOGH ]EH * "@#QK0_^2L>-?^Q7\(?^
MG#Q'0 :'_P E8\:_]BOX0_\ 3AXCH ]EH * /&OVC/\ DD_Q/_[%?Q!_Z;YZ
M #]HS_DD_P 3_P#L5_$'_IOGH ]EH * /S1_X*H_\DG\/?\ 8T67_IOU&@:/
MTNH$% !0 4 % !0!^:/_  2N_P"23^(?^QHO?_3?IU V?I=0(* "@ H * /F
MC0OVJ_!OBS1M8UCP_'=:O_9]UHMLMK926,MQ<C7+Q;'3Y$/VP10^=*3F&ZDM
M[F%5)F@BW)O!V*6H_M)+JD$3^%O#=_<K;^(]%\.:Q>7*VB6NDW]SJMG8WME.
MOVY)Y+B%+C"R6T=Q:F1XR)I(UDV@%/P]^U?H=UIFD75_I6J'[?\ V)86MXEI
M:0V^HZYJ^EVFJ6VGV\']H7$L$LT5TI#3LMK$P9'O#@.X%CIM6^*ZQ>$?BGXQ
ML/"TND>(/"EA>P7,&K1VCRR2Z?I@U>UCEDTZ[G62W"WH8*)P5,DH 1B201S/
MB?\ :>TGX,ZL_A7XD7UJ=5CM;?4Q>V"1V-I-I<\DT;W M[Z\:02V\D+(]K!-
M=W,RF.6".4O-!; ['3>+?VE=!\&Q7%[?:1?C2Q?W.DVFJ27.DVEE>ZE:2RQ7
M-K&]]J-NT3Q-;W.7N5@AD\AEBED:2W6<$&O?'?PQ?M801>';_7M.N;#PYKD%
MY%!9_9=VL7<B:(OEWUS!,+B>[MD$3>3L@D:*262!%>2, X#1?VH=#M;GQ_XG
MU[PS=:;H>A:I;Z%?>(5MK1OL1M;:U+6-^L-W+>32P:C>7$*FUMYK8>8'21D,
MLQ!V._\ !W[2N@_$"[T6P\.:1?ZG<7\M_'<BTN=)N(M.6P;3_/DN+F+46MY4
M":C;/BTEN7PS(5$T;QJ"-GQ+XU\3^'_&=EHEK]@U"WU:*?[%:3V%YIHADCLK
MB=#)K#R7%M<.\UL4:T@M?M4<$INMCPVTAD .R^%'BJ[\=>"/!WB6_CBCN]9T
M;2]1N$@5EB66[M8YW6,.SL$#.0H+,0,9)/- 'D_C#XF^+/!FM:KI!ETO4_-_
ML?[-+'87%I_8_P#;NMPZ/IWVM7O9?M^_?<2MY!M<?8G1O*^UPO&#*5E\2O&]
MIKHTN]O-&OFM/$=GX9EM;;2KJTEU*6XTZ#69KJ">749X[1+2QG>1H9$G,YLY
M%29)+J*.$ [_ .'VI:MJVO\ B*T\0#2]3O?#OD62:S8:=)I_ERW\,5Y<Z>(+
MBZO)1LB6RG>59O*F\Z./8)+5R01[+0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!2T[3K31[2UL+"UBM;2U
MBC@M[>"-8HH8HE")'&B *J*H 50    !B@"[0 4 % !0!S.N>"_#WB>[TJ_U
MG0;#4;O2I?/T^XN[.&>6SEW(_F6[R(S1/NC0[D(.54YRHP =-0 4 % %*ZTZ
MTOI;.:YM8II+.4SVSR1J[02M%) 9(RP)1S'*Z%EP=CLN<,00"[0 4 % !0 4
M % !0!2U'3K36+2ZL+^UBNK2ZBD@N+>>-98IHI5*/'(C@JR,I(92"""01B@"
MGX?\.:3X2L+?2=#TNUTRPM]_DVEE;QV]O'O=I&V11*J+N=F8X RQ)/)- &S0
M 4 % !0 4 % !0 4 4DTZTBNY[]+6);N>*&"6X$:B62*!I'BC9P-S(C2R%5)
MPI=R "S9 +M !0 4 4M1TZTUBTNK"_M8KJTNHI(+BWGC66*:*52CQR(X*LC*
M2&4@@@D$8H \G_X4-X4D^6YFUZ]A;B6UOO%NOWMI.A^]%/;7.H20S1./E>*5
M'CD4E65E)! /9: "@ H X#Q5\,M"\8W<=_>B_M[M(E@:XTO6-1TF66)&9TCF
M?3;FW:9(V=S&LA<1F20H%,DFX N^$? .C>"?M;::EU)-=>6)KJ_U&\U.[=(M
MWEQ&YOYYYO*C+NR1;_+1I)&50TCE@#LJ "@"EJ.G6FL6EU87]K%=6EU%)!<6
M\\:RQ312J4>.1'!5D920RD$$$@C% 'D__"AO"DGRW,VO7L+<2VM]XMU^]M)T
M/WHI[:YU"2&:)Q\KQ2H\<BDJRLI((![+0 4 ?FC_ ,%4?^23^'O^QHLO_3?J
M- T?I=0(* "@ H * "@#\T?^"5W_ "2?Q#_V-%[_ .F_3J!L_2Z@04 % !0
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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MY'9+= \LK!%;9$FY%:5]L8DDBBW>9-$K@&S0 4 % !0 4 % !0 4 % !0 4
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M\16UOKR7^I0:C]FN;34HK?2-3LUOVM4TNV'V^YN;V.2X-Q)>2E88BU_.\29
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H _-'_@JC_R2?P]_P!C19?^F_4:!H_2Z@04 % !0 4 % 'YH_\ !*[_
M ))/XA_[&B]_]-^G4#9^EU @H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M#\T?^"J/_))_#W_8T67_ *;]1H&C]+J!!0 4 % !0 4 ?FC_ ,$KO^23^(?^
MQHO?_3?IU V?I=0(* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H _-'_@JC
M_P DG\/?]C19?^F_4:!H_2Z@04 % !0 4 % 'YH_\$KO^23^(?\ L:+W_P!-
M^G4#9^EU @H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@#\T?\ @JC_ ,DG
M\/?]C19?^F_4:!H_2Z@04 % !0 4 % 'YH_\$KO^23^(?^QHO?\ TWZ=0-GZ
M74""@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * /S1_X*H_\DG\/?\ 8T67
M_IOU&@:/TNH$% !0 4 % !0!^:/_  2N_P"23^(?^QHO?_3?IU V?I=0(* "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H _-'_@JC_R2?P]_V-%E_P"F_4:!
MH_2Z@04 % !0 4 % 'YH_P#!*[_DD_B'_L:+W_TWZ=0-GZ74""@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * /S1_X*H_\ ))_#W_8T67_IOU&@:/TNH$%
M!0 4 % !0!^:/_!*[_DD_B'_ +&B]_\ 3?IU V?I=0(* "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H _-'_ (*H_P#))_#W_8T67_IOU&@:/TNH$% !0 4
M% !0!^:/_!*[_DD_B'_L:+W_ --^G4#9^EU @H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@#\T?^"J/_))_#W_ &-%E_Z;]1H&C]+J!!0 4 % !0 4 ?FC
M_P $KO\ DD_B'_L:+W_TWZ=0-GZ74""@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * /S1_X*H_\DG\/?]C19?\ IOU&@:/TNH$% !0 4 % !0!^:/\ P2N_
MY)/XA_[&B]_]-^G4#9^EU @H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@#
M\T?^"J/_ "2?P]_V-%E_Z;]1H&C]+J!!0 4 % !0 4 ?FC_P2N_Y)/XA_P"Q
MHO?_ $WZ=0-GZ74""@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * /S1_P""
MJ/\ R2?P]_V-%E_Z;]1H&C]+J!!0 4 % !0 4 ?FC_P2N_Y)/XA_[&B]_P#3
M?IU V?I=0(* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H _-'_@JC_R2?P]
M_P!C19?^F_4:!H_2Z@04 % !0 4 % 'YH_\ !*[_ ))/XA_[&B]_]-^G4#9^
MEU @H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@#\T?^"J/_))_#W_8T67_
M *;]1H&C]+J!!0 4 % !0 4 ?FC_ ,$KO^23^(?^QHO?_3?IU V?I=0(* "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H _-'_@JC_P DG\/?]C19?^F_4:!H
M_2Z@04 % !0 4 % 'YH_\$KO^23^(?\ L:+W_P!-^G4#9^EU @H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M,%O#>2"T22!IYB/,MC%/"20S6TT!)F)-Q,"/9: "@ H * "@ H * "@ H *
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M^#WA#Q;'JD6K:1]H34[JXO;L?:;A/,N+C2&T*5_W<J[=U@QAPN%&?, $OST
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M89MME*[VT7GF5VN/+C3[0[L\OF.2U &+HOPA\+Z%<V5]#:W5Q>V=T+R&\O\
M5+_4;M95MKJS13<7MQ-*T217EP$A9S$C322*@D=G(!QNB?LY^%[5-1;6/M6K
MS7>J:SJD9GU"_%O93:CJ%Q?1RV5J;IX;.ZMQ/L2[MEAN P>57C:5P0#LM(^#
MWA#1K:VLXM(^T0P6NM66V^N;B_\ -M]<N8[S44G-Y+*9_M,T:LYE+MU4$*S
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M9EB3;&"4C"H7+2%?,=V8 NT % !0 4 % !0 4 % !0 4 % !0 4 % 'YH_\
M!5'_ ))/X>_[&BR_]-^HT#1^EU @H * "@ H * /S1_X)7?\DG\0_P#8T7O_
M *;].H&S]+J!!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M=O\ D6]-_P"QH\#_ /J3:70![+0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % 'C7PP_Y&3XN_P#8T6G_ *C.@T >RT % !0 4 %
M'C7PP_Y&3XN_]C1:?^HSH- 'LM !0 4 % !0 4 % !0 4 % !0 4 % !0!^:
M/_!5'_DD_A[_ +&BR_\ 3?J- T?I=0(* "@ H * "@#\T?\ @E=_R2?Q#_V-
M%[_Z;].H&S]+J!!0!XU^SG_R2?X8?]BOX?\ _3?!0![+0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 >-:Y_R5CP5_V*_B_P#].'AR
M@#V6@ H * "@ H \:T/_ )*QXU_[%?PA_P"G#Q'0![+0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % 'C7QV_Y%O3?^QH\#_\ J3:70![+0 4 % !0 4 % !0
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M?+AU;7K>]LF_LK4V\VW30])LV?"VA*XFMY5PP#?+NQM*D@6/3/\ AX%\ _\
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MXT6:VL$BT6[L]1TJ..P5X+2*Y,MB+N6TN//D9GEB9FCB?,:@'UA0(* "@ H
M* /&OBY>:S]L\ Z/H^OW6B?VWKTME=75E#9RW'V>+1M5O@B"^MKJ(9EM8\GR
MRVT$ C- 'FGA7]HZ]UR_T70UTBUOKS4_[4LK6]MI+V*QGU&R2^N;9Y)/L5Q;
MVUK?V5HEY#MN[FZ6&Z@9;>XMV%VP,I? _P#:5UCXF3^'--U/PA+'/>6%B]_?
M:=%?SV%O>7>E0ZS&6E>R%M%;O;3Q*0]XUS'=2" 02P;;QP#Z]H$% !0 4 %
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M^$__ $+WBC_P"T__ .6- 6#_ (>H_"?_ *%[Q1_X!:?_ /+&@+!_P]1^$_\
MT+WBC_P"T_\ ^6- 6.9\5?\ !1WX#>.K2.P\2^ =9UFTCE6=+?4=&TJ[B655
M9!(J3WSJ'"NP# 9 8C.": L%U_P4=^ U]K5GXEN? .LS:U9Q&"VU.31M*>]@
MB82 QQW#7QD1")7!56 ^=N/F.0+!8?\ !1WX#:5J+:Q9> =9MM1:*>!KR'1M
M*CN3%<7+7DT9E6^#E)+AVF=<X:5FD(+DF@+'3?\ #U'X3_\ 0O>*/_ +3_\
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MU'X3_P#0O>*/_ +3_P#Y8T!8/^'J/PG_ .A>\4?^ 6G_ /RQH"P?\/4?A/\
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MJ/PG_P"A>\4?^ 6G_P#RQH"P?\/4?A/_ -"]XH_\ M/_ /EC0%@_X>H_"?\
MZ%[Q1_X!:?\ _+&@+!_P]1^$_P#T+WBC_P  M/\ _EC0%@_X>H_"?_H7O%'_
M (!:?_\ +&@+!_P]1^$__0O>*/\ P"T__P"6- 6#_AZC\)_^A>\4?^ 6G_\
MRQH"P?\ #U'X3_\ 0O>*/_ +3_\ Y8T!8/\ AZC\)_\ H7O%'_@%I_\ \L:
ML'_#U'X3_P#0O>*/_ +3_P#Y8T!8/^'J/PG_ .A>\4?^ 6G_ /RQH"P?\/4?
MA/\ ]"]XH_\  +3_ /Y8T!8/^'J/PG_Z%[Q1_P" 6G__ "QH"P?\/4?A/_T+
MWBC_ , M/_\ EC0%@_X>H_"?_H7O%'_@%I__ ,L: L> _&7XRW__  4&O_"?
MPY^'/A/5+?0;?5+2]UG6;VT1GL79+B$.XAN# D20&9P'F$ES(!%&$9/WH&Q^
MUE @H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
$* /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>card02.jpg
<TEXT>
begin 644 card02.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_[@ .061O8F4 9       _]L 0P " @(#
M @,# P,#!00$! 4%!04%!04'!@8&!@8'" <(" @(!P@)"@H*"@H)"PP,# P+
M# P,# P,# \,# P,# P,_\  "P@$( ,P 0 1 /_$ !\   $% 0$! 0$!
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MXO+G1S-906\MX42<M+"XA*02.)-T;2*S>V_#GP)JR?&>+X67-O+_ ,(E\/\
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MGX4Z[?\ [1GB#Q+X7T&*ROIOA;>QZ7XBN-,#64'B9[U[6WEDN3;RH;A+8JK
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M7X=281&2&58V8I9,#/?-!'="VT]H;S+F7R$ZGP]\6]'\33^'K.SMKO[9J_\
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M$Y_"VL16.J>%=6@TN6[L+%-?WZ<^G&XU"2*WMD\I+YK[Y[F:.#/V3:KMO8K
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MS0RA#;RL)?.995\U1%MZ5\'/[,_X1?\ XF^_^Q/%GB3Q1_Q[;?._MO\ MO\
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M * _]G6_]G?Z[[1_QZ^7Y7^M_>?<^_\ /][FN)_X9H^$'_1*O"?_ (3NG?\
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M(/\ HE7A/_PG=._^1Z]?TS3+/1;.TT_3[2*TL[2*.WM[>WC6*&&&)0D<<<:
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M@_Z&/Q9_X':=_P#*VC_ATE\(/^AC\6?^!VG?_*VC_ATE\(/^AC\6?^!VG?\
MRMH_X=)?"#_H8_%G_@=IW_RMH_X=)?"#_H8_%G_@=IW_ ,K:/^'27P@_Z&/Q
M9_X':=_\K:/^'27P@_Z&/Q9_X':=_P#*VC_ATE\(/^AC\6?^!VG?_*VC_ATE
M\(/^AC\6?^!VG?\ RMH_X=)?"#_H8_%G_@=IW_RMH_X=)?"#_H8_%G_@=IW_
M ,K:/^'27P@_Z&/Q9_X':=_\K:/^'27P@_Z&/Q9_X':=_P#*VC_ATE\(/^AC
M\6?^!VG?_*VC_ATE\(/^AC\6?^!VG?\ RMH_X=)?"#_H8_%G_@=IW_RMH_X=
M)?"#_H8_%G_@=IW_ ,K:/^'27P@_Z&/Q9_X':=_\K:/^'27P@_Z&/Q9_X':=
M_P#*VC_ATE\(/^AC\6?^!VG?_*VC_ATE\(/^AC\6?^!VG?\ RMH_X=)?"#_H
M8_%G_@=IW_RMH_X=)?"#_H8_%G_@=IW_ ,K:/^'27P@_Z&/Q9_X':=_\K:/^
M'27P@_Z&/Q9_X':=_P#*VC_ATE\(/^AC\6?^!VG?_*VC_ATE\(/^AC\6?^!V
MG?\ RMH_X=)?"#_H8_%G_@=IW_RMH_X=)?"#_H8_%G_@=IW_ ,K:/^'27P@_
MZ&/Q9_X':=_\K:/^'27P@_Z&/Q9_X':=_P#*VC_ATE\(/^AC\6?^!VG?_*VC
M_ATE\(/^AC\6?^!VG?\ RMH_X=)?"#_H8_%G_@=IW_RMH_X=)?"#_H8_%G_@
M=IW_ ,K:/^'27P@_Z&/Q9_X':=_\K:/^'27P@_Z&/Q9_X':=_P#*VC_ATE\(
M/^AC\6?^!VG?_*VC_ATE\(/^AC\6?^!VG?\ RMH_X=)?"#_H8_%G_@=IW_RM
MH_X=)?"#_H8_%G_@=IW_ ,K:/^'27P@_Z&/Q9_X':=_\K:/^'27P@_Z&/Q9_
MX':=_P#*VC_ATE\(/^AC\6?^!VG?_*VC_ATE\(/^AC\6?^!VG?\ RMH_X=)?
M"#_H8_%G_@=IW_RMH_X=)?"#_H8_%G_@=IW_ ,K:/^'27P@_Z&/Q9_X':=_\
MK:/^'27P@_Z&/Q9_X':=_P#*VC_ATE\(/^AC\6?^!VG?_*VC_ATE\(/^AC\6
M?^!VG?\ RMH_X=)?"#_H8_%G_@=IW_RMH_X=)?"#_H8_%G_@=IW_ ,K:/^'2
M7P@_Z&/Q9_X':=_\K:/^'27P@_Z&/Q9_X':=_P#*VC_ATE\(/^AC\6?^!VG?
M_*VC_ATE\(/^AC\6?^!VG?\ RMH_X=)?"#_H8_%G_@=IW_RMH_X=)?"#_H8_
M%G_@=IW_ ,K:/^'27P@_Z&/Q9_X':=_\K:/^'27P@_Z&/Q9_X':=_P#*VC_A
MTE\(/^AC\6?^!VG?_*VC_ATE\(/^AC\6?^!VG?\ RMH_X=)?"#_H8_%G_@=I
MW_RMH_X=)?"#_H8_%G_@=IW_ ,K:/^'27P@_Z&/Q9_X':=_\K:/^'27P@_Z&
M/Q9_X':=_P#*VC_ATE\(/^AC\6?^!VG?_*VC_ATE\(/^AC\6?^!VG?\ RMH_
MX=)?"#_H8_%G_@=IW_RMH_X=)?"#_H8_%G_@=IW_ ,K:/^'27P@_Z&/Q9_X'
M:=_\K:/^'27P@_Z&/Q9_X':=_P#*VC_ATE\(/^AC\6?^!VG?_*VC_ATE\(/^
MAC\6?^!VG?\ RMH_X=)?"#_H8_%G_@=IW_RMH_X=)?"#_H8_%G_@=IW_ ,K:
M/^'27P@_Z&/Q9_X':=_\K:/^'27P@_Z&/Q9_X':=_P#*VC_ATE\(/^AC\6?^
M!VG?_*VC_ATE\(/^AC\6?^!VG?\ RMH_X=)?"#_H8_%G_@=IW_RMH_X=)?"#
M_H8_%G_@=IW_ ,K:/^'27P@_Z&/Q9_X':=_\K:^=_C=\$=1_X)R:CX0^)?PT
M\7ZM<^'KG5K.QUO1+Z\17U!U2YF5':&V6WDBDMUGC!D@,EM(1+&79_W/[GT4
M4445^7'_  22_P"20>(_^QLOO_3=IM?J/111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M1111117Y<?\ !6W_ ))!X<_[&RQ_]-VI5^H]%%%%%?EQ_P $DO\ DD'B/_L;
M+[_TW:;7ZCT4444444444444444444444444444444444444444444444444
M44444444444444444444444444444444444444444445^7'_  5M_P"20>'/
M^QLL?_3=J5?J/111117Y<?\ !)+_ ))!XC_[&R^_]-VFU^H]%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%?EQ_P %;?\ DD'AS_L;+'_TW:E7ZCT44445^7'_
M  22_P"20>(_^QLOO_3=IM?J/11111111111111111111111111111111111
M11111111111111111111111111111111111111111111111111111111117Y
M<?\ !6W_ ))!X<_[&RQ_]-VI5^H]%%%%%?EQ_P $DO\ DD'B/_L;+[_TW:;7
MZCT444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444445^7'_  5M_P"20>'/^QLL?_3=
MJ5?J/111117Y<?\ !)+_ ))!XC_[&R^_]-VFU^H]%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%?EQ_P %;?\ DD'AS_L;+'_TW:E7ZCT44445^7'_  22_P"2
M0>(_^QLOO_3=IM?J/1111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111117Y<?\ !6W_
M ))!X<_[&RQ_]-VI5^H]%%%%%?EQ_P $DO\ DD'B/_L;+[_TW:;7ZCT44444
M444444444444444444444444444444444444444444444444444444444444
M4444444444444444444444444445^7'_  5M_P"20>'/^QLL?_3=J5?J/111
M117Y<?\ !)+_ ))!XC_[&R^_]-VFU^H]%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%?EQ_P %;?\ DD'AS_L;+'_TW:E7ZCT44445^7'_  22_P"20>(_^QLO
MO_3=IM?J/111111111111111111111111111111117Q+X;_;W^''BGX:^+?B
M?96FK?V?X8N[2TO].>*R_M0?;)8(89E@6\9/*=YB%=Y$W&*8 $I@^]ZQ\8[.
MQU;5=)TSPYK>N-HDL46MSZ;8JT.F&6WANTW?:)8)+QS!,LAAL$O)U&U3$))(
M4DHVWQ^\+7?B+P%H$0NV3QUI,^K^'=1\@"SODMX4NI(<%Q<12K;R+-^^@CC*
MG:)#*#&#0?C]X6U^#XCZC&+N#2/ 5W>V.K:I- /L[7&G0?:+]((XW>Y?[*N
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MRW&JQKK4NLVSZAIT$_\ 95E)<W$D$$EUY*J6M[2U+[9!YTP]@\8P_$?PM/\
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M%*.VU)$9NI\#>+K/Q_X;\/\ BC3XY8K/6]/LM2MTN%59DAO(4GC60(SJ'"N
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MBBBBBBBBBBBO(/VA-,O-:^%GQ+T_3[26[O+OPSKUO;V]O&TLTTTMA.D<<<:
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M](UG3+'P7J>EWFL:[>V2_P"D7>I3W$T6NW<4MO.B7-NCB1KJ657"W*A_;9?
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MRGC#XAKX)\,V_B.^T'4))9I=(M5TJ$V;7PN]5N[>QAMRS72VN]9KA%=OM/E
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M\=K%'([Q7!B^B?!/Q9;Q#+IFD:[X5UOP_P"()X@;NQFTJ\N[&UF$1E9!K%K
M^FR(0/D<7 +$K&R1S[H5]$V:=XPT?9=67VG3]5M,2VM_9O'YMO<Q_-%<6MU&
MKKN1BLD4J!ADHZ@Y%?"_PK^$.DZW%\&O#.O^"I?L/A;P=K^EZW8WFE7%OIAU
MP2^''F69)(DM;Y)9A<3QR_O[>>:)KJ)Y)8!*GD'CO3O&VO\ @+2Y+OP3YWC7
M3_!.E1Z=>W?@?4-:\23W4>D1W,MW#KWVJVCTR[M[Q[A4@F+WJSP&XCCGENK>
M!_MJP\+:=X;^-.N^(I/#GES^)?#VBV-KJMMI;S>9<:?/J<M\ES=P1.+?,!L
M#<O&MQY<449E:#;'X_\ '7P'%:ZM\9]1LO"4L^I>,/AQ)I.FWNGZ-+=S75]:
M6^LM=P2W%K#(87DB;3T3SVC%R4ABB,KP;$/B+\,]3T ?$/1?!NDRVVE7&G^
M;R539W-_;7TB:]J#:]-<PK*DNJ7$^G11B_C\U[N_B\N!VD>6,-[;^SMX3;PM
MX;O72ZB-GJ6H2WEE8VOAJ\\,6FFPB&"U:WM]*OYI9K='F@DN&SM$LL\DP7$F
MYODZ#X/Z=XB\+?$OPQX:\'?\)!)J?A/5X(->U_P<^@>()=481R6D-_?:E:V2
MZI+<W(,ZW210FV>TC>Y>:XF2X/4V6AV&JZ3J$>D^#=0@\>RRZG'X-UQ_"]_I
M\.EV*7$T>CB.YN+.%--L;&V5([FQD6 W0BNBMG?+?H]_[;JNC:2GCZXN_'GA
MJ76Y9M0TY_!]\-#N-7MM*A2"V1XP\%O,NG7"WRRSRW,HA$L4EM_I4JVABL_E
MSP1\(]3M?A;X,T/Q+X7U"X\3W$7P]SK<-K<PWT6BPZWHDD^FF: )/I;Z7&@#
MQ*\2R")M25C=&_%M[:_@:\T&'Q=H]IX?EB\$V'C&WENM!L;)DANO#C^&K%IX
M;"TA11+;_P!JR&XNK> ?Z4$O8/+N9)I+6XHZ'X6G_P"$N\"W_A/PY=Z3X'@\
M0Q2V6FOI<^G"TN%\/>)H+^]6QFBCDL;2>2>SA5)$@62Z2:=8<W2W%WY!X[\
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MTN?M5I'Y\4LR Q-&_P!F=+BWF,$E8GP[TG6'\&^,O$4WPVM+%(_,\,Z)HO\
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M@.:Y;Q+%X=^'U]+XUO+6[N+[4+O1]%$AN9KG[/\ VK?6>FQK;0W$_E6L3RO
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M]B\RPW7UCH6B>.8OAKJ6FPW_ -C\42VFMKHTVH3+=O8>=+<MI$=[-BY$TMI
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M*.R!,-&\Q.*[:[\76=EXDTKPN\<IO-2T_4]2A<*ODK#ILUC!*KDL&#LU]&4
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MLENMJEQ\I9HA KY01BC]E^&U\.?#_P ,>#%T6[TG4/#.DZ;9:K;S:/=6%O\
MVCY6+MH)Y8([>\W7"RN\UM),CLWF^8PE5GZG6M,O)?BGX-U!+25K.#PSXMMY
MK@1L88YI[_P\\4;R ;5>189"BDY81N0"%;'@G@3X;3^'-8\)>(+;0;NWU2^^
M(/CP:M>-%.9_[$GD\3SVT4CODQ:?+.+.>.(;;9[AX[@*9Y?,>C^RA\/=:T*\
MM]2UF>*SU6RT1-/\0VD/@_4-&FU+5[AK9WO+_5;JYE@UNX@DMKA1=P*RL;F:
M8.$N 'O?';X;3^)-8^+FO1:#=WNH6'P^TP^&YHXIY/+UNWD\1RQ2V*)E#J%N
M[P&&6-3<V_G8C:,7#"2C\1?AGJ>@#XAZ+X-TF6VTJXT_P#>2J;.YO[:^D37M
M0;7IKF%94EU2XGTZ*,7\?FO=W\7EP.TCRQAN6U7X;:K:> M&^Q&TO-!NO%CZ
MG?:5_P *]U:+2;'2QI%Q8K;?\(DUV;V6)M2CBNMBD 7,W]H>7Y<;2'M_!WPQ
MM? WB;X3^)=2TW^U_)TGQ+IT&JVWABZMY;"76M3LKS2K,61%U=Z=:6=I)>6T
M?G,L-G"'AD>'SA&WD%A\(;R[\":CJ%[X*EE\1Z)\%_!UOH%Q-I3-J5AKUG::
MZ[1V$C1>=#?0S?9B5B*S))Y)P&V5VW[5NB1#P]\7;KQ1X=U#6;R;1-2D\(W]
MC!*\>EV,>CJMY$;J-HH[%Q.MQ-=F1XSJ-I+%9J]\8_L,/O?[0%OXIT.#1O&O
M@72/[5\0Z/\ ;]/CLPAD-W;ZQ!Y$<!0O&@B&IQZ;<7,IDA:*UMIV$P7?'+YW
M\)_A=KOA?QNWAJ\CU"X\*^#9;K6-%OM4E$\U_?:W8VT!N_M:#?/<+<MK[7B3
M% AO[=TB:,V_D>6^$? WB2V\.^%8)O#^H1RP^&?V?[>5'LIE:.;2O$EQ/?QL
M"F0]I$0]PIYA0AG"J<U[;\=M!TG4?'?@2_\ %'A#4/$7ARUT3Q3%?I:Z9<:I
M:133W>A-;?;+*W$C72,T3&.$07!655NO*5;9[B#RWXC>"_%<]AX _P"$JLHK
M_2K6+Q2L]IK/A>^\=+;M<W]I+H<5U8Z;<^;)?6VG+- ]^7N$5Q<(UQ*]VLLO
MMOQ*^'VIM\+?#'A"YOM0UZ\M-0\!6E]J$+W,5]=+9:WI7VN],D$K3Q/Y<<D[
MRK+OB :3S<KOKQ+QW\/-3TRRUW1=)T"*U\):=X\MYO[,D\,W.LZ/_8LGA.#(
MBT*Q>![RW.L3"0I;@K'>;[MUS!,PZG2?AYXOT9/"MKX;U+=J \$_$1=+U671
M[C3+#3;S5]1T:\TJU:RNOM3VD5JF(H;64.R06Q3RL1M&M[X;^'-)MOBGHFH>
M&_ VMZ#9P^&?$EKJUQJ-K<0PRZO+?Z&[++)++(MU?,L3F;4%,JWX52E[>"V;
MR-M_!.NO\2&T*#3)6\+1:W:>-I[B0"/3 T^G7MBVF10Y(EN$U6"'6"RKL$TK
MSR>5<K ]WQ'P"^$<5]+X=D\7^%Y9%L_A;X TD0:G:R_9EN3%K<&H0/;SCR6N
M(X9A%)O0RQ17$D64CN95DI?">V3X6:=\(9[SPOJUC:^%O">L^%]9BL?#>HW#
MQ:]<OH-U*4M[*TDDN(II+2[<WT"2VDD@)^T,\J;_  3Q1X;\5R?#;0+.+X?1
M1>*M$\!Z-::+(_@.^U77C);:-%.9[76TN;2'2;BUNFG2.VDW7<<UOY\44TES
M;V[?4FI^!KS6O'-VFH>'Y;O2KOXCR7%P+BR:6TFTV7X;'3I)) Z&-[=YR;=F
M.8S*3"3O^6MO]G#3]=U:YO-;UYY;M="T]/!-G?7MP)[F]N?#VIZE9ZIJ: O(
MT*:DT5HTJN_FM+;;9/,C@M[B7Q_X@:=K^J^/;76-/\$VEIK4/BS08[FZLO ]
MVVK1Z-#J]I:O=MXJ^U16TL5S8A3-!!#-+#;3R6DT8C@NKB+VWX,_#/P[IWA3
MQU\-[SPI_9MK=:MXH_M&TATZ:PL[K3M:U"^-IY%U!'%#-G3C!&?L\K/;*L<#
M^2Z*B^"W>F?&>[MK+QD;34$\7VDI\"1W(CA:T^R2:9):SZX+!PRK;S^)/L]Q
M+.ELLK:79VTHM5@$RS>B>)_@M/8:W:_#/0]&NXOA[XKM-+&L&RNIXS9V^@63
MV=Q%+>/*)5_M"*+1K$1(\K36L6H-MADWW#>=Z9HGQ6L-%M/C#/X=EO?B/#%'
MX;>PN($6YGL4T\6!MI((&BM!;OXF']IM=)*A_LPF1;E8L6P]$^'7P^UCP!XK
MO-(U.'5KKPAX$^W:]I-Y>))J%YJ-YJ^GV\;W4<MJDEQ>7:W!U]KJ!QNW7]L8
MX'1K;R.I^*?@G7=2\8G2-&TR6XTGQI%HLVM2 "+3;5?#NJVLE\+T9(N'UG3;
M@V)38SR1VD4,BR6GF/:<MX$^&T^I>,?!]SKF@W9M=,N_BY?*9XIX[=;BY\96
M5WISS+\L<GF1J;FU$@92T:740WPQR)B>%O"=K\,(- M;/P?=Z=!X5^(/B77-
M6BTOP_=.G]G:Q!XBM=,FM5LK9A?8@NK&)DM!.]I'L2985A<1\1=:7?>(](L;
M74/AY:7<$NK>,M2T=O$7P[OO$5Q=2ZMXFU29;<023Z>-'S +20S7\D,,ZW"$
MO$MI,]">#;[7-'T2Z\>Q>(4D;P3\,Q<B7PU?>(HM0UBTC\1/<6FL6"VES)=1
M1R3I+<HQBECF\AQ<6]P89*+WX5SZMHGQ#U>'X>_V7?:;\/K;_A%K?3=+GLK=
M-6M[WQ3-;7VG:>!_HNH/OM[J*,AK_3VNS 9!+)*9=O\ :LT[7]?NO%DFD^";
M2;7M/TF6/P[>Q^![O6M8G$=JURMW8Z]#=6UOIDMO</,L,#E[I98/M$,<\EU;
M0/U-U\,]3L_ACXYDTO298=9U?QCJEUJ'VJSN;UKC18?&ES<R1M9>;'+<V+Z<
M\\GV&!E6\2>81HTMX[2XGP^^!=AK/B3PLVN:9%J_AFXT_P 87<6FCPK?^'=#
MT]I)O#-M%9/HVH2RA4EEM+F]2*<;);AGO(XMZ+,-O1=&:X\-_#V[^,/AK4/$
MVE'P=X;B6SN]#O-?FL_$:PR-J4VH:?';W$YN)XVA6.XDAD\@PW<;26SW.V[-
M%\&?$6*;QD'AU!;R?1/"20DW>+V32(/$OB&YETI-1,FQM3CT>:.U><76Y;J1
M)S? LMX>)U/P4UV/B<_P\\&:AH6AWFG_  ]6&"[T&\@L;FTLM>U*?64@T5FM
MYFM_LK2"YT]([>6\+RE89/MT<UQU/PK^#J#Q?X+U*[MOMFBI:>+-3LK6V\,Z
MCX8TG2;@7'AB&VMAI5[-(8MT]G<7T:385[DO>QQ^9&DP-'^"=K=3^&KJ^\,W
M9GU?X@^.5UV5UNE>;0)9_$MU;VMRVX$:3<3I9RFU)%E<R2*[Q2-<,9.6\4^"
M-:_LWPE;ZIHL4GAS3-0^(EI]@U;P9J'BRR@!\0J-"$6C6$L4L:1Z=%,EI<A3
M!;VI\A=JW,0:[H/P>\36/CRQTW7==^TZAI]WX8DTWQ'=>#]3U'5+K3M(TS3/
MMJ1>(8[UK?38K^XM;Z.:TG+.YN+AR)1>(9.IUSP'%X>UKXB6>F^$I8+[Q!X\
M\!>(H[BQT:4PW6F6FH>'!<RRWEO"80\=TE_-)#)*)E!GNS'Y4C2M>_9S^&?_
M  KO_A4']G>%/["^V?#ZX_X27[/IWV+S]8B_X1_R/[2V1IONTWWOE^=F5=US
MMQF6N(AM+7PEXG^$=WKOAO5E\7V.K:@WB[6XK"Z>#5;R/PMK;F2)HA_Q,_.V
MO)81V\4S6%OFR\O3WD%F_O?Q8T;2;CQ(MW\0/#4OB;PD=/M8M-LXM#N-?AL]
M76:Y:[FN-/M;>XD+SP-;K;W!AD6 0W,?F6QN=MWYWX6\+3P3^'((/#EW;?$^
MVN]+?Q/XG?2YXK>]MXIXFU9WU9HA;WEI>6X=+.S1Y&MFDM!]DL38LUCRWP@^
M &DQV?P;T_6O!\K6=SX#FE\36]_#</#>:O;+H264.L1SDK</:K+>"SM[H.MJ
M$86\<0@7RZ/A[PSXO\9_!+QUK/B32M6G\0R_#X^&]+MKZVN#J,OE:!&U\_V>
MY4W2W=YJLD\4QPOVM+2RD".JQS2^P>(O!.NZ!\2_!7]FZ9+<>&;SQ-<Z\\L
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M_A#>>/\ XI^/-0G\%2ZW9Q?!?6+?2[A]*:\A37EO[A[>.UD,3J+X*^8U0^<
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MPNK^U]*N]/\ [0^)GBJ_L_M=M)!]ILY_LWE7$/F*OF12;3LD7*M@X)Q7SO\
M$3X2^*=?\5_M4ZUIND7=KJ%M_P (!XB\(ZB^C&\\_5/#NGO= :>)4*2RL\9M
M6,>\KYS(R.&,;XGB_P &^+]<A\276C1>(;.^^,MWKNDZQ>S>&KB7[)IUMXCT
MS1M),]JUI$;.*+P_)?RAK@P/+OD=YC*L!B/&GPKGTS_A;FE>(?A[JVL^,;J[
MMT^&NK:)I<[6>EZ6F(] MK"_MA#;Z/\ V7<*TEX':T#+^\9KM&!;WKX\:;XK
ME\/?![1/%7A33_%;)*)?$NM3>'K[Q+8V.IVVCSQ"8:'IAMIKE+N:694D*"&V
M.UFB61H2GR=:?#KX@>+_  AX;T3Q?X/U:Z@L_CQ8/_95WI,IL[/PQ%;B+;#:
M>;>00Z3$&>-%CFFLXU)19I%^9MO0OAGXOTS[38Z[X4U:Z^&&D?%?Q;)J'A>W
MTZX?SM'F^S-HEQ:Z='&K7.DVUZSSRV]N'B?)E^S7 1MGU)^P]X4UCPGH_P 5
M(M7T#5M%^V_$'Q%>V=OK1D>\>SFCM!%(T\DL_P!ISM(,ZS3+*RLPFD^\?._V
M2_@1XFO/V=U\)^(M<UO1I=<T3Q/H[:)J6FVD4.EMJ%Y>1K<K";2WOF?:WF!)
M;HHPD; 53&4/%7@W7?B=\!_#OP';PUK>F^(QI_A'2=6EFTT&QTV#3KFP-U>B
M_,R6%VBQPETAM;N6Y<LJ-%&R3^1Y;\8/ ?C2S\??M#>+;7PEJ'B#1EU#X:W+
M>&9-&>YL?%UM:P1I-#%*L+3%[*8),6A:2(%'BN;>>)RB_4G[9W@_7?&EG\(+
M;0;;4'EMOB/X9N[BZTVU%S-I]M&MTLEZP>&>)$@+*Q>:-H@=N\%3@^)?$/\
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MHHHHHHHHHHHHHHHK\N/^"MO_ "2#PY_V-EC_ .F[4J_4>BBBBBORX_X))?\
M)(/$?_8V7W_INTVOU'HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHK\N/^"MO_
M "2#PY_V-EC_ .F[4J_4>BBBBBORX_X))?\ )(/$?_8V7W_INTVOU'HHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHK\N/^"MO_ "2#PY_V-EC_ .F[4J_4>BBB
MBBORX_X))?\ )(/$?_8V7W_INTVOU'HHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHK\N/^"MO_ "2#PY_V-EC_ .F[4J_4>BBBBBORX_X))?\ )(/$?_8V7W_I
MNTVOU'HHHHHHHHHHHHHHHHHHHHHHHHHHHHHKXE\->*?B'^T/XB^)O_"-^./^
M$-\/>$]6U+POIOV/2;.[U&ZUBTAMOM%S?_;UNHFM(92WD1V_D2SI(?,>%HUW
M=M_PUMX0_P"0I_9NK?\ "(?VM_8O_":>1;_\([]J_P!7YGG?:?M'V3[1_HWV
MW[/]C\_Y?/V?/5+3_P!L'PI>ZZ^D3:#K=I9CQC<> QK$T-B;%M?B#E+<)#>R
M7>R7: DIMA&"R[VC&XKY:/VR-6D\ _&;QKJ/AN7P[%X(\3#0K8RVMOJ[$)/9
MVDJ300:M:"6X665FDV7$4$:2Q".6[:*4MZEXY_;!\*?#[7?&ND:GH.MM9^"Y
M=!C\0:Q##8O8V*ZZ(C:RE#>K=RI^\PXAMI'4JWR$;2UWQ[^UMX0^'?\ PM3^
MTM-U:7_A7/\ PCO]K?9X+=O/_M_9]F^R[[E-^S>/-\SRMO.W?5[7_P!JSP7X
M=UV_TRXBU"32M*U"UT?6/$T-LCZ!I.IW(?9:7EV90R.C"-)G6-X;:2:&.>6%
MW(7Q+]K/]K&7P?X(^(X^'<NH#5O#,NEV4OB"VTV*\TBSU.:^@$^G/+*LJ&X2
MV+F4F(PP,\<+S1W<D,+?;7C/Q++X1TF;4X-#U#6I4EM(4L-+BBDNY6NKB.W!
M43RPQ*B&3?*[R(D<2O(S!5-?._B/]L'PIX7E32KO0=;;Q&-;T7P_<^'HX;$W
MUI?:[%<3Z<)9S>BP9)XX"P:*\D$89!)Y;;@MVS_:V\(:CIT3VFFZM/KTOB&^
M\+1^%XH+=]9?5M/=1=QJ%N3:F*WB=9YKD7/V:*)AOF60B.J7[)GQ6UWXMV?Q
M0OM:OI;F+2_'GB#2=+6XL18S6^F6RVS6\$D)AAE5T$AW><GG DJYW# Y;P'^
MV+!J>C_$G7O%_AJ[T6#P[XLG\+Z580F"]U'5+V..)$T^"*VN)#/J#S[R4C46
MZI)&%GE6&XG7WOP'\9M,\:Z[K'A2[TK4/#OB/2XH;N71]86V6YFL9PH2]MGL
M[FY@N+?S"8G>*9S%*ICD",4#?-*_M/:CX'^*GQSTKQ/#JVI^&O"W_"(RVXTS
M24N$T:RO;#S=0O;F6)$D>))'21TW37 C$DD4+0PSM'ZC>?M?_#^WU&5+::[O
M_#UK=V.GW_B^RCBG\-6%[?(SPP7%\LW_ %R666-)+>W>>!)IHF? [?XM_'G0
M/A!J/A'1+^TN]0U?Q7=S6>DV%FUI$\[P(K2$S:A<VELGS/'&JM,))9)42-')
M.WSO4_VG],\*>,;O2/&0E\*V-EX.D\47MOJEG;/-;*FJG3E+7UAJMU$[RG:(
MK6*VD=RZ8N/-/V8%O^U]X;%YK6FZEX4\3:/J&C^#KKQO>6>I:=#;S)IMNV/*
M7-R5>X=2K!58QH2T,LL5Q%-#&>'OVR? FHQ7,_B"#4/"<4?AFS\80OK26FVY
MT.\E\B*XB.GW5X-YE9$$#[+AWD14B=B0-O1OVK/!<EGX@N/%46H>";G0M/MM
M8N]/\36R6=Z=,NE3R;N&.&6<3(TK_9RD;--'=#[-)$DS(C>=_#[X]^(O'WQW
MA\,-8ZMH>A/\/DUQ]#UK3(;6\BU&354B29G42,<VTB HD[I&Q:*18[J*:./T
M3Q/^U)X;\.WGB=;;0];UK2O"DL%OXBUS2;2&YTW29G;]_'*3<)/.]G&1+=K:
M07!MHS^\"N&1:/Q!_:Q\,^!=8FTBUT/5O$7D>$W\;2WFBMIDMFNA)(\;7"RW
M6H6WFXV!@L0<NK*4W<X[?XA_'[PM\._AJ_Q7G%WJ/A[[)IM]$UC /M$]OJ4L
M$5NZ173P8SYZ,0Y1E7.1N&VN6US]IO3-"BTRU;P7XFNO$=[%JMVWA:TL;:?6
MK6QTN6>":]GC6[\A;>22';;.L[&[:2);<3,Q"T;/]K_X?ZG_ ,)"^GS7=Y!I
M7A.3QK;W%O'%)%JFC0^8D\EJ1-E)8)XVMY8+H6TJS KL*JSJ7G[6WA#3-1EM
M;_3=6MM/L+NQTS6]=:"WDT;0M6O$9ET_4+R&YD198G"17$D(FMK:6:));B,O
MQB?$?]M'PA\+];\;:1JWA[Q#+!X._LY=7U.SLK>>R@EU2R>\L8SBZ$X^T%/(
M61H5A6X9$DDC5U<]3<?M,Z?8V>BS7?@[6X[SQ#+:Q>'-.@GT2_N]=$Z^;)-9
M?V?JMS"+>WAQ-/<3RP01Q,K>82P%=OX4^.?A+Q;X+U+QW#>2VFFZ1%?/K$-W
M;R1WVDS:<ADO+6]M5#RQW%N%.^,!B1ADWHZ,W@GBC]K^,?"O4OB?I7AC5M,T
M6.TL[NTU>\M]&U:WE^T7]O9F$6=AXABG,H,K!DDD@\ED<.?,00ORW[6?[6,O
M@_P1\1Q\.Y=0&K>&9=+LI?$%MIL5YI%GJ<U] )].>6594-PEL7,I,1A@9XX7
MFCNY(86]MU_]JSP7X=UV_P!,N(M0DTK2M0M='UCQ-#;(^@:3J=R'V6EY=F4,
MCHPC29UC>&VDFACGEA=R%^EJ*****************************_+C_@K;
M_P D@\.?]C98_P#INU*OU'HHHHHK\N/^"27_ "2#Q'_V-E]_Z;M-K]1Z****
M*************************^6],_9ZUCX=^*?$WB3X;>-/[(@\47=SJ.L:
M+K6GR:SI;:C.8V:\LTCO;&>VE<B3S?W\B2!U78BPPJGG>F?L7RV'A*T^%,_C
MN6]^&D.H1WKZ/<:7$NKSP)(+PV,FJP31*+=[X?:&9+-+G:3 MPJX87O^&.?^
MIN_YJO\ \+/_ .09_P"4[_CZ_P#)C_R!5'QC^QM>>(O#/Q;\%6/C6*TT/Q_K
M<GB-A-HS7-]8ZE/=V%W,!.M_#%+;DVCJD?V=)$$BDS2>61)>^*7['/\ PLK_
M (7A_P 5=]B_X69_PB7_ ##/._LW_A'?+_Z>D\_S]G_3+R\_QXYH_&O]C:\^
M*-Y\3WTGQK%I%G\18O#@UF&ZT9M0FBF\/L#;O9RQW]HL:.JH)$DCF)(8JZA@
MJ7M4_8LT!_%^N>(-.3P\^GZ_JUIK.J66N>$K37+Q;@7 FU!+&_N9E>WBOT&U
MXY([A8&:22W\DL%6C\4OV+Y?&^D_$;PUX?\ '<OA_P /^-]0@UV^T\Z7%?E-
M:%Q%-<SI/)-'+]GN1%&SP ADGC1XYT@\VUE][^/?P<_X7=X=L=#_ +7^P?8]
M6TS5?+GMOMNG7WV&82_9-1L_-A^U6DG5HO-C^=8WW'9M;Y;TK]@6#2?$3:];
M^+;2U1_%G@[Q4;"P\.06%G$_AV&\22TMXK>Y5(XIWNB8V*O)$J@2O=RL\[=O
MI_['/]A:C?>)M)\7?9O%$?C;7_&&D:B^F>=;VD6O)!!?:;<VAN@+F*6"+895
MD@F5MKQM%M99/7_@#\$I?@?9^,K:?Q)+KTOB/Q-JGB-[JXM(K:96OUA4QR"
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MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBORX_X*V_\D@\.?\
M8V6/_INU*OU'HHHHHK\N/^"27_)(/$?_ &-E]_Z;M-K]1Z**************
M************************************************************
M*******************_+C_@K;_R2#PY_P!C98_^F[4J_4>BBBBBORX_X))?
M\D@\1_\ 8V7W_INTVOU'HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHK\N/^"M
MO_)(/#G_ &-EC_Z;M2K]1Z*****_+C_@DE_R2#Q'_P!C9??^F[3:_4>BBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBORX_X*V_\D@\.?\ 8V6/_INU*OU'HHHH
MHK\N/^"27_)(/$?_ &-E]_Z;M-K]1Z******************************
M************************************************************
M***_+C_@K;_R2#PY_P!C98_^F[4J_4>BBBBBORX_X))?\D@\1_\ 8V7W_INT
MVOU'HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHK\N/^"MO_)(/#G_ &-EC_Z;
MM2K]1Z*****_+C_@DE_R2#Q'_P!C9??^F[3:_4>BBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBORX_X*V_\D@\.?\ 8V6/_INU*OU'HHHHHK\,/@C\;M1_X)R:
MCXO^&GQ+\(:M<^'KG5KR^T36[&S17U!U2VA9T6:Y6WDBDMU@D(CG,EM(3%('
M9_W/T1_P]M^$'_0N>+/_  !T[_Y94?\ #VWX0?\ 0N>+/_ '3O\ Y94?\/;?
MA!_T+GBS_P  =._^65'_  ]M^$'_ $+GBS_P!T[_ .65'_#VWX0?]"YXL_\
M '3O_EE1_P /;?A!_P!"YXL_\ =._P#EE1_P]M^$'_0N>+/_  !T[_Y94?\
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M_P /;?A!_P!"YXL_\ =._P#EE1_P]M^$'_0N>+/_  !T[_Y94?\ #VWX0?\
M0N>+/_ '3O\ Y94?\/;?A!_T+GBS_P  =._^65'_  ]M^$'_ $+GBS_P!T[_
M .65'_#VWX0?]"YXL_\  '3O_EE1_P /;?A!_P!"YXL_\ =._P#EE1_P]M^$
M'_0N>+/_  !T[_Y94?\ #VWX0?\ 0N>+/_ '3O\ Y94?\/;?A!_T+GBS_P
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MYXL_\ =._P#EE1_P]M^$'_0N>+/_  !T[_Y94?\ #VWX0?\ 0N>+/_ '3O\
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-BBBBBBBBBBBBBBO_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>logo01.jpg
<TEXT>
begin 644 logo01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0!:17AI9@  34T *@    @ !0,!  4
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M 0$! 0$!         0(#! 4&!P@)"@O_Q "U$0 " 0($! ,$!P4$!  ! G<
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MX'W6786.&PT*$5:R7W]?Q/Q4_P""G_\ P5X'C<ZQ9Z1XB\4F&35K_2-"\/\
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M ,&LGPW\57CS^#/B/XO\-KR4M=5MH=8A0^@;]U(!]6)]Z]7"TL#45JU64/\
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<JM:I5FZE5MM]6=-&C3I05.E%)+H@HHHK,T/_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>sig01.jpg
<TEXT>
begin 644 sig01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X0 L17AI9@  34T *@    @  0$Q  (
M   *    &@    !'<F5E;G-H;W0 _]L 0P ! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M_]L 0P$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!_\  $0@ +0#^ P$B  (1 0,1 ?_$
M !\   $% 0$! 0$!           ! @,$!08'" D*"__$ +40  (! P,"! ,%
M!00$   !?0$" P $$042(3%!!A-180<B<10R@9&A""-"L<$54M'P)#-B<H()
M"A87&!D:)28G*"DJ-#4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T
M=79W>'EZ@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%
MQL?(R<K2T]35UM?8V=KAXN/DY>;GZ.GJ\?+S]/7V]_CY^O_$ !\!  ,! 0$!
M 0$! 0$        ! @,$!08'" D*"__$ +41  (! @0$ P0'!00$  $"=P !
M @,1! 4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P%6)RT0H6)#3A)?$7&!D:
M)B<H*2HU-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H*#
MA(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3
MU-76U]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_:  P# 0 "$0,1 #\ _O-\8^-?
M"GP]\+ZWXU\<>(M*\+>%/#=A-J>N:_K5U'8Z;IMC -TDD\TA :1R5BM[>,/<
M75Q)%;6L4UQ+'&WP3I7Q_P#VU?CU;OXF_9S^!/P]^&GPQF>=O#7C/]J75O%N
MC^*/'-@DSK::YI/PW\'V+:MX?T+58%2[T^;Q)J,&I3VDL4[Z;!YH5>X^(>B0
M?&[]L3P;\,_%'V;5?A=\"/AE:?&K6?"%TOGZ;XB^*OB[Q)J/AOX>7?B*PD5K
M;5+#P=I&@>)-=TBTN%>"+Q!=V.H21/+8VK1_<0.3R0?<C!)!SUSUQV^[QSZ4
M ?&?[/'[3WBGQI\0?&7[/?[0/@C2?A+^T9X'L;;Q!%HFC:U=:QX'^+?@"Z*Q
M1?$KX1ZOJ=GI^I:KH5E?,VD^)-%O+8ZQX7U3RX+\RQ7$-PWV?G^[P><<L?3/
M&WG'Z9]Z^&_V\_AU<W_P@/QX\$6-FOQL_98N)_C?\,-;F @GDMO"\+7_ (]\
M$WMY%B:3PWX\\$P:UH6KZ<S?99YI-.O)$$UC!(GUE\//&VE_$CP#X&^(>B%O
M[%\>^$?#GC'2,_ZP:?XET>SUFS1R0N66WNXU;Y5Y7IVH [+).?7(QG=CMVQS
MZ^N.>U+^!Y_WNOK]W.?\!Z4SD$[N !VQU]<<X.W@?,<@>M?&_P"U7^V#8?LR
M:E\.-%M_ASXG^*NL^,9O$GB/Q+HO@ZZL8]8\"_!WP#8PWWQ$^*UY8W69-7T[
MPLE]IB#2+/9>ZK+=/%:2>;"RL ?9>?8_F_\ A1GUR?4C</TQ@?G^-8WAWQ!I
M'BS0=$\4>'M1@U;0/$6DZ?KFB:E:.KV^H:5JMI#>V%["_ :*XM9HI8^,@/AN
M:V<X."3],+_/I].] "<Y[X/;YNWOC/\ G'I2$\\':>^2QXQ_=(Y]?;D],T;N
M3GD X.[:#[X^A'.>HP1ZT#CH"O7(P.>3@_-SG)QCGK@'B@!<C&>/KN;&3W'!
M'4]NF1ZUSNO^,/"/A18W\4>*/#GAI9D9XGU_7M.T82QHP5WC;4;FVWHC,%9E
MRJL0"03@_"?[0G[2OQ#\5?%&X_8__9 &BZG\>?[+LM5^+GQ.U6*/4O _[,7@
MC7$F2Q\0>(K..Y1]<^(VM1HTO@CP0IQ<M'_:>KM%IT)65WA#_@F/^S!;VT>I
M_&GP]J_[3_Q(N3%<:]\3?CWK&H^-M;U342KM=R:?I-U=CP_X<T>XN)I9$T'2
M+"*P@C,<4@G,(DH _0"RU&RU2UBOM*OK/4K*90T5W874-[;2@X8&*X@>2)PR
M,K J^,$$9!JV"0.#GD\G(_/(P.>>P[=#7\_EM^S9X:_9U_X*7_ -O^"?GQ,U
MW1/"OBVY\1I^V3^R]X=\2:KXJ^#/ACP%9Z)=O8_$&^M+O4=4TCX>>+9]7GTO
M3M!\.0R6%UJ,Z+<Z=9);?:*_H#((&3G@C!^4  $[<_3/)X]^F* #)(.X<''<
MXQQZ9Z^^#SBO+?B7\</A'\'K5+GXE_$'PQX2>>,RV>G:GJD;:WJ2@[<:5X?M
M_.UK57+$(J6%C<-O(7@FOSC_ &IOVG/VG/$_[87AG]AW]DR/PQIHU/X56_C'
MX^?&FXTJ?Q!X@_9[TSQ%XB73-#UC2M)DNH]&U#6M2TB&Y.DZ?J=O,UO<7EIK
M$L<EI;.I^U_@I^R=\'O@?"=2TO2;SQO\1;U4G\3?&'XEW;>-?BAXJU+!^T:C
MJ'BC61/<V44KLWDZ5HB:9I%G$8X+2Q2.-10!YHW[7GC_ ,7A&^"G[)_QL\<Z
M;=,L=CXJ\8PZ3\*/"MR)&VK>0R>);B77I[!<K(\RZ&C&,EHT8@K7J&C>(_VJ
M]3$,][X!^"NC6TL2N<>/?$NM.DCCYHEFL_#MM!-]G?,<DB[5E928P!BO7/B-
MJ5YH'PX^(&LZ8=VI:1X*\5ZO8"9G=?MUCH=_>6N[EI AGBC#!,\9V#/7XG_X
M)2:I?Z[_ ,$_?V;M?U#4+_4KK6_">IZK)=:A<W-Y.6NO%&N/*D<]V/.>U\]9
M7M5.4C@9(X_D5< 'UZ8_C=)"H^T_"ZVG\QMS+:^*KJ(QX^7:K7%LP?)*ON9A
MCYA@G%6)+#XLI''(OB;P=)*%)FMU\+ZFD3R\[(H9CKC-'"S;5:6569!E\'[M
M>B)<1RO-#$X:6!D6:/:P$9D3>F<C!W+\P*D@\YP0:F^8]1Z<@C.0><XQC!R!
MCWR* ,3PZ/$0TFU'BMM'DUT>:;LZ M['I:J97\A8%O7DNMZP>6)RYVM,',8"
M;16WGG&"?7EN/KQ2 X. Q.6_V>_/^>_<BGY_WN.OW.* $S['\W_PHS['\W_P
MI02?[WX;31S_ +7Y** $S['\W_PI.<Y/Z!LX],XS[^Y_1W/JW'7[O'^1['^8
MI,^I/YI0 9/'I_P+GTYVYZTF<>Q]R_0=>,>AQGMQ2Y.<?-GT^7T^G^?KQ1EN
M,C&1SR,@^B\<_CS^- !GV/YO_A1GV/YO_A2\_P"U^.W]/?Z^_>D!)_O?^._Y
M]_I[\  ,^Q_-_P#"A<YS]<_>YZ8Z^@_,\\4$GWQGG.W_ #^'X<4H_'Z''Z8Y
M_I0!^=7Q'^,_@']G3]K[XB>._B[XCT;P9\.-<_9?^&]]-XIU2*X!@U71OC#K
M?A*.R:6WCF>:&2?QMI32*(]UOYJS/B'S'7]"H9H9XH)[=XY[>YB22":)EDCE
MBFC$L4L;KD2121D.CJ=KJP;IBOYV_P#@M]IVNR>.O@.-+DT@-XLA\#>'M+MO
M$HFE\.7^JZ)^T5\+]4GL=:M;=3<W%C+9ZI%-=P6_[R:&V8$'8,?I_!^S-\=O
MB39G1?VAOVC+P^!EM;.R'PJ_9ZT2?X4:%?V%I!'#+8>)?'L]_JWQ#UC3KU$$
M%W9:5J7A>&2#,9&UW6@#SC]ISXJ:I^U#K&M?L2?LVZB-7G\0/;:+^U%\:-%F
MCO?"7P,^&%[*X\3>$K?5H)A:ZM\7O&^EPW7AW2/"UI.\OA^QU"\UO6OLHMX8
MV_1WP_H>E^&-#T3PUH=HECHGA[2-,T+1[&/Y8K+2])LH;"PM8Q@X2"TMX85'
M'RH/>N8^&WPM^'/P<\)6'@7X7>"_#G@3PCIAE:ST/PWIT&GV(FG9GN+NY\H>
M=>W]T[-+>:C>RW-]=RL9;B>20L3WIW*N#G:/[@8G;GIZGCMST]Q0 X?WNG)Z
MY^8$< \'H,#C.<9%?GUJUCI>M_\ !373;+6X(KJ*Q_87UQ-.MKN*"2VNX/$/
MQGM;'Q%!Y<JL;B*6SLK%+Q JH(VC242)( OZ"$[AD#/RGL0<Y&!UX;\,COBO
MS<^/DQ^&G_!0O]BOXI75S NB?%KP9\8?V8=31@5>#7;NSL?BEX,E64Y1_MU]
MX8U;31#E9 \H=2R[EH [7]ADWO@32?C-^R_JUU]IN?V:OBMJN@>$F>5VGE^#
M_CV(>/OA89!([2*-.TC5[WPS&%)@CCT!8(6*QX'W<>1E@.&SU)Q@XY'?WQUK
MX2M OAG_ (*2ZO:V)\FW^+'[(6G:[K]N@ 2\USX9?%&31-)U&100QFM]%\7S
MV)E;):'R(L@1"ON_!SGY>, =>GH>OJ?TH :,C.[D=#D'GTZAL=OTKY]_:M^,
M-S^SY^S;\;/C38V2:CJGPY^'GB+Q%H]E+N>WN-:AM'@T1+H!2$L?[5GLWOG.
M%BM%FDD9(U+#Z&Y]1^7_ ->L+Q%X<T#QEX?UOPKXIT;2_$7AKQ%IU[HNO:#K
M%G#?Z5J^EZA UK?Z?J%E<+)!<VMS;R/#-#(C(Z,<CH0 ?DS\'_\ @F!X>T'P
MI\.OBQX*^//QA^#_ .TKXO\ "=EJW[0?QL^%7B72[ZZ^/FL^*F'BK66\:V/B
MO3?$V@:O::3KM_)'X.U&RLK>?1]%A@L+9VM'VCZ2MOV$=+U6+R/BC^TS^UK\
M7+%]GVS1O$?QEO/#'A[4$ "/!>:5\.-+\'"6WF4,MQ;"X6"59&#1_,:\+^*?
M[(G[-?[(7PZUWXH^&?VC/VC_ -E/P#X0B>:+1O OQGUS6?"!N;AW_L[PMX9^
M'GCZ/QCIVH7^IW?E6&A>%M'MH_M$HAM+2WBB#LOV?^R%KWQ@\3_L\_#CQ%\=
M([N'XB:YIU]JES#J^E6.A^)1X>O-5OI_!Q\7Z1I6W2M-\82^%#H\WB:STZ.*
MTMM8>ZACAB9'C4 ]%^%GP>^%?P2\.?\ "(_"7P%X:\ Z TYNY[#P[I\5FVH7
MCDEK_5KW$E_J^HL6;??ZI=7=U(#\TYQBO3LYQ@$@L >3@8/).>HS@#C)]J0+
MG/ '(X((Z#V/;)(_G2_,,+\OH/U.3Z=!C@\]30!^#7_!-CPCX[T[_@H1_P %
M$_$WQ)L#9^-[[58=/\17$\E[)-K.GR>.O$-W\/\ 4-/65FM;308_ D6E0Z?#
M!O+AFE!50R5^\BJ?09ZYY(P3T&>>1Q].U4X=)TVVOKW4[?3M/@U+4H[:/4=2
MALX(K_4([-72SCO;N.-;B[2U21UMEGE=8%=A$%#'/ ?%[XO_  _^!/P^UWXG
M?$_7XO#OA'PY%$UU>-!-=WE]>W4J6NF:/HVF6BS7VL:YK%]-#8Z3I-A;RWE_
M=RI%%'RQ !UGBS3UU;PKXFTHOY*ZIX>UK3S*%+^6+S3;FW,FQEVN$$N\*1@X
MQ@YQ7YY?\$@KQ;C_ ()X_L]Z:'#2^%K+QQX1N2HVQ^?X:^(_BW2Y @W2 QL(
M5=<' #8P,8K2TS]H+]MWXV-'J/P/_97\,?"GP)<R1?V?XU_:K\6:EH6OZSI=
MS$9(]3L/A7X(L]1\0:<CQ-"Z6_B#5=/G8N8Y(%PQ'PE_P37^%'[:T/PS^,'@
MSPS^TY\._A[HGPU_:G^.G@^\\)6?P0L?%=JE\_BI->U.]T?7-6\06UY:Z5<W
M>KW#Z5ILUGYEE"2MTSR.&H _H& P3T5B?O#K[ @_>XZ$@#TYP*=R!U!QR>23
MG\!P,]>/QXKYA\*?"G]HS3BK^*OVI[CQ'(UN$FAL_@[X'T:W%QYI=I[=EFNI
MHU$8$*Q.TH +,[.Y4CW'P?X?UKP]IKV>O^,M6\;:C-.]PVK:O8Z/ITD:,JA;
M6TL]%LK&VBMX]I8"03SEF)>9AM"@'5%U+,H*[EV%U.25R3M) '&2#ALG..GH
M_L<K@'/0D=?7'/XGGGIS2\KW49ZG;R..!UZ YQGH.*,-P 0![#(//3)/?G/Z
M=Z /%-*_:#^%6K?'#Q7^SA!XA>T^,/A'PEH_CR]\):C97EE-J/@K6BL$'BCP
M_=RQBRUG2;6_8Z7J,UK,9+'4U:VGB# $^T ]!D< G W+D8R#CH/PSGVJA_9>
ME'4QK(TZP.M"S_LT:L;*V;4QIXF-Q]@^WA!=?81.?.^R^;Y'F_O?+W_-5_YN
M0""PZG/.X@G"G/ XZ8QUZ"@!Y)XVXX(S\Q(Q_G\A^ *<8;@ #@\\#C/IU&?3
MCI3(]PS]P=,^O.2!CC!&?<GUXJ0;N0=GK\N2?3D''OSGVYH ,$XR 2.<\YP>
MF"02/?G)QVI<>P/U8G'N,C@^_6@@G^+&/;^?/^12?,?XNF#D#J".X/3GI@T
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M/RQIMA#>F^-R7,YG<(L8MQ"@B$?)+&:7?P-JX)/6;1[]3QDX.?7GK[__ *J
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(?\_G[T ?_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
